syndrome	score	normalized_score
DRAVET SYNDROME	2.7202119000000002	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52074085	55.90523480909704
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	1.34778266	49.5469731604365
MYOCLONIC-ASTASTIC EPILEPSY	1.220712254	44.87563097566038
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.193694	43.88239019173469
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	42.353915884273576
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	1.0909091	40.10382794075711
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	1.066415079	39.20338261147964
HYPERLIPOPROTEINEMIA, TYPE I	1.0232558	37.616768017226896
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0232558	37.616768017226896
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.00270409	36.86124930193857
EHLERS-DANLOS SYNDROME, TYPE I	1.00163132	36.82181230072554
PITUITARY DERMOID AND EPIDERMOID CYSTS	1.000541419	36.78174553239767
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	36.78174553239767
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	36.761841972678674
DYSTROPHIC EPIDERMOLYSIS BULLOSA	1.0	36.761841972678674
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	1.0	36.761841972678674
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	34.35176355194975
LAFORA DISEASE	0.82300606	30.2552187202769
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.329304051643916
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.76597865	28.158786085745746
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	27.519141578639516
EARLY MYOCLONIC ENCEPHALOPATHY	0.7307892039999999	26.865157232787627
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.705447414	25.933546353502823
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.7029457100000001	25.84157910639241
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.6271692	23.055895020531302
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.6271692	23.055895020531302
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.6198357000000001	22.786302052424666
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.610695934	22.450307419065403
BILATERAL POLYMICROGYRIA	0.606829964	22.308187240854284
ROLANDIC EPILEPSY	0.5906213	21.71232689629804
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5564516399999999	20.45618725511788
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5348101000000001	19.660604381592478
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.374483289334922
MEDULLOBLASTOMA	0.519029304	19.0804732528374
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.518324164	19.05455100758878
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	18.639807067971432
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.380920986339337
INHALATIONAL ANTHRAX	0.5	18.380920986339337
PAROXYSMAL HEMICRANIA	0.5	18.380920986339337
CREST SYNDROME	0.5	18.380920986339337
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.380920986339337
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.48410971	17.7967646564593
SPINOCEREBELLAR ATAXIA TYPE 10	0.44863225999999995	16.492548245965686
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43961312	16.160988046556227
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.434614804	15.977240743634713
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.429205304	15.77837755948351
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.426914	15.694145003924142
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.41931105	15.414646557497965
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.39879430399999993	14.660413183252373
GLOMUVENOUS MALFORMATION	0.392857	14.442146951860623
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.385930204	14.187505171931642
PLACENTAL INSUFFICIENCY	0.3768113	13.852277464119615
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.36507529	13.420840119109837
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.401893800993959
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.14300771936186
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.14300771936186
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.039458433366901
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34912821	12.834596084224174
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.348076944	12.795949609660923
COG4-CDG	0.344567104	12.666921426231536
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.512821151910996
SPINOCEREBELLAR ATAXIA TYPE 42	0.33846121	12.44245751590161
ACITRETIN/ETRETINATE EMBRYOPATHY	0.33496432	12.313905398325769
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.2539350702789
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.2539350702789
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.333333	12.2539350702789
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.2539350702789
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.31587301	11.61207367705435
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.31332961400000003	11.518573755228408
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.304116984	11.179900507015647
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.29943673000000004	11.007845749075651
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.29653465	10.901159942723579
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.2630543	9.670360606833608
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.39742797243112
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25512821	9.378982938792378
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.254187719	9.344408757273651
PALLISTER-HALL SYNDROME	0.250545554	9.21051606310523
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.250545554	9.21051606310523
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.250168973	9.196672251893318
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.190460493169669
HYPERPARATHYROIDISM 2	0.25	9.190460493169669
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	9.190460493169669
HYPEREKPLEXIA 1; HKPX1	0.25	9.190460493169669
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.190460493169669
SEVERE HEMOPHILIA A	0.25	9.190460493169669
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	9.190460493169669
DYSTONIA 6, TORSION	0.25	9.190460493169669
CONGENITAL FACTOR II DEFICIENCY	0.25	9.190460493169669
HEMOPHILIA B	0.25	9.190460493169669
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	9.190460493169669
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	9.190460493169669
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.24651401	9.06230907967133
TRICHOTHIODYSTROPHY	0.24434208400000001	8.982465079282978
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515400000004	8.934787543573353
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.549749745598861
UNILATERAL POLYMICROGYRIA	0.23245135999999997	8.545340162654238
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.22747180399999997	8.362282511888134
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.305571709321615
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.22536641400000001	8.284884497417279
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.22463191000000002	8.257882777440978
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.22332433	8.20981372811434
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.222851819	8.192443353401991
CONGENITAL MYASTHENIC SYNDROME	0.222851819	8.192443353401991
JUVENILE MYOCLONIC EPILEPSY	0.2214368	8.140424648535651
CLEFT VELUM	0.2208333	8.118238876905142
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.21415611399999995	7.872773220350957
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.20952369999999998	7.702477148930933
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.20952369999999998	7.702477148930933
AUTOIMMUNE HYPOPARATHYROIDISM	0.20952369999999998	7.702477148930933
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.20952369999999998	7.702477148930933
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.20952369999999998	7.702477148930933
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.20657895	7.594222714781888
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.206135503	7.577920786244629
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.543099859242582
ADNP SYNDROME	0.204591729	7.521168810415099
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.202661814	7.450221580164397
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.20216920000000002	7.43211218214287
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.20216920000000002	7.43211218214287
ROMANO-WARD SYNDROME	0.200541419	7.372271954254741
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.352368394535734
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.2	7.352368394535734
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.352368394535734
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.2	7.352368394535734
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.2	7.352368394535734
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.186788954	6.866706009189945
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.664400446156418
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.664400446156418
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.17511509999999997	6.437553633229822
WRINKLY SKIN SYNDROME	0.16843297399999999	6.191906373176295
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.16341620399999998	6.007480667223019
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.1611447	5.923975996134712
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15970406399999998	5.87101556316256
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.863723337141493
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.863723337141493
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.157487054	5.789514191890712
DE BARSY SYNDROME	0.15693867399999997	5.769354732989734
EHLERS-DANLOS SYNDROME, TYPE VI	0.15603913999999997	5.736286206232681
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.15281849	5.617889179883376
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.15220579	5.595365199306715
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.457416754922659
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14829852	5.451726757022127
FREE SIALIC ACID STORAGE DISEASE	0.146648063	5.391052917605426
PHACE SYNDROME	0.145170963	5.336752000827582
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.145170963	5.336752000827582
COMBINED SAPOSIN DEFICIENCY	0.1450262	5.331430246298091
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.143881114	5.289334775720965
FAMILIAL MULTIPLE NEVI FLAMMEI	0.14339841899999997	5.271590018409961
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.14339841899999997	5.271590018409961
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.14285699999999998	5.251686458690956
RESTRICTIVE DERMOPATHY, LETHAL	0.14285699999999998	5.251686458690956
GANGLIONEUROMA	0.14285699999999998	5.251686458690956
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	5.251686458690956
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.14285699999999998	5.251686458690956
CONGENITAL FACTOR XIII DEFICIENCY	0.14285699999999998	5.251686458690956
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.14285699999999998	5.251686458690956
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	5.251686458690956
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.251686458690956
HEREDITARY THROMBOPHILIA DUE TO CONGENITAL ANTITHROMBIN DEFICIENCY	0.14285699999999998	5.251686458690956
FAMILIAL ISOLATED HYPERPARATHYROIDISM	0.14285699999999998	5.251686458690956
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.14285699999999998	5.251686458690956
SCHINZEL-GIEDION SYNDROME	0.14162570000000002	5.206421602669998
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.057205433150262
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.1365903	5.021311023600771
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.870161034145905
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.1316284	4.838902439916537
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.128791063	4.734596705499303
NIEMANN-PICK DISEASE, TYPE C2	0.128791063	4.734596705499303
LATHOSTEROLOSIS	0.128399729	4.720210546832766
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12752317999999999	4.687986991013457
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.127018519	4.669434723081682
ANEMIA, SIDEROBLASTIC, AND SPINOCEREBELLAR ATAXIA	0.12649583	4.6502197126628255
NON-DISTAL MONOSOMY 20Q	0.12376703900000001	4.549904329144358
SPINOCEREBELLAR ATAXIA 13	0.12121729999999999	4.4561712269547815
SPINOCEREBELLAR ATAXIA TYPE 37	0.1211226	4.452689880519969
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.120915814	4.445088046265807
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.12036106	4.424694267384096
CEREBELLAR ATAXIA, CAYMAN TYPE	0.119758264	4.402534376090332
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.11974118999999998	4.40190670440049
PAPILLARY TUMOR OF THE PINEAL REGION	0.1185898	4.359579487171569
PINEOCYTOMA	0.1185898	4.359579487171569
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.343531105058396
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.11270772899999999	4.143343722597493
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.11195645	4.115725322722101
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.1114059	4.095486090624043
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.1070381	3.9349177172557765
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000002	3.924652487550695
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.10633090400000002	3.9089198896600665
AICARDI SYNDROME; AIC	0.10491369	3.8568204925505984
EPISODIC ATAXIA, TYPE 1; EA1	0.1045184	3.842288904037218
NOONAN SYNDROME 7; NS7	0.103573389	3.8075485589927753
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.1029573	3.7848999925336697
%600223 SPINOCEREBELLAR ATAXIA 4; SCA4;;SPINOCEREBELLAR ATAXIA, AUTOSOMAL DOMINANT, WITH SENSORY AXONAL NEUROPATHY	0.1028139	3.779628344394787
8Q24.3 MICRODELETION SYNDROME	0.10236869300000002	3.763261715015658
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.102084794	3.752825064841456
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10179004400000001	3.741989511920009
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.10152670000000001	3.732308501407556
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.10108697300000001	3.716143326922436
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.10054555400000001	3.69623976720343
THYROCEREBRORENAL SYNDROME	0.100541419	3.696087756986873
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.10025636	3.685608463075983
PSEUDOAMINOPTERIN SYNDROME	0.09993327400000002	3.6737312266003985
17Q23.1Q23.2 MICRODELETION SYNDROME	0.09951041	3.6581859670564634
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.09912173399999999	3.64389752136589
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.09902601300000001	3.640378641090424
CONGENITAL ANALBUMINEMIA	0.0989922	3.639135612927801
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310399999999	3.6376983719540372
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.098393854	3.617139311830817
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.098393854	3.617139311830817
PRADER-WILLI SYNDROME	0.09829781900000001	3.6136088883369712
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.6071399437668807
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.6071399437668807
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.6071399437668807
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.6071399437668807
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.6071399437668807
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.09775640000000001	3.593705328617965
ALSTROM SYNDROME; ALMS	0.096727054	3.555864673630756
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.09601120399999999	3.5295487090546143
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.09532895400000001	3.5044679423687546
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.09515970300000001	3.4982459638530368
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.09468210400000002	3.4806885448887277
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.09450785	3.4742826468776205
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.09446700000000001	3.4727809256330366
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.094365144	3.4690365114570665
MARINESCO-SJÖGREN SYNDROME	0.094158744	3.461448867273906
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0930783	3.4217297556855772
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.092920609	3.4159327440630634
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.09290085000000001	3.415206366827525
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.09213609	3.3870923805604995
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.09184856	3.3765222481380945
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.09145051900000001	3.3618895277974485
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.09145051900000001	3.3618895277974485
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.09141455400000002	3.3605673881509013
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.09137276000000001	3.359030963727495
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.091167254	3.3514761846310575
POSTAXIAL TETRAMELIC OLIGODACTYLY	0.0909091	3.3419859680784425
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.0909091	3.3419859680784425
CORNEODERMATOOSSEOUS SYNDROME	0.0909091	3.3419859680784425
TENDONS, EXTENSOR, OF FINGERS, ANOMALOUS INSERTION OF	0.0909091	3.3419859680784425
RARE CIRCULATORY SYSTEM DISEASE	0.0909091	3.3419859680784425
KUFOR-RAKEB SYNDROME	0.0909091	3.3419859680784425
TRISOMY 18P	0.0909091	3.3419859680784425
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0909091	3.3419859680784425
SPINOCEREBELLAR ATAXIA TYPE 12	0.0909091	3.3419859680784425
SAGLIKER SYNDROME	0.0909091	3.3419859680784425
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.09025541000000001	3.3179551195993224
AICARDI SYNDROME	0.09017920999999998	3.315153867241003
SLC35A2-CDG	0.089845904	3.3029009247404586
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.089369319	3.2853807822839096
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08915431	3.2774766554032055
AMISH INFANTILE EPILEPSY SYNDROME	0.08873365	3.262012418958978
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.08825747	3.2445071650484283
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.08662845999999999	3.184621756856515
WILLIAMS SYNDROME	0.08443729000000001	3.1040703115812414
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.08428160000000001	3.098346860404515
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.08396535000000001	3.086720927880655
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.08331235399999999	3.062715592119863
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.08226293900000001	3.024137163726105
DERMATOMYOSITIS	0.08219867	3.021774516904363
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.081429344	2.99349267606689
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.08111081900000001	2.981783110352543
DDOST-CDG	0.08103594900000001	2.9790307512440486
TRISOMY 8P	0.08103594900000001	2.9790307512440486
BECKWITH-WIEDEMANN SYNDROME	0.08097168	2.9766681044223064
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.08035600999999999	2.954034941174987
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.08022400400000002	2.949182157463542
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.07978141000000001	2.932911586777486
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.079545804	2.9242502762376708
HSD10 DISEASE	0.07948717300000001	2.922094892680971
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.07937742900000001	2.9180605010955216
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.079209069	2.9118712773810005
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.07896718300000001	2.902979102473598
ETHYLMALONIC ENCEPHALOPATHY	0.078941619	2.902039322745408
NEUROFIBROMATOSIS TYPE 1	0.078941619	2.902039322745408
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.078421629	2.882923532538035
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.07837885	2.8813508977002855
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.07788021	2.8630199728190293
PEDIATRIC-ONSET GRAVES DISEASE	0.07746865400000001	2.847890416184122
N SYNDROME	0.07746865400000001	2.847890416184122
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.847890416184122
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.07746865400000001	2.847890416184122
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.07692310000000001	2.827834846248559
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.07692310000000001	2.827834846248559
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	2.827834846248559
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.827834846248559
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.827834846248559
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.827834846248559
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.07692310000000001	2.827834846248559
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.827834846248559
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.827834846248559
DERMOODONTODYSPLASIA	0.07692310000000001	2.827834846248559
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.07647713	2.811440167584003
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8052630752773338
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.076018599	2.794583723422429
GRISCELLI SYNDROME	0.075219663	2.7652133644441452
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.07501014	2.7575109130285034
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.074483139	2.7381373855470597
JUVENILE ABSENCE EPILEPSY	0.07412774999999999	2.725072631290231
NIEMANN-PICK DISEASE TYPE B	0.07412250000000001	2.724879631619875
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0735978	2.70559069313681
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.07305992000000001	2.6858172335765462
KENNEDY DISEASE	0.07265559	2.670953318011733
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07265559	2.670953318011733
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.6658060351842443
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.072369839	2.660448584906198
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0723447	2.6595244289608466
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.072287404	2.65741812246318
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.07197415400000001	2.6459024754652387
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.6459024754652387
3MC SYNDROME 2	0.07197415400000001	2.6459024754652387
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.6459024754652387
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.07197415400000001	2.6459024754652387
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.07197415400000001	2.6459024754652387
GM2 GANGLIOSIDOSIS, AB VARIANT	0.07197001900000001	2.645750465248682
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.071920273	2.6439217106579087
3MC SYNDROME 3	0.07142860000000001	2.625846905529676
3MC SYNDROME 1	0.07142860000000001	2.625846905529676
STIFF SKIN SYNDROME	0.07142860000000001	2.625846905529676
HYPOALPHALIPOPROTEINEMIA	0.07142860000000001	2.625846905529676
3MC SYNDROME	0.07142860000000001	2.625846905529676
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07142860000000001	2.625846905529676
ADULT-ONSET STILL DISEASE	0.07142860000000001	2.625846905529676
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.625846905529676
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 6; FPLD6	0.07142860000000001	2.625846905529676
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.07142860000000001	2.625846905529676
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHORYLASE KINASE DEFICIENCY	0.07142860000000001	2.625846905529676
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.625846905529676
PRIMARY BILIARY CHOLANGITIS	0.07142860000000001	2.625846905529676
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.071410574	2.6251842365662763
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.07123096000000001	2.618581295082196
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.071001303	2.6101386807402758
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.06878306000000001	2.5285919821172755
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5253069439185967
PONTINE TEGMENTAL CAP DYSPLASIA	0.068658623	2.524017448787721
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.0683405	2.5123226613338465
SPINOCEREBELLAR ATAXIA TYPE 26	0.0683405	2.5123226613338465
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.06789368999999999	2.495897102722034
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.06789368999999999	2.495897102722034
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.067732664	2.4899774903565413
CHRISTIANSON SYNDROME	0.0677057	2.48898624404959
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.067378873	2.4769714815231856
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.067212254	2.4708462601755397
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.470694249958983
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.066876204	2.4584924431806208
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.066856414	2.457764926327982
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.4507906902399768
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.4507906902399768
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.4507906902399768
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.4507906902399768
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.4507906902399768
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.4507906902399768
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0662919	2.437012351868617
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.06565660000000001	2.413657553663375
SPINOCEREBELLAR ATAXIA 5; SCA5	0.064820114	2.3829067875190164
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.3827114350907737
WILLIAMS-BEUREN SYNDROME; WBS	0.06428032	2.363062965793216
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.063748	2.3434939020743197
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0627413	2.3064857557604244
FABRY DISEASE	0.062258719000000004	2.288745189299407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.062165750000000006	2.285327477613049
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.062061939999999996	2.2815112307978653
SPINOCEREBELLAR ATAXIA 1	0.06197244	2.27822104594131
WHITE-SUTTON SYNDROME; WHSUS	0.061841784000000004	2.2734178907165283
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.061511063000000005	2.261259977577482
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.061387573	2.2567202577122756
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06109523	2.245973190544457
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0607197	2.232168016028457
GIANT CELL ARTERITIS	0.0603006	2.2167611280577075
SPINOCEREBELLAR ATAXIA TYPE 34	0.060291899999999995	2.2164413000325447
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.060277554000000004	2.2159139146476052
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0600359	2.20703026848754
DYSTONIA-APHONIA SYNDROME	0.059910473	2.202419340934432
LYSINURIC PROTEIN INTOLERANCE	0.059889200000000004	2.2016373062701473
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.059871714	2.2009944887014132
MACHADO-JOSEPH DISEASE TYPE 2	0.0597517	2.196582552998904
MACHADO-JOSEPH DISEASE TYPE 1	0.0597517	2.196582552998904
MACHADO-JOSEPH DISEASE TYPE 3	0.0597517	2.196582552998904
15Q OVERGROWTH SYNDROME	0.059708969	2.19501168272957
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.1911594460710946
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05960418000000001	2.1911594460710946
EMANUEL SYNDROME	0.059459202999999995	2.1858298245074215
7Q11.23 MICRODUPLICATION SYNDROME	0.059259468999999995	2.17848723476285
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.059210599999999995	2.1766907203074877
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.1736185331738307
GITELMAN SYNDROME	0.059127030000000004	2.1736185331738307
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.058852919000000004	2.163541707908858
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0588235	2.1624602112798637
MYASTHENIA GRAVIS; MG	0.0588235	2.1624602112798637
CLEFT LIP AND ALVEOLUS	0.0588235	2.1624602112798637
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.0588235	2.1624602112798637
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0588235	2.1624602112798637
OROMANDIBULAR DYSTONIA	0.0588235	2.1624602112798637
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.0588235	2.1624602112798637
CITRULLINEMIA TYPE II	0.058806973000000005	2.1618526483175815
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.058323464	2.144077966867213
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.05812102399999999	2.136635899578264
ANGELMAN SYNDROME	0.057780872999999996	2.124131322269416
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1240223969316507
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.05772	2.121893518663013
DYSBETALIPOPROTEINEMIA	0.05772	2.121893518663013
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.05772	2.121893518663013
NIEMANN-PICK DISEASE, TYPE B	0.05772	2.121893518663013
LECITHIN:CHOLESTEROL ACYLTRANSFERASE DEFICIENCY	0.05772	2.121893518663013
FISH-EYE DISEASE	0.05772	2.121893518663013
ATHEROSCLEROSIS SUSCEPTIBILITY	0.05772	2.121893518663013
AUTOSOMAL SEMI-DOMINANT SEVERE LIPODYSTROPHIC LAMINOPATHY	0.05772	2.121893518663013
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.057486689	2.1133165765505253
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.1075343431884845
DOORS SYNDROME	0.05707942399999999	2.0983447649795215
MEIER-GORLIN SYNDROME 1; MGORS1	0.056680180000000004	2.083667820142982
EPISODIC ATAXIA, TYPE 6	0.056292618999999995	2.0694203639062088
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.056224779	2.066926440546782
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.056031329	2.0598148622171677
WILSON DISEASE	0.056005400000000004	2.058861664416658
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.055861654	2.0535772966804533
SPINOCEREBELLAR ATAXIA 26	0.055651110000000004	2.0458373114241577
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.042326187897347
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.042326187897347
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.042326187897347
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.042326187897347
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.042326187897347
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.042326187897347
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.042326187897347
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.042326187897347
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.042326187897347
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.042326187897347
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.055135553000000004	2.0268844864622495
TEMPLE SYNDROME	0.054048580000000006	1.986925356807681
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.05385859	1.9799409744512917
XQ12-Q13.3 DUPLICATION SYNDROME	0.05378426999999999	1.9772088343558818
EPISODIC ATAXIA, TYPE 2	0.053571499999999994	1.969387017239355
ERYTHERMALGIA, PRIMARY	0.05307093	1.9509851420030917
SPINOCEREBELLAR ATAXIA 18	0.053010949999999994	1.9487801667215703
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.052944093	1.946322380252803
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.052718293	1.938021556335372
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9348345619692346
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	1.9348345619692346
KNIEST-LIKE DYSPLASIA, LETHAL	0.0526316	1.9348345619692346
LETHAL KNIEST-LIKE DYSPLASIA	0.0526316	1.9348345619692346
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	1.9348345619692346
MECKEL SYNDROME, TYPE 1; MKS1	0.0526316	1.9348345619692346
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9348345619692346
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.05161315	1.89739446401216
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.05161315	1.89739446401216
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.051563309	1.8955622170464
CHROMOSOME 17Q12 DELETION SYNDROME	0.05138562	1.8890300421081165
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.05137010999999999	1.8884598659391196
16P13.2 MICRODELETION SYNDROME	0.051332073	1.8870615557560053
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.8815122086628617
ADRENOLEUKODYSTROPHY	0.051064319000000004	1.877218425520453
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.050545554	1.8581476685694962
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.050541419000000004	1.8579956583529393
NEUROLEPTIC MALIGNANT SYNDROME	0.05	1.8380920986339335
IMMUNE DYSREGULATION-POLYENDOCRINOPATHY-ENTEROPATHY-X-LINKED SYNDROME	0.05	1.8380920986339335
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.049932963	1.835627695033611
XP22.13P22.2 DUPLICATION SYNDROME	0.049886718999999996	1.8339276804134264
ALG13-CDG	0.049802	1.830813253923343
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.04975873399999999	1.8292227160685528
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.049627554000000004	1.8244002976385774
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.049585960000000005	1.822871225583566
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.049556132999999995	1.8217747301230465
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.049335500000000004	1.8136638546430888
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.049114434	1.8055370612855564
COG5-CDG	0.049108719	1.8053269673586825
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.804155551264223
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.04907410999999999	1.8040546767698495
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.04906420399999999	1.8036905139632682
LISSENCEPHALY, X-LINKED, 2	0.04893869900000001	1.7990767189864878
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.04893246	1.79884736185442
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.04884065	1.7954722571429085
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.048708949999999994	1.7906307225551064
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.048705973	1.7905212825515542
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.04869111400000001	1.7899750383416821
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.048388319	1.7788437364015648
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.048388319	1.7788437364015648
DISTAL 17P13.1 MICRODELETION SYNDROME	0.04820264999999999	1.7720182019643391
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.048160419	1.7704657126159915
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.048160419	1.7704657126159915
HAMAMY SYNDROME; HMMS	0.04811831	1.7689177082123637
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.048022503	1.7653956664184873
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.047892103000000005	1.7606019222252502
SPINOCEREBELLAR ATAXIA 2; SCA2	0.04788794	1.7604488826771176
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.047643703999999995	1.7514703174410784
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.047619	1.7505621528969857
APOLIPOPROTEIN A-I DEFICIENCY	0.047619	1.7505621528969857
HYPERLIPOPROTEINEMIA, TYPE V	0.047619	1.7505621528969857
TANGIER DISEASE; TGD	0.047619	1.7505621528969857
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.047619	1.7505621528969857
FISH-EYE DISEASE	0.047619	1.7505621528969857
SPINOCEREBELLAR ATAXIA 42	0.047619	1.7505621528969857
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.047619	1.7505621528969857
HYPOALPHALIPOPROTEINEMIA, PRIMARY	0.047619	1.7505621528969857
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.047619	1.7505621528969857
TURNPENNY-FRY SYNDROME; TPFS	0.047499794	1.7461799207627904
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.04747941	1.7454305673760193
MENTAL RETARDATION, X-LINKED 98; MRX98	0.04745448299999999	1.744514204941166
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.0474338	1.7437538597636453
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.04731445	1.7393663339242063
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.04713263299999999	1.7326824061022594
SALT-AND-PEPPER SYNDROME	0.047118604	1.732166674221225
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.046734039000000005	1.7180293564630018
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.717063292017802
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.046506589999999993	1.7096679122681577
MALAN OVERGROWTH SYNDROME	0.046256699	1.7004814588157633
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.045832329000000005	1.684880835937818
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.045775053999999996	1.6827753014388325
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.04571528	1.6805778990967575
HALLERMANN-STREIFF SYNDROME; HSS	0.04550375	1.672801666664277
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.045467169	1.6714568817230744
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.045179024	1.6608641407678568
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.045062889999999994	1.6565948410122018
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04504809	1.6560507657510062
MICROHYDRANENCEPHALY; MHAC	0.04497356	1.6533109056687825
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.651544499161995
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.044913110000000006	1.6510886523215342
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.6338583769889397
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.044377319	1.6313919882491508
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.044202130000000006	1.6249517179157993
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04407925	1.6204344227741962
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.044023854	1.6183979637762778
FAMILIAL THROMBOCYTOSIS	0.044019719000000006	1.618245953559721
LASSA FEVER	0.044019719000000006	1.618245953559721
KEUTEL SYNDROME; KTLS	0.044019719000000006	1.618245953559721
VIRAL HEMORRHAGIC FEVER	0.044019719000000006	1.618245953559721
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.04401900300000001	1.6182196320808684
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.04398066299999999	1.6168101830596353
CHROMOSOME 1P36 DELETION SYNDROME	0.043823392999999995	1.6110286481725924
QAZI-MARKOUIZOS SYNDROME	0.043812239	1.6106186065872294
PGM3-CDG	0.043685219	1.6059491174198595
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.043631803999999996	1.6039854836308889
PRIMARY CILIARY DYSKINESIA	0.043478300000000004	1.598342393840715
HAND-FOOT-GENITAL SYNDROME	0.043478300000000004	1.598342393840715
FAMILIAL AFIBRINOGENEMIA	0.043478300000000004	1.598342393840715
GESTATIONAL CHORIOCARCINOMA	0.043478300000000004	1.598342393840715
YELLOW FEVER	0.043478300000000004	1.598342393840715
ASHERMAN SYNDROME	0.043478300000000004	1.598342393840715
HYDATIDIFORM MOLE	0.043478300000000004	1.598342393840715
PLACENTAL SITE TROPHOBLASTIC TUMOR	0.043478300000000004	1.598342393840715
GESTATIONAL TROPHOBLASTIC NEOPLASM	0.043478300000000004	1.598342393840715
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.043478300000000004	1.598342393840715
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.043478300000000004	1.598342393840715
WERNER SYNDROME	0.043478300000000004	1.598342393840715
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.04343510899999999	1.5967546131240729
49,XXXYY SYNDROME	0.04329801999999999	1.5917149689698804
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.043297969000000006	1.5917130941159403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.04324875399999999	1.589903860063254
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.043195624	1.5879507033992462
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.04316571	1.5868510096584756
EPISODIC ATAXIA, TYPE 8	0.043143799999999996	1.5860455577008536
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.04312171000000001	1.5852334886116777
PEHO SYNDROME	0.043055783999999986	1.5828099274177863
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.042985614	1.580230348966564
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.04289368999999999	1.576851053405067
49,XYYYY SYNDROME	0.04289368999999999	1.576851053405067
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.5718095343969345
HARTNUP DISORDER	0.04275367299999999	1.5717037705775785
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0423591	1.557198540304893
COG2-CDG	0.04221225399999999	1.5518002108585727
DISTAL MONOSOMY 12Q	0.04221225399999999	1.5518002108585727
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.042208118999999995	1.551648200642016
EPISODIC ATAXIA TYPE 3	0.042208118999999995	1.551648200642016
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.042208118999999995	1.551648200642016
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.551648200642016
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0422078	1.5516364736144266
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.0422078	1.5516364736144266
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0422078	1.5516364736144266
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0422078	1.5516364736144266
19P13.3 MICRODUPLICATION SYNDROME	0.04217420399999999	1.5504014227715124
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04216521	1.5500707867648102
3P25.3 MICRODELETION SYNDROME	0.04201393	1.5445094553111836
ZELLWEGER SYNDROME	0.04193561900000001	1.5416305987044614
GABRIELE-DE VRIES SYNDROME	0.04189021	1.5399612802223235
EPISODIC ATAXIA, TYPE 7; EA7	0.041666699999999994	1.5317446409230102
EPISODIC ATAXIA, TYPE 5	0.041666699999999994	1.5317446409230102
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.041666699999999994	1.5317446409230102
EPISODIC ATAXIA, TYPE 3	0.041666699999999994	1.5317446409230102
HISTIDINEMIA	0.041666699999999994	1.5317446409230102
EPISODIC ATAXIA TYPE 7	0.041666699999999994	1.5317446409230102
EPISODIC ATAXIA, TYPE 4	0.041666699999999994	1.5317446409230102
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.5317446409230102
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.04152505	1.5265373260075803
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.041469549999999994	1.5244970437780965
SPINOCEREBELLAR ATAXIA TYPE 6	0.04142321	1.5227935000210828
3Q13 MICRODELETION SYNDROME	0.04131981	1.5189923255611077
SHPRINTZEN OMPHALOCELE SYNDROME	0.04131981	1.5189923255611077
PITT-HOPKINS SYNDROME	0.041309859	1.5186265084716375
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.041085580000000003	1.5103815993158474
300270 ADRENOMYODYSTROPHY	0.040936193999999995	1.5048898947909166
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.040697983	1.4961328196527628
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.04056659399999999	1.4913027179978144
ACROCEPHALOPOLYDACTYLY	0.04009282	1.473885913079051
245800 LAURENCE-MOON SYNDROME	0.039938600000000005	1.4682165018100244
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.03988436	1.4662225395014261
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.03988436	1.4662225395014261
DEND SYNDROME	0.039841769	1.4646568158899678
16P13.11 MICRODELETION SYNDROME	0.03975175399999999	1.461347698684797
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.03974096	1.4609508913625442
VELOCARDIOFACIAL SYNDROME	0.03968849	1.4590219975142376
MACHADO-JOSEPH DISEASE; MJD	0.039514600000000004	1.4526294808136087
MOEBIUS SYNDROME; MBS	0.0393528	1.4466814147824292
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.443714734135234
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.03911958299999999	1.4381079282830866
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.039009459999999996	1.4340596039595295
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.039002919000000004	1.4338191447511865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.038970473	1.4326263700265407
LISSENCEPHALY 2; LIS2	0.038809543999999994	1.4267103235597194
9Q31.1Q31.3 MICRODELETION SYNDROME	0.038709709999999994	1.423040241828219
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.038709709999999994	1.423040241828219
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.038599784	1.4189991595875304
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4161139431821466
MYOCLONUS AND ATAXIA	0.0385141	1.4158492579199438
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0384747	1.41440084134622
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0384615	1.4139155850321807
WIDOW'S PEAK SYNDROME	0.0384615	1.4139155850321807
BAZEX SYNDROME; BZX	0.0384615	1.4139155850321807
MAL DE MELEDA	0.0384615	1.4139155850321807
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0384615	1.4139155850321807
DERMOCHONDROCORNEAL DYSTROPHY	0.0384615	1.4139155850321807
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4139155850321807
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0384615	1.4139155850321807
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.4139155850321807
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.4139155850321807
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4139155850321807
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4139155850321807
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4139155850321807
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.0384615	1.4139155850321807
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.0384615	1.4139155850321807
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4139155850321807
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4139155850321807
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0384615	1.4139155850321807
MUCOLIPIDOSIS III GAMMA	0.0384615	1.4139155850321807
MYCETOMA	0.0384615	1.4139155850321807
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0384615	1.4139155850321807
CYCLIC NEUTROPENIA	0.0384615	1.4139155850321807
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0384615	1.4139155850321807
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4139155850321807
BLACKFAN-DIAMOND ANEMIA	0.0384615	1.4139155850321807
LIP, HAMARTOMATOUS	0.0384615	1.4139155850321807
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4139155850321807
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4139155850321807
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4139155850321807
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.038424919	1.4125708000909782
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.038424919	1.4125708000909782
CANAVAN DISEASE	0.03826399	1.4066547536241567
CEREBROFACIOARTICULAR SYNDROME	0.038136774	1.4019780591357607
ALPERS-HUTTENLOCHER SYNDROME	0.038069694	1.3995120747762333
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.037927729	1.394293179880582
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.3926584175298988
YOU-HOOVER-FONG SYNDROME; YHFS	0.037736954	1.3872799394782442
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0376773	1.385086948557206
16P12.1P12.3 TRIPLICATION SYNDROME	0.03749473	1.378375339068254
PITT-HOPKINS-LIKE SYNDROME	0.037360629	1.373445539297876
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.037254763999999996	1.3695537468974381
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.037106214	1.3640927752723968
MCLEOD SYNDROME; MCLDS	0.037037	1.3615483411420999
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3615483411420999
DISTAL 16P11.2 MICRODELETION SYNDROME	0.037034723	1.361464634427928
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.3528825824194064
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.03678400399999999	1.3522477421703796
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.036587399	1.3450201802293416
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.03630668	1.3347004327126133
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.03629715000000001	1.3343500923586138
SLC39A8-CDG	0.036255719000000006	1.3328270124838437
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.036255719000000006	1.3328270124838437
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.036255719000000006	1.3328270124838437
OROFACIODIGITAL SYNDROME TYPE 14	0.036255343999999995	1.3328132267931037
PMM2-CDG	0.036134142999999994	1.328357654784173
THUMBS, CONGENITAL CLASPED	0.0361093	1.3274443803440457
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.03604598	1.3251166205103357
OCULODENTODIGITAL DYSPLASIA	0.035907939	1.3200419790825852
SPINOCEREBELLAR ATAXIA TYPE 13	0.035807283	1.3163416791169835
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3111570462580504
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3111570462580504
SPINOCEREBELLAR ATAXIA TYPE 23	0.03566016	1.3109331666404371
SPINOCEREBELLAR ATAXIA TYPE 35	0.03566016	1.3109331666404371
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.035569773	1.3076103740300524
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.035297193	1.2975898311451395
INHERITED CREUTZFELDT-JAKOB DISEASE	0.035118329000000004	1.2910144610425385
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.035028354	1.2877068143110466
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.034833333999999994	1.2805375198895348
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.28004917558077
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.03475615	1.2777000938787157
SPINOCEREBELLAR ATAXIA TYPE 1	0.03461275	1.2724284457398336
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.03461275	1.2724284457398336
SPINOCEREBELLAR ATAXIA 12	0.03461275	1.2724284457398336
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0344828	1.2676512443754842
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.03443497399999999	1.2658930725212985
MEIER-GORLIN SYNDROME 5; MGORS5	0.034427299999999994	1.265610962146
ISOTRETINOIN-LIKE SYNDROME	0.034427299999999994	1.265610962146
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.034313750000000004	1.261436654990003
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.034313750000000004	1.261436654990003
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.034299292999999995	1.2609051890406036
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.034276619	1.2600716510357153
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.034147369	1.2553201829607463
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.03403064399999999	1.251029156956485
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.034005933999999995	1.2501207718413403
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.033889419999999996	1.2458375025857358
9P13 MICRODELETION SYNDROME	0.033889419999999996	1.2458375025857358
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.033889419999999996	1.2458375025857358
HOLMES-GANG SYNDROME	0.03375787399999999	1.2410016293215977
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.033755623	1.2409188784153176
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.033485089999999995	1.2309735870209226
DENT DISEASE	0.033485089999999995	1.2309735870209226
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.033485089999999995	1.2309735870209226
RAMOS-ARROYO SYNDROME	0.03346038	1.2300652019057778
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.033369719	1.2267323365506928
GLYCOGEN STORAGE DISEASE VI	0.0333568	1.2262574103142476
EPILEPSY, PYRIDOXINE-DEPENDENT	0.033356234	1.2262366031116914
SPINOCEREBELLAR ATAXIA 34; SCA34	0.03330541	1.2243682192552718
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.033283113	1.2235485404648072
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0332372	1.2218606940143155
ANAL SPHINCTER DYSPLASIA; ASDP	0.032983229999999995	1.2125242890085142
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.032830709	1.2069173361089993
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2059227444744283
HYDROXYKYNURENINURIA	0.032803653999999995	1.2059227444744283
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2059227444744283
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2059227444744283
TUBEROUS SCLEROSIS-1	0.032799519	1.2057707342578714
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2057707342578714
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2057707342578714
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.032738010000000005	1.2035095501199742
SPINOCEREBELLAR ATAXIA TYPE 36	0.03271165	1.2025405079655744
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.032652640000000004	1.2003711916707664
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.032487842999999995	1.1943129503991947
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.1858671745388656
DYSTONIA, JUVENILE-ONSET	0.0322581	1.1858671745388656
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.1858671745388656
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.1858671745388656
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.1858671745388656
WEST SYNDROME	0.0322581	1.1858671745388656
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.1858671745388656
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.1858671745388656
ROWLEY-ROSENBERG SYNDROME	0.0322581	1.1858671745388656
SECKEL SYNDROME 2; SCKL2	0.0322581	1.1858671745388656
DESMOID TUMOR	0.0322581	1.1858671745388656
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	1.1858671745388656
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.1858671745388656
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.1858671745388656
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.1858671745388656
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.1858671745388656
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.1858671745388656
SECKEL SYNDROME	0.0322581	1.1858671745388656
THROMBOCYTOPENIA 1	0.0322581	1.1858671745388656
COG1-CDG	0.0322581	1.1858671745388656
INFANTILE MYOFIBROMATOSIS	0.0322581	1.1858671745388656
MILD CANAVAN DISEASE	0.0322581	1.1858671745388656
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.1858671745388656
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.03195515	1.1747301745132428
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.031842644	1.1705942467202646
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.031725763	1.166297485868656
15Q13.3 MICRODELETION SYNDROME	0.031723083	1.166198964132169
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.031529989999999994	1.1591005097801386
NARP SYNDROME	0.031389972999999995	1.15395322695265
SPINOCEREBELLAR ATAXIA 27; SCA27	0.03126091	1.1492086333421305
SPINOCEREBELLAR ATAXIA 15	0.03126091	1.1492086333421305
SPINOCEREBELLAR ATAXIA TYPE 27	0.03126091	1.1492086333421305
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1479587307150592
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.03111751	1.1439369852032482
HUNTINGTON DISEASE-LIKE 1	0.03096915	1.1384829983281817
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.1338976570170873
HUNTINGTON DISEASE-LIKE 3	0.030844418999999998	1.1338976570170873
2Q24 MICRODELETION SYNDROME	0.030676129	1.1277110066315055
8P INVERTED DUPLICATION/DELETION SYNDROME	0.030676128999999996	1.1277110066315053
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.030546779	1.1229558623723392
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.030439623	1.119016610433915
NORMAL PRESSURE HYDROCEPHALUS	0.030302999999999997	1.1139940972980817
CARIBBEAN PARKINSONISM	0.030302999999999997	1.1139940972980817
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.1139940972980817
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.1139940972980817
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03024371	1.1118144876875216
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.030213499999999997	1.1107039124415268
GLYCINE ENCEPHALOPATHY	0.030092559999999997	1.1062579352733513
CURRY-JONES SYNDROME	0.029957354	1.101287513667593
CURRARINO SYNDROME	0.029957354	1.101287513667593
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.029953219	1.1011355034510362
HUNTINGTON DISEASE-LIKE 1	0.029792479000000004	1.0952264049723481
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.0922300942805225
SPINOCEREBELLAR ATAXIA TYPE 3	0.0294487	1.0825884557008223
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0294118	1.0812319437320304
VARIANT ABETA2M AMYLOIDOSIS	0.0294118	1.0812319437320304
AL AMYLOIDOSIS	0.0294118	1.0812319437320304
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.029263249999999998	1.075770972106989
STICKLER SYNDROME, TYPE II	0.029263249999999998	1.075770972106989
MENINGIOMA	0.0292549	1.0754640107265172
SPINOCEREBELLAR ATAXIA TYPE 43	0.029081210000000003	1.0690788463942829
SPINOCEREBELLAR ATAXIA TYPE 14	0.029081210000000003	1.0690788463942829
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.029004790000000003	1.0662695064307306
OSTEOPENIA AND SPARSE HAIR	0.029004790000000003	1.0662695064307306
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.052270964625954
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.052270964625954
SPINOCEREBELLAR ATAXIA TYPE 29	0.028381714	1.0433640849817618
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.028381714	1.0433640849817618
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0412186638842362
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0412186638842362
MENKES DISEASE	0.028319219000000003	1.0410666536676794
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.02783616	1.023308515046199
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.02783616	1.023308515046199
SPINOCEREBELLAR ATAXIA TYPE 40	0.02783616	1.023308515046199
SPINOCEREBELLAR ATAXIA 44; SCA44	0.02783616	1.023308515046199
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0211630939486736
DIMPLES, FACIAL	0.027777800000000002	1.0211630939486736
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0211630939486736
OROFACIAL CLEFT 3	0.027777800000000002	1.0211630939486736
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0211630939486736
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0211630939486736
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0211630939486736
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0211630939486736
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0211630939486736
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0211630939486736
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0211630939486736
DWARFISM, LEVI TYPE	0.027777800000000002	1.0211630939486736
GANGLIOCYTOMA	0.027777800000000002	1.0211630939486736
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0211630939486736
CLEFT CHIN	0.027777800000000002	1.0211630939486736
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0211630939486736
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0211630939486736
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0211630939486736
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0211630939486736
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0211630939486736
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.0211630939486736
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	1.0211630939486736
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0211630939486736
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0211630939486736
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0211630939486736
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0211630939486736
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0211630939486736
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0211630939486736
19P13.13 MICRODELETION SYNDROME	0.027614793	1.015170656374233
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0136178729311491
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.027369249999999998	1.0061440434107356
ACUTE INTERMITTENT PORPHYRIA	0.027368649000000002	1.0061219495437101
TRISOMY 20P	0.02724851	1.0017054186109546
19P13.12 MICRODELETION SYNDROME	0.027201083	0.9999619147317164
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9935623029955863
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9935623029955863
BENIGN OCCIPITAL EPILEPSY	0.027027	0.9935623029955863
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9935623029955863
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.026954273	0.9908887245144394
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.026954273	0.9908887245144394
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.026954273	0.9908887245144394
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.02672351	0.982405451575298
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.026678254000000002	0.9807417576549827
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.026678254000000002	0.9807417576549827
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.026672583	0.9805332812491555
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.026511973	0.9746289618099236
HAREL-YOON SYNDROME; HAYOS	0.026159503999999997	0.9616715521316553
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026148954	0.9612837146988438
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.026132700000000002	0.9606861877194198
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.026132700000000002	0.9606861877194198
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.026132700000000002	0.9606861877194198
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.026132700000000002	0.9606861877194198
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.026132700000000002	0.9606861877194198
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.026124354	0.9603793733863158
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.025983473	0.955200328327363
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.025964123	0.9544889866851916
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.0258673	0.9509295948598709
GRISCELLI SYNDROME TYPE 1	0.025819873	0.9491860909806327
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02551296	0.937903403775272
KAGAMI-OGATA SYNDROME	0.025491703	0.9371219573004588
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.025477173000000002	0.9365878077365959
TETRASOMY 5P	0.025445593	0.9354268687670985
CK SYNDROME	0.025445593	0.9354268687670985
GABRIELE-DE VRIES SYNDROME; GADEVS	0.025442054	0.9352967686083572
SPINOCEREBELLAR ATAXIA TYPE 7	0.025422703999999997	0.9345854269661857
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.025024209000000002	0.9199360167492834
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.024935754	0.9166842480175901
COHEN-GIBSON SYNDROME; COGIS	0.024904173999999998	0.9155233090480928
LAMB-SHAFFER SYNDROME	0.024904173999999998	0.9155233090480928
TURNER SYNDROME	0.02488712	0.9148963725950907
MOSAIC MONOSOMY X	0.02488712	0.9148963725950907
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.02488712	0.9148963725950907
MONOSOMY X	0.02488712	0.9148963725950907
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.02488188	0.914703740543154
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.024778583	0.9109063525529022
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9091282190185257
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.024495709	0.9005073832667227
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.02448279	0.9000324570302776
SPINOCEREBELLAR ATAXIA TYPE 5	0.0243902	0.8966286780820274
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0243902	0.8966286780820274
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.0243902	0.8966286780820274
ORAL SENSIBILITY, DISTURBANCE OF	0.0243902	0.8966286780820274
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.024358619999999997	0.89546773911253
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.024357674	0.8954329624100239
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.024342773	0.8948851742027891
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.024233029	0.8908507826173393
KAGAMI-OGATA SYNDROME	0.023814273	0.8754565407202285
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.023814273	0.8754565407202285
MEND SYNDROME; MEND	0.023814273	0.8754565407202285
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.023814273	0.8754565407202285
CHROMOSOME 5Q12 DELETION SYNDROME	0.023814273	0.8754565407202285
INFANTILE LIVER FAILURE SYNDROME 1	0.023814273	0.8754565407202285
MEND SYNDROME	0.023814273	0.8754565407202285
GRISCELLI SYNDROME TYPE 2	0.023797219	0.8748296042672264
FAMILIAL MULTIPLE LIPOMATOSIS	0.023797219	0.8748296042672264
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.023794923	0.874745199078057
SPINOCEREBELLAR ATAXIA 46; SCA46	0.023755360000000003	0.8732907903240921
SPINOCEREBELLAR ATAXIA 23; SCA23	0.023755360000000003	0.8732907903240921
FRIEDREICH ATAXIA	0.023755360000000003	0.8732907903240921
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.023755360000000003	0.8732907903240921
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.023716803999999998	0.8718734007449932
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.02369301	0.8709986894770955
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.023636903000000004	0.8689360928095345
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.02361196	0.8680191421852099
SPINOCEREBELLAR ATAXIA 14	0.02361196	0.8680191421852099
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.02361196	0.8680191421852099
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.023551593	0.865799940070845
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.023468313999999997	0.8627384506332023
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.02344494	0.8618791793389331
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.023444749999999997	0.8618721945889581
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.023397373	0.8601305288018186
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.023343759999999998	0.8581596161681373
RETT SYNDROME; RTT	0.023325559000000003	0.8574905138823927
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.023272854	0.8555529810012227
CHROMOSOME 15Q25 DELETION SYNDROME	0.023272854	0.8555529810012227
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.023272854	0.8555529810012227
SWEENEY-COX SYNDROME; SWCOS	0.023272854	0.8555529810012227
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.023268719	0.8554009707846656
EDINBURGH MALFORMATION SYNDROME	0.023268719	0.8554009707846656
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0232558	0.8549260445482206
MICROTRIPLICATION 11Q24.1	0.0232558	0.8549260445482206
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.0232558	0.8549260445482206
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.0232558	0.8549260445482206
GLYCOGEN STORAGE DISEASE IA	0.0232558	0.8549260445482206
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.0232558	0.8549260445482206
PRIMARY LIPODYSTROPHY	0.0232558	0.8549260445482206
GLYCOGEN STORAGE DISEASE IB	0.0232558	0.8549260445482206
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.0232558	0.8549260445482206
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.0232558	0.8549260445482206
CHOLESTEROL-ESTER TRANSFER PROTEIN DEFICIENCY	0.0232558	0.8549260445482206
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.0232558	0.8549260445482206
AROMATASE DEFICIENCY	0.0232558	0.8549260445482206
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0232558	0.8549260445482206
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.0232558	0.8549260445482206
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.0232558	0.8549260445482206
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY	0.0232558	0.8549260445482206
HYPERLIPIDEMIA, FAMILIAL COMBINED, 3; FCHL3	0.0232558	0.8549260445482206
WOODHOUSE-SAKATI SYNDROME	0.0232558	0.8549260445482206
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.0232558	0.8549260445482206
WOODHOUSE-SAKATI SYNDROME	0.0232558	0.8549260445482206
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.023249369	0.8546896291424944
GAUCHER DISEASE	0.02305418	0.8475141219696891
COSTELLO SYNDROME; CSTLO	0.023010173999999998	0.8458963803518394
CHROMOSOME 16Q22 DELETION SYNDROME	0.023010173999999998	0.8458963803518394
RENPENNING SYNDROME 1; RENS1	0.023006039	0.8457443701352824
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.02297406	0.8445687631908382
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.022949303999999997	0.8436586870309624
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.0227273	0.83549741106566
SOTOS SYNDROME 2	0.0227273	0.83549741106566
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0227273	0.83549741106566
SPONDYLOOCULAR SYNDROME; SOS	0.0227273	0.83549741106566
FRONTOMETAPHYSEAL DYSPLASIA	0.0227273	0.83549741106566
ATAXIA WITH VITAMIN E DEFICIENCY	0.022707949999999998	0.8347860694234885
SPINOCEREBELLAR ATAXIA 40; SCA40	0.022707949999999998	0.8347860694234885
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.022707949999999998	0.8347860694234885
NEPHROSIALIDOSIS	0.02265578	0.8328682041277741
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02265578	0.8328682041277741
SPINAL ARACHNOIDITIS	0.02265578	0.8328682041277741
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02265578	0.8328682041277741
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02265578	0.8328682041277741
OCCIPITAL HORN SYNDROME	0.022605844	0.8310324647870262
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.022601709	0.8308804545704693
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8276268477466773
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8276268477466773
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8276268477466773
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8276268477466773
COSTELLO SYNDROME	0.022464619999999998	0.8258408104162765
XQ21 MICRODELETION SYNDROME	0.022344183	0.8214133244546131
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.022277173	0.818949913424024
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.02206029	0.8109768948514635
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.021920273	0.805829612023975
PRADER-WILLI SYNDROME; PWS	0.021920273	0.805829612023975
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.021750423	0.7995856131649156
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.021385449	0.7861684966527791
COFFIN-SIRIS SYNDROME 8; CSS8	0.021374719	0.7857740420884123
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.021374719	0.7857740420884123
X-LINKED ADRENOLEUKODYSTROPHY	0.02133178	0.7841955253559475
COFFIN-LOWRY SYNDROME	0.021307329	0.7832966615578734
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7825274200145951
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.02125721	0.7814541948000446
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.02125721	0.7814541948000446
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.02125721	0.7814541948000446
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.021251304	0.781237079361354
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.021209004	0.7796820534459098
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.021209004	0.7796820534459098
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.02112675	0.7766582448962891
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.02102928	0.7730750681592121
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.02102928	0.7730750681592121
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.02102928	0.7730750681592121
GRANULOMAS, CONGENITAL CEREBRAL	0.02102928	0.7730750681592121
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.02102928	0.7730750681592121
TRANSALDOLASE DEFICIENCY	0.0208333	0.7658704823694065
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.0208333	0.7658704823694065
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0208333	0.7658704823694065
CLEFT LIP/PALATE	0.0208333	0.7658704823694065
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0208333	0.7658704823694065
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.0208333	0.7658704823694065
RIBOFLAVIN DEFICIENCY	0.0208333	0.7658704823694065
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0208333	0.7658704823694065
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.0208333	0.7658704823694065
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7624718500790323
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7624718500790323
AYMÉ-GRIPP SYNDROME	0.020695764	0.7608144056718521
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.02066345	0.759626483510347
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.020604439999999998	0.7574571672155392
MULTIPLE SYSTEM ATROPHY	0.020604439999999998	0.7574571672155392
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020580274000000003	0.7565687805424276
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.02053611	0.7549452305535461
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.753589086203174
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.02024799	0.744353408644378
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.020080339	0.7381902490758164
SMITH-MAGENIS SYNDROME	0.020034973	0.7365225113528839
BAND HETEROTOPIA; BH	0.019954873	0.7335778878108724
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	0.7335778878108724
PITT-HOPKINS SYNDROME	0.019634413000000003	0.7217971879323078
BRAIN-LUNG-THYROID SYNDROME	0.019566554	0.7193025660978837
RIDDLE SYNDROME	0.019566554	0.7193025660978837
PERMANENT NEONATAL DIABETES MELLITUS	0.019551154	0.7187364337315044
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7135223178753096
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.7135223178753096
HHHH SYNDROME	0.019409319	0.7135223178753096
COHEN SYNDROME	0.019350103	0.7113454286410555
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.019294964	0.709318417436524
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.019259024	0.7079971968360258
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.019251964	0.7077376582316987
UROCANIC ACIDURIA	0.01921271	0.7062946088869032
MARINESCO-SJOGREN SYNDROME; MSS	0.019199064000000002	0.7057929567913441
FRAXE INTELLECTUAL DISABILITY	0.01917522	0.7049164074313474
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.019117253999999997	0.7027854704995591
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.019114734	0.7026928306577881
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.019021	0.6992469961623209
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.019016263999999998	0.6990728920787382
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.6936187581563039
TOE, MISSHAPEN	0.0188679	0.6936187581563039
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.6936187581563039
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.6936187581563039
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.6936187581563039
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.6936187581563039
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.6936187581563039
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.6936187581563039
VESICOURETERAL REFLUX 1	0.0188679	0.6936187581563039
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.6936187581563039
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.6936187581563039
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.6936187581563039
CARPAL DISPLACEMENT	0.0188679	0.6936187581563039
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.6936187581563039
VAN DEN BOSCH SYNDROME	0.0188679	0.6936187581563039
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.6936187581563039
THROMBOCYTOPENIA 3	0.0188679	0.6936187581563039
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.6936187581563039
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.6936187581563039
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.6936187581563039
KNUCKLE PADS	0.0188679	0.6936187581563039
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.6936187581563039
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.6936187581563039
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.6936187581563039
LETTERER-SIWE DISEASE	0.0188679	0.6936187581563039
MONOPHALANGY OF GREAT TOE	0.0188679	0.6936187581563039
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.6936187581563039
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.6936187581563039
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.6936187581563039
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.6936187581563039
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.6936187581563039
RAYNAUD DISEASE	0.0188679	0.6936187581563039
PUBIC BONE DYSPLASIA	0.0188679	0.6936187581563039
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.6936187581563039
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.6936187581563039
TRACHEOBRONCHOMEGALY	0.0188679	0.6936187581563039
SPINOCEREBELLAR ATAXIA 31	0.01865351	0.6857373868557813
ADULT-ONSET DYSTONIA-PARKINSONISM	0.018630873000000003	0.6849052090390458
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01853655	0.6814377218186568
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6814377218186568
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.01848375	0.6794966965624993
MOSAIC TRISOMY 15	0.01846839	0.678932034669799
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.018442963	0.6779972913139597
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.018409494000000002	0.6767669092249762
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.018292733999999998	0.6724745965562461
22Q11.2 DELETION SYNDROME	0.018101243	0.6654350346750559
TENORIO SYNDROME; TNORS	0.018085319000000002	0.6648496391034832
TRANSIENT NEONATAL DIABETES MELLITUS	0.018074054	0.6644355169536608
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.018046739	0.663431367240177
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.01794591	0.6597247074759138
AMISH LETHAL MICROCEPHALY	0.01784585	0.6560463175681277
X SMALL RINGS	0.017839934	0.6558288345110173
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017815584	0.6549336836589825
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.017717829000000004	0.6513400297969435
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.017578563999999998	0.6462203918746181
JUVENILE HUNTINGTON DISEASE	0.017574429	0.6460683816580612
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.0175439	0.6449460793844773
MYOPATHY, DISTAL 3	0.0175439	0.6449460793844773
PANDAS	0.0175439	0.6449460793844773
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0175439	0.6449460793844773
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.0175439	0.6449460793844773
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.0175439	0.6449460793844773
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.0175439	0.6449460793844773
DISTAL MYOPATHY, TATEYAMA TYPE	0.0175439	0.6449460793844773
DYSTONIA 7, TORSION	0.0175439	0.6449460793844773
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0175439	0.6449460793844773
EPISODIC ATAXIA TYPE 1	0.0175439	0.6449460793844773
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.0175439	0.6449460793844773
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.0175439	0.6449460793844773
TIBIAL MUSCULAR DYSTROPHY	0.0175439	0.6449460793844773
DISTAL MYOPATHY, WELANDER TYPE	0.0175439	0.6449460793844773
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.0175439	0.6449460793844773
MELAS	0.01736635	0.6384190143422281
ALCOHOL DEPENDENCE	0.0172414	0.6338256221877421
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6338256221877421
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6338256221877421
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6338256221877421
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6338256221877421
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6338256221877421
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6338256221877421
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6338256221877421
PALMOMENTAL REFLEX	0.0172414	0.6338256221877421
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6338256221877421
RHEUMATOID ARTHRITIS	0.0172414	0.6338256221877421
MOTION SICKNESS	0.0172414	0.6338256221877421
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6338256221877421
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6338256221877421
SICKLE CELL ANEMIA	0.0172414	0.6338256221877421
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6338256221877421
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6338256221877421
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6338256221877421
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6338256221877421
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6338256221877421
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6338256221877421
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6338256221877421
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6338256221877421
CERVICAL RIB	0.0172414	0.6338256221877421
TRANSSEXUALITY	0.0172414	0.6338256221877421
CARDIAC ARRHYTHMIA	0.0172414	0.6338256221877421
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6338256221877421
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6338256221877421
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6338256221877421
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6338256221877421
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6338256221877421
MYOPATHY, CONGENITAL	0.0172414	0.6338256221877421
DIASTEMATOMYELIA	0.0172414	0.6338256221877421
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6338256221877421
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6338256221877421
269800 SENILE PLAQUE FORMATION	0.0172414	0.6338256221877421
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6338256221877421
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6338256221877421
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6338256221877421
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6338256221877421
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6338256221877421
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6338256221877421
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6338256221877421
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6338256221877421
SPINOCEREBELLAR ATAXIA 20	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA TYPE 8	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA TYPE 28	0.017176410000000003	0.6314364700779378
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA 38; SCA38	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA 45; SCA45	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA TYPE 30	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA 43; SCA43	0.017176410000000003	0.6314364700779378
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.017176410000000003	0.6314364700779378
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.017176410000000003	0.6314364700779378
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.017176410000000003	0.6314364700779378
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.6311296557448337
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.017160279	0.6308434648050764
PYRIDOXINE-DEPENDENT EPILEPSY	0.017054724	0.6269630685756503
SPINOCEREBELLAR ATAXIA TYPE 21	0.017033009999999998	0.6261648219390554
SPINOCEREBELLAR ATAXIA TYPE 2	0.017033009999999998	0.6261648219390554
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.017033009999999998	0.6261648219390554
ARNOLD-CHIARI MALFORMATION TYPE I	0.017033009999999998	0.6261648219390554
SPINOCEREBELLAR ATAXIA TYPE 25	0.017033009999999998	0.6261648219390554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016948053999999997	0.6230416828924246
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.016877373	0.6204433191399538
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.016847064000000002	0.6193291044716038
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.016847064000000002	0.6193291044716038
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.016785239	0.6170563035916429
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.016653979	0.6122309442143091
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.016529213	0.6076443162387459
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.016413353999999998	0.6033851259896332
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.016402499999999997	0.6029861129568617
MYOCLONIC-ATONIC EPILEPSY	0.016402499999999997	0.6029861129568617
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.016387633	0.602439574652254
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016383764000000002	0.6022973430856619
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.016375264	0.601984867428894
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.016371073	0.6018307985491865
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.016301509999999998	0.599273534536041
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.599273534536041
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.599273534536041
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01629358	0.5989820131291976
PRIMARY DYSTONIA, DYT4 TYPE	0.016128999999999998	0.5929317491773342
OPTIC ATROPHY 2	0.016128999999999998	0.5929317491773342
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.016128999999999998	0.5929317491773342
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.016128999999999998	0.5929317491773342
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.016128999999999998	0.5929317491773342
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.01584163	0.5823674986496455
PEHO-LIKE SYNDROME; PEHOL	0.015840373999999997	0.5823213257761278
PROPIONIC ACIDEMIA	0.015749233	0.578970814736896
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.015721253999999997	0.5779422551603423
MONOSOMY 18Q	0.015705853	0.5773760860321211
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.015686153999999997	0.5766519145071013
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01567665	0.5763025299609931
MEHMO SYNDROME	0.015627429	0.5744930753372559
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.015536633	0.5711552471335045
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5687407661145809
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5687407661145809
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5687407661145809
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.015426633	0.5671114445165099
DESMOSTEROLOSIS	0.015294819999999999	0.5622657558405652
HYPERPROLINEMIA, TYPE I	0.015285363	0.5619180991010295
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.015175699999999999	0.5578866852247797
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.015171473	0.5577312929187611
N-ACETYLASPARTATE DEFICIENCY; NACED	0.015171473	0.5577312929187611
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.015053214	0.5533838742489141
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.014933024	0.5489654684622179
EPILEPSY, HOT WATER, 1	0.014925589999999999	0.548692180928993
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5486851961790181
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5486851961790181
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.014898164	0.5476839506510504
PERLMAN SYNDROME	0.014898164	0.5476839506510504
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.014835993	0.545398430173767
SMITH-MAGENIS SYNDROME; SMS	0.014759403	0.5425828406970795
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.014750472999999998	0.5422545574482635
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.014665172999999998	0.5391187723279939
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.014633832999999999	0.5379666562005702
JOUBERT SYNDROME 31; JBTS31	0.014630054	0.5378277331997554
ANGELMAN SYNDROME (TYPE 1)	0.014625919	0.5376757229831984
ANGELMAN SYNDROME (TYPE 2)	0.014625919	0.5376757229831984
KOOLEN-DE VRIES SYNDROME	0.014529813	0.5341426893985722
WITTEVEEN-KOLK SYNDROME	0.014529812999999999	0.5341426893985721
WARBURG MICRO SYNDROME 2; WARBM2	0.01444966	0.531196117478936
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.014417779	0.5300241131950051
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.014378569	0.5285826813712564
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5236413383824987
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.014218762999999999	0.5227079184529704
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.01421455	0.5225530408127396
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.014209053999999999	0.5223509977292577
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.014209053999999999	0.5223509977292577
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.014209053999999999	0.5223509977292577
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.014209053999999999	0.5223509977292577
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014209053999999999	0.5223509977292577
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.014209053999999999	0.5223509977292577
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.014166754	0.5207959718138134
DANDY-WALKER SYNDROME	0.0140845	0.5177721632641927
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.0140845	0.5177721632641927
EPISODIC ATAXIA TYPE 5	0.0140845	0.5177721632641927
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.0140845	0.5177721632641927
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.0140845	0.5177721632641927
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0140845	0.5177721632641927
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.014039414	0.5161147188570125
WIEDEMANN-STEINER SYNDROME; WDSTS	0.013968323	0.5135012827493328
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.013960649	0.5132191723740345
BANGSTAD SYNDROME	0.013923318999999998	0.5118468528131944
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.013869853	0.5098813441702831
YUNIS-VARON SYNDROME	0.01385902	0.5094831031361932
XQ28 (MECP2) DUPLICATION	0.013835193	0.5086071787275102
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.013756694000000002	0.5057214108944968
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5035857684469359
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5035857684469359
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5035857684469359
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5035857684469359
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.5035857684469359
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5035857684469359
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.5035857684469359
MEVALONIC ACIDURIA; MEVA	0.013677344	0.5028043587339648
RING CHROMOSOME 14 SYNDROME	0.013671174	0.5025775381689933
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671174	0.5025775381689933
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.013671174	0.5025775381689933
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.013663499999999999	0.502295427793695
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.01364756	0.5017094440326505
ADENYLOSUCCINASE DEFICIENCY	0.013622593	0.5007916111241186
SPINOCEREBELLAR ATAXIA 47; SCA47	0.013571979	0.4989309472545135
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.013516954	0.49690812689996683
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.013516954	0.49690812689996683
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.013516954	0.49690812689996683
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013516954	0.49690812689996683
KRABBE DISEASE	0.013451114	0.49448772722448564
STICKLER SYNDROME	0.01344284	0.4941835597440037
MOWAT-WILSON SYNDROME	0.013422769	0.4934457128137701
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.013328434	0.4899777844512775
INFANTILE DYSTONIA-PARKINSONISM	0.013328434	0.4899777844512775
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.013324299	0.4898257742347204
KOOLEN-DE VRIES SYNDROME; KDVS	0.013302823	0.48903627691651513
SCHAAF-YANG SYNDROME; SHFYNG	0.013279213	0.4881683298275402
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.013279213	0.4881683298275402
FUMARASE DEFICIENCY; FMRD	0.013266844	0.48771362260418016
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013257433	0.48736765690937534
MEHMO SYNDROME; MEHMO	0.013257433	0.48736765690937534
COFS SYNDROME	0.013224399	0.4861532662216498
PEHO SYNDROME; PEHO	0.013218483	0.4859357831645395
TEMPLE-BARAITSER SYNDROME	0.013151579	0.4834762688891994
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.013135173000000002	0.48287315410979564
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.013050323	0.47975391181841387
48,XXYY SYNDROME	0.013042393	0.47946239041157046
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.012991772999999998	0.4776015059709134
RAYNAUD-CLAES SYNDROME; MRXSRC	0.012991772999999998	0.4776015059709134
15Q26 OVERGROWTH SYNDROME	0.012987559999999999	0.4774466283306826
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.0129714	0.47685255696440404
NEONATAL ADRENOLEUKODYSTROPHY	0.012963699	0.4765694540193725
ALLAN-HERNDON-DUDLEY SYNDROME	0.012933090000000001	0.47544421079843086
DISTAL MONOSOMY 10Q	0.012816203	0.47114722937577025
LYSOSOMAL ACID LIPASE DEFICIENCY	0.012815754	0.4711307233087245
6Q TERMINAL DELETION SYNDROME	0.012794133000000001	0.4703358955234333
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.012794133000000001	0.4703358955234333
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.012794133000000001	0.4703358955234333
JABERI-ELAHI SYNDROME; JABELS	0.012794133000000001	0.4703358955234333
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.012794133000000001	0.4703358955234333
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.012761404	0.4691327171975095
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.012751133	0.4687551363186081
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.012737794	0.4682647701085345
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.01272129	0.46765805266861743
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01268503	0.4663250682786881
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.012665073	0.46559141219843936
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.012665073	0.46559141219843936
WHIM SYNDROME	0.012589619000000002	0.46281758417423297
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.012566093	0.46195272507998364
BIOTINIDASE DEFICIENCY	0.012508904000000001	0.45985035209940817
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.012494863	0.4593341790762697
SECONDARY SYRINGOMYELIA	0.012446218999999998	0.4575459360353506
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.012357074	0.4542688016326963
TEMPLE SYNDROME	0.0122702	0.45107515337316184
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.012268599	0.45101629766416357
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.012195779	0.4483393003317131
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.012177803	0.4476784694604122
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.012123654000000001	0.44568785247943365
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.012119519	0.4455358422628767
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.012048200000000002	0.4429140244552272
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.012048200000000002	0.4429140244552272
UNVERRICHT-LUNDBORG DISEASE	0.012048200000000002	0.4429140244552272
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.4426072101221232
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.4426072101221232
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.4426072101221232
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.4426072101221232
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.4426072101221232
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.4426072101221232
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.4426072101221232
WIEDEMANN-STEINER SYNDROME	0.012020539	0.44189715514442085
BOWEN-CONRADI SYNDROME	0.011997409	0.4410468537395929
21Q22.11Q22.12 MICRODELETION SYNDROME	0.011997408999999999	0.4410468537395928
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.011997408999999999	0.4410468537395928
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.011997408999999999	0.4410468537395928
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.011974014	0.440186810446642
WOLF-HIRSCHHORN SYNDROME	0.011958333	0.43961034800266846
MYOPATHY AND DIABETES MELLITUS	0.011904799999999998	0.437642376316345
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.011904799999999998	0.437642376316345
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.011904799999999998	0.437642376316345
SPINOCEREBELLAR ATAXIA TYPE 11	0.011904799999999998	0.437642376316345
SPINOCEREBELLAR ATAXIA TYPE 32	0.011904799999999998	0.437642376316345
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.011904799999999998	0.437642376316345
WOLFRAM-LIKE SYNDROME	0.011904799999999998	0.437642376316345
CEREBELLAR ATAXIA, BENIGN, WITH THERMOANALGESIA	0.011904799999999998	0.437642376316345
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.011904799999999998	0.437642376316345
PIERPONT SYNDROME	0.011890573	0.43711936559059966
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.011879924	0.43672788873543267
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.011873993000000001	0.4365098542506928
EMANUEL SYNDROME	0.011842473	0.43535112099171386
46,XX GONADAL DYSGENESIS	0.01180093	0.4338239237906429
ALG11-CDG	0.011775523	0.43288991567164303
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.011749349	0.43192771121985013
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.011736709	0.4314630415373155
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.011707160000000001	0.43037676586886486
SPINOCEREBELLAR ATAXIA 48; SCA48	0.011707160000000001	0.43037676586886486
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.011707160000000001	0.43037676586886486
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.011707160000000001	0.43037676586886486
SPINOCEREBELLAR ATAXIA TYPE 18	0.011707160000000001	0.43037676586886486
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.011700653	0.43013755656314856
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.011671503	0.429065948869645
AICARDI-GOUTIERES SYNDROME 5	0.011636384	0.4277749097414065
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.011602803	0.42654041032612194
VITAMIN E, FAMILIAL ISOLATED DEFICIENCY OF	0.011578100000000001	0.4256322825438709
HOLOPROSENCEPHALY	0.011565293	0.4251614736337268
1P36 DELETION SYNDROME	0.011565293	0.4251614736337268
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.011520259	0.4235059408423292
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4225516401865604
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4225516401865604
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4225516401865604
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.011466443	0.42152756555472753
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.011412779	0.4195547780671056
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.011345019	0.417063795655037
GLYCOGEN STORAGE DISEASE IXC	0.011327990000000001	0.41643777824808426
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.41643777824808426
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.41643777824808426
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.41643777824808426
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.011327990000000001	0.41643777824808426
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.011281914	0.41474393961735107
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.011277779	0.4145919294007941
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011277779	0.4145919294007941
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.011237353	0.41310579517720664
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.011229969	0.41283434573608024
XP21 MICRODELETION SYNDROME	0.011187973	0.4112904954205957
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.011187973	0.4112904954205957
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.011187973	0.4112904954205957
GLYCEROL KINASE DEFICIENCY; GKD	0.011187973	0.4112904954205957
ALSTRÖM SYNDROME	0.011187973	0.4112904954205957
9Q33.3Q34.11 MICRODELETION SYNDROME	0.011155099	0.4100819866275859
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.011130084	0.4091623891506393
COHEN SYNDROME	0.011041609	0.4059098851821066
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.011041608999999999	0.40590988518210647
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.011019739	0.40510590369816407
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.011019739	0.40510590369816407
BOHRING-OPITZ SYNDROME	0.010934773	0.40198239703311345
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.010920889	0.40147199561916475
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.010882023999999999	0.40004324663089663
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.01086884	0.3995585785063288
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.01083013	0.39813552760356646
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.010797684	0.3969427528789209
2P15P16.1 MICRODELETION SYNDROME	0.010797684	0.3969427528789209
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.01073636	0.3946883696817884
GAUCHER DISEASE TYPE 3	0.01073636	0.3946883696817884
MERRF	0.01073636	0.3946883696817884
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.010695934	0.3932022354582009
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.010691799	0.39305022524164385
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.010663582999999999	0.39201295310854267
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.010652934	0.3916214762533756
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.010652919	0.3916209248257461
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.010652919	0.3916209248257461
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.010647003	0.39140344176863573
RECURRENT ACUTE PANCREATITIS	0.010642419	0.39123492548503297
MARDEN-WALKER SYNDROME	0.010477694	0.38517933106608343
2Q32Q33 MICRODELETION SYNDROME	0.010477694	0.38517933106608343
1Q44 MICRODELETION SYNDROME	0.010446114000000001	0.3840183920965863
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.010396893	0.38220893747284906
2Q31.1 MICRODELETION SYNDROME	0.010396893	0.38220893747284906
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.010396892999999999	0.382208937472849
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.010393354	0.38207883731410774
RUBINSTEIN-TAYBI SYNDROME	0.010338303000000002	0.38005506115166987
JACOBSEN SYNDROME	0.010338303	0.3800550611516698
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.010336469999999999	0.37998767669533384
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.010323829999999999	0.37952300701279923
ALPHA-2-DEFICIENT COLLAGEN DISEASE	0.010323829999999999	0.37952300701279923
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010298423	0.3785889988937994
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.010298423	0.3785889988937994
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.010298423	0.3785889988937994
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.010298423	0.3785889988937994
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.010298423	0.3785889988937994
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.010298423	0.3785889988937994
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.010298423	0.3785889988937994
AICARDI-GOUTIERES SYNDROME 7	0.010298423	0.3785889988937994
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.010298423	0.3785889988937994
MONOSOMY 5P	0.01026572	0.3773867763757669
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010184083	0.37438564988264333
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.010150423	0.37314824628184295
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.010118028999999999	0.37195738317297994
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.010101	0.37133136576602727
ATYPICAL WERNER SYNDROME	0.010101	0.37133136576602727
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37133136576602727
H SYNDROME	0.010101	0.37133136576602727
MANDIBULOACRAL DYSPLASIA	0.010101	0.37133136576602727
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.010101	0.37133136576602727
NEUTRAL LIPID STORAGE MYOPATHY	0.010101	0.37133136576602727
AKT2-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37133136576602727
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.010101	0.37133136576602727
MICROCEPHALIC PRIMORDIAL DWARFISM-INSULIN RESISTANCE SYNDROME	0.010101	0.37133136576602727
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.010101	0.37133136576602727
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.010101	0.37133136576602727
HYPERCHOLESTEROLEMIA DUE TO CHOLESTEROL 7ALPHA-HYDROXYLASE DEFICIENCY	0.010101	0.37133136576602727
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.010101	0.37133136576602727
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.010101	0.37133136576602727
APOLIPOPROTEIN C-II DEFICIENCY	0.010101	0.37133136576602727
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.010101	0.37133136576602727
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.010101	0.37133136576602727
LIPE-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37133136576602727
CIDEC-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37133136576602727
LYSOSOMAL ACID LIPASE DEFICIENCY	0.010101	0.37133136576602727
T-CELL LYMPHOMA, SUBCUTANEOUS PANNICULITIS-LIKE; SPTCL	0.010101	0.37133136576602727
LCAT DEFICIENCY	0.010101	0.37133136576602727
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.010101	0.37133136576602727
ACQUIRED GENERALIZED LIPODYSTROPHY	0.010101	0.37133136576602727
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.010101	0.37133136576602727
FAMILIAL PARTIAL LIPODYSTROPHY, DUNNIGAN TYPE	0.010101	0.37133136576602727
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.010101	0.37133136576602727
TANGIER DISEASE	0.010101	0.37133136576602727
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 3; CGL3	0.010101	0.37133136576602727
PROTOPORPHYRIA, ERYTHROPOIETIC	0.010101	0.37133136576602727
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.010101	0.37133136576602727
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.010101	0.37133136576602727
HYPERLIPOPROTEINEMIA, TYPE IV	0.010101	0.37133136576602727
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.010101	0.37133136576602727
ALAGILLE SYNDROME 1; ALGS1	0.010101	0.37133136576602727
HYPERCHOLESTEROLEMIA, AUTOSOMAL RECESSIVE; ARH	0.010101	0.37133136576602727
CHOLESTERYL ESTER STORAGE DISEASE	0.010101	0.37133136576602727
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.010101	0.37133136576602727
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.010101	0.37133136576602727
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 2; XLP2	0.010101	0.37133136576602727
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.010101	0.37133136576602727
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN DEBRANCHING ENZYME DEFICIENCY	0.010101	0.37133136576602727
HYPERLIPIDEMIA DUE TO HEPATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.010101	0.37133136576602727
HYPERTRIGLYCERIDEMIA, FAMILIAL	0.010101	0.37133136576602727
GLYCOGEN STORAGE DISEASE IXA	0.010101	0.37133136576602727
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01002304	0.3684654125658372
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.009939814	0.36540587150581905
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.009936022999999999	0.3652665073629006
MARDEN-WALKER SYNDROME	0.009935679000000001	0.36525386128926207
NEONATAL MARFAN SYNDROME	0.009932139999999999	0.3651237611305207
6Q16 MICRODELETION SYNDROME	0.009855474	0.3623053777538433
CHROMOSOME 9P DELETION SYNDROME	0.009855474	0.3623053777538433
TOLUENE EMBRYOPATHY	0.009855474	0.3623053777538433
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.009835123	0.36155723750785734
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.009835123	0.36155723750785734
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.36044302283950747
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36044302283950747
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.36044302283950747
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36044302283950747
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36044302283950747
COFFIN-SIRIS SYNDROME 5	0.009792122999999998	0.3599764783030321
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.009760543	0.358815539333535
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.009760543	0.358815539333535
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.009760543	0.358815539333535
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.009757004	0.3586854391747937
RETINITIS PIGMENTOSA 59; RP59	0.009752868999999999	0.35853342895823664
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.009752868999999999	0.35853342895823664
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.009752868999999999	0.35853342895823664
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.009707783	0.3568759845510564
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.009707783	0.3568759845510564
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.009707783	0.3568759845510564
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.009707783	0.3568759845510564
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.009707783	0.3568759845510564
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.009707783	0.3568759845510564
WOLFRAM SYNDROME	0.009638529	0.35433007994708055
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.009606323	0.3531461280645085
HALL-RIGGS SYNDROME	0.009580149	0.35218392361271555
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00957661	0.35205382345397424
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.009474284	0.3482921312122779
PYRUVATE DEHYDROGENASE DEFICIENCY	0.009470963	0.3481700451350867
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.009425929	0.3465145123436891
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.009425929	0.3465145123436891
COG8-CDG	0.009425929	0.3465145123436891
CLASSICAL EHLERS-DANLOS SYNDROME	0.00939426	0.3453503015702563
CONGENITAL HYPOTHYROIDISM	0.009392554000000001	0.34528758586785097
NIEMANN-PICK DISEASE, TYPE A	0.009392554000000001	0.34528758586785097
GM2-GANGLIOSIDOSIS, AB VARIANT	0.009356213	0.3439516237687218
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00930992	0.34224980781828057
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34038745290394473
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34038745290394473
CARNOSINASE DEFICIENCY	0.00925926	0.34038745290394473
CARNOSINEMIA	0.00925926	0.34038745290394473
GAUCHER DISEASE TYPE 2	0.00925926	0.34038745290394473
PAINE SYNDROME	0.00925926	0.34038745290394473
HYDROXYLYSINURIA	0.00925926	0.34038745290394473
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34038745290394473
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34038745290394473
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.34038745290394473
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.34038745290394473
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34038745290394473
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34038745290394473
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.009254243	0.3402030187427678
DISTAL TRISOMY 17Q	0.009254242999999999	0.34020301874276776
10Q22.3Q23.3 MICRODELETION SYNDROME	0.009254242999999999	0.34020301874276776
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.009250703999999998	0.3400729185840264
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.009241059000000001	0.3397183506182
HENNEKAM-BEEMER SYNDROME	0.009175819	0.3373200080479024
ADRENOMYODYSTROPHY	0.009175819	0.3373200080479024
CONO-SPONDYLAR DYSPLASIA	0.009175819	0.3373200080479024
TRISOMY 13	0.009175819	0.3373200080479024
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.009175819	0.3373200080479024
4Q21 MICRODELETION SYNDROME	0.009175819	0.3373200080479024
DPM1-CDG	0.009175819	0.3373200080479024
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.009169903	0.3371025249907921
8P23.1 MICRODELETION SYNDROME	0.009169903	0.3371025249907921
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.009162229	0.33682041461549367
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.009143023	0.3361143666785664
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.009100022999999999	0.3345336074737412
SARCOSINEMIA	0.009064904	0.33324256834550275
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.009064904	0.33324256834550275
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.00906345	0.3331891166272745
LISSENCEPHALY, X-LINKED, 1; LISX1	0.009060769	0.3330905581289457
CRANIOFACIAL DYSSYNOSTOSIS	0.00903873	0.33228036389370985
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.33228036389370985
MUCOLIPIDOSIS TYPE II	0.00903873	0.33228036389370985
TRISOMY XQ28	0.00903873	0.33228036389370985
RING CHROMOSOME 7 SYNDROME	0.00903873	0.33228036389370985
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.009015683	0.33143311372176554
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.008892912999999999	0.3269198623827797
ALLAN-HERNDON-DUDLEY SYNDROME	0.00888451	0.32661095262468337
DISTAL MONOSOMY 19P13.3	0.008849913	0.32533910317795456
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.008849913	0.32533910317795456
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.008847	0.32523201593228823
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.008847	0.32523201593228823
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.008814794	0.32404806404971614
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.008810659	0.32389605383315906
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.008765572999999999	0.3222386094259788
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.008755824	0.32188021822858726
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.008708689	0.320147448807205
CHROMOSOME 13Q14 DELETION SYNDROME	0.00867357	0.31885640967896656
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.0086344	0.3174164483288967
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.008628484	0.3171989652717863
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.008624349	0.3170469550552293
ACROCALLOSAL SYNDROME; ACLS	0.008624349	0.3170469550552293
20Q13.33 MICRODELETION SYNDROME	0.008624349	0.3170469550552293
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00862081	0.316916854896488
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.008532074	0.3136547560872004
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00851935	0.31318699840994
SPASTIC ATAXIA 9, AUTOSOMAL RECESSIVE; SPAX9	0.00851935	0.31318699840994
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.31226916550140815
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.008494383	0.31226916550140815
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.31226916550140815
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008494383	0.31226916550140815
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008458923	0.31096559058505696
NEURAMINIDASE DEFICIENCY	0.008347359	0.3068642924472171
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.008308494	0.3054355434589489
ARTERIAL TORTUOSITY SYNDROME	0.008308494	0.3054355434589489
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.008308494	0.3054355434589489
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.008308494	0.3054355434589489
DISTAL TRISOMY 15Q	0.008304358999999999	0.3052835332423918
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.008304358999999999	0.3052835332423918
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.008304358999999999	0.3052835332423918
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00826924	0.3039924941141534
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00826924	0.3039924941141534
OROFACIODIGITAL SYNDROME TYPE 6	0.008243973	0.3030636326530297
TRISOMY 17P	0.008224154	0.30233504970697317
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.008224154	0.30233504970697317
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.008220019	0.30218303949041614
RING CHROMOSOME 10 SYNDROME	0.008220019	0.30218303949041614
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.008220019	0.30218303949041614
COFFIN-LOWRY SYNDROME; CLS	0.008220019	0.30218303949041614
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.008220019	0.30218303949041614
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.008167269999999999	0.30024388908819927
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.008167269999999999	0.30024388908819927
GORLIN SYNDROME	0.008167269999999999	0.30024388908819927
FLOATING-HARBOR SYNDROME	0.008165564	0.3001811733857939
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008165564	0.3001811733857939
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.008161429000000001	0.30002916316923695
OCULOCEREBRORENAL SYNDROME OF LOWE	0.008161429000000001	0.30002916316923695
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.008161429	0.3000291631692369
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.008129223	0.2988452112866648
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008129223	0.2988452112866648
HEART AND BRAIN MALFORMATION SYNDROME	0.008129223	0.2988452112866648
AICARDI-GOUTIÈRES SYNDROME	0.008129223	0.2988452112866648
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.008129223	0.2988452112866648
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.008129223	0.2988452112866648
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.008129223	0.2988452112866648
LISSENCEPHALY 8; LIS8	0.008129223	0.2988452112866648
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.008129223	0.2988452112866648
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.008129223	0.2988452112866648
LISSENCEPHALY 1; LIS1	0.008129223	0.2988452112866648
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.008129223	0.2988452112866648
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.008129223	0.2988452112866648
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008129223	0.2988452112866648
SIFRIM-HITZ-WEISS SYNDROME	0.00808293	0.29714339533622364
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00808293	0.29714339533622364
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00808293	0.29714339533622364
ATAXIA-PANCYTOPENIA SYNDROME	0.00805605	0.29615523702399804
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.008013049999999999	0.2945744778191728
COFFIN-SIRIS SYNDROME	0.007993863	0.29386912835724305
SMITH-LEMLI-OPITZ SYNDROME	0.007993863	0.29386912835724305
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.29236560578240245
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.29236560578240245
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.2922135955658454
CROME SYNDROME	0.007948829	0.2922135955658454
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.007948829	0.2922135955658454
1Q41Q42 MICRODELETION SYNDROME	0.007948829	0.2922135955658454
GLUTAMINE DEFICIENCY, CONGENITAL	0.007948829	0.2922135955658454
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007948829	0.2922135955658454
LISSENCEPHALY 5; LIS5	0.007948829	0.2922135955658454
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.2922135955658454
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.2922135955658454
SMITH-FINEMAN-MYERS SYNDROME	0.007948829	0.2922135955658454
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.2922135955658454
INTELLECTUAL DISABILITY, WOLFF TYPE	0.007948829	0.2922135955658454
FRYNS SYNDROME	0.007948829	0.2922135955658454
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.2922135955658454
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.007948829	0.2922135955658454
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.007948829	0.2922135955658454
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.2922135955658454
LOWRY-MACLEAN SYNDROME	0.007948829	0.2922135955658454
KEPPEN-LUBINSKY SYNDROME	0.007948829	0.2922135955658454
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.007948829	0.2922135955658454
SECKEL SYNDROME 7; SCKL7	0.007948829	0.2922135955658454
RING CHROMOSOME 22 SYNDROME	0.007846503	0.28845190332414905
FOLATE MALABSORPTION, HEREDITARY	0.007839643	0.28819971708821657
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.007839643	0.28819971708821657
JOUBERT SYNDROME	0.007839643	0.28819971708821657
GALACTOSEMIA	0.007839643	0.28819971708821657
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.007839643	0.28819971708821657
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.007839643	0.28819971708821657
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.007839643	0.28819971708821657
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.007838829	0.28816979294885076
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.007838829	0.28816979294885076
CONGENITAL ADRENAL HYPERPLASIA	0.00783646	0.28808270414521747
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.00783646	0.28808270414521747
%608572 BURN-MCKEOWN SYNDROME	0.00783646	0.28808270414521747
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.007762939999999999	0.2853799735233861
FRYNS-SMEETS-THIRY SYNDROME	0.007762939999999999	0.2853799735233861
ARTERIAL TORTUOSITY SYNDROME	0.007762939999999999	0.2853799735233861
MARFAN SYNDROME	0.007762939999999999	0.2853799735233861
SHPRINTZEN-GOLDBERG SYNDROME	0.007762939999999999	0.2853799735233861
CHROMOSOME 10Q26 DELETION SYNDROME	0.0077331629999999995	0.28428531615496566
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0077331629999999995	0.28428531615496566
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0077331629999999995	0.28428531615496566
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.007692282999999999	0.28278249205512257
OPSISMODYSPLASIA	0.0076786	0.28227947977141044
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.0076786	0.28227947977141044
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.007665923	0.28181344990072277
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.007665923	0.28181344990072277
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.007665923	0.28181344990072277
GLASS SYNDROME	0.007622923	0.2802326906958976
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.007622923	0.2802326906958976
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.007622923	0.2802326906958976
W SYNDROME	0.007587804	0.2789416515676591
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.007587804	0.2789416515676591
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.007587804	0.2789416515676591
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.2789416515676591
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.007587804	0.2789416515676591
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.007587804	0.2789416515676591
HYPERMANGANESEMIA WITH DYSTONIA 2	0.007587804	0.2789416515676591
PELGER-HUET ANOMALY; PHA	0.007587804	0.2789416515676591
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.007587804	0.2789416515676591
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.007587804	0.2789416515676591
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.007587804	0.2789416515676591
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.2789416515676591
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.2789416515676591
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.007587804	0.2789416515676591
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.2789416515676591
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2789416515676591
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.007587804	0.2789416515676591
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.278789641351102
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.0075836689999999995	0.278789641351102
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.0075836689999999995	0.278789641351102
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.278789641351102
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.0075836689999999995	0.278789641351102
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.0075836689999999995	0.278789641351102
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.0075836689999999995	0.278789641351102
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.0075836689999999995	0.278789641351102
WARBURG MICRO SYNDROME 3; WARBM3	0.0075836689999999995	0.278789641351102
SALLA DISEASE	0.0075789429999999994	0.2786159048859392
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0075789429999999994	0.2786159048859392
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0075789429999999994	0.2786159048859392
WILSON-TURNER SYNDROME	0.007538583	0.2771321969439219
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.007538583	0.2771321969439219
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.007538583	0.2771321969439219
SHUKLA-VERNON SYNDROME; SHUVER	0.007538583	0.2771321969439219
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.007538583	0.2771321969439219
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.007538583	0.2771321969439219
48,XXXY SYNDROME	0.0075167129999999995	0.2763282154599794
49,XXXXY SYNDROME	0.0075167129999999995	0.2763282154599794
ATHYREOSIS	0.007513173999999999	0.27619811530123806
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.007513173999999999	0.27619811530123806
PERMANENT CONGENITAL HYPOTHYROIDISM	0.007513173999999999	0.27619811530123806
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.007509039	0.2760461050846811
CARDIOFACIOCUTANEOUS SYNDROME	0.007452444000000001	0.27396556863823734
CHARGE SYNDROME	0.007452444000000001	0.27396556863823734
OHDO SYNDROME	0.007448309	0.2738135584216803
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.007442173	0.2735879877593359
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.007442173	0.2735879877593359
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.007442173	0.2735879877593359
DISTAL MONOSOMY 10P	0.00740741	0.2723100358468397
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.2723100358468397
KID SYNDROME	0.00740741	0.2723100358468397
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00740741	0.2723100358468397
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.2723100358468397
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00740741	0.2723100358468397
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.2723100358468397
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.2723100358468397
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.2723100358468397
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.007362493	0.2706588041909529
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.007362493	0.2706588041909529
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.00735931	0.27054179124795386
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.007298224	0.2682961573692108
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.00729741	0.26826623322984505
FAMILIAL DYSAUTONOMIA	0.007294089	0.2681441471526538
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.007294089	0.2681441471526538
MAPLE SYRUP URINE DISEASE; MSUD	0.007294089	0.2681441471526538
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.007294089	0.2681441471526538
CUTIS LAXA	0.007191744	0.26438175643596
PEROXISOME BIOGENESIS DISORDER 5B	0.007124504	0.26190989018171706
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.007124504	0.26190989018171706
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.007124504	0.26190989018171706
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.007124504	0.26190989018171706
OPTIC ATROPHY 11; OPA11	0.007124504	0.26190989018171706
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.007124504	0.26190989018171706
JOUBERT SYNDROME 24	0.007124504	0.26190989018171706
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.007124504	0.26190989018171706
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.007124504	0.26190989018171706
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.007124504	0.26190989018171706
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.007120369	0.26175787996516003
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.007120369	0.26175787996516003
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.007081504	0.26032913097689186
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.007081504	0.26032913097689186
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.007081504	0.26032913097689186
16P13.11 MICRODUPLICATION SYNDROME	0.007081504	0.26032913097689186
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.007081504	0.26032913097689186
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.007081504	0.26032913097689186
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.007081504	0.26032913097689186
DISTAL TRISOMY 18Q	0.007081504	0.26032913097689186
HARROD SYNDROME	0.007077369	0.2601771207603349
CLASSIC HOMOCYSTINURIA	0.007077369	0.2601771207603349
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.25888608163209637
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.00704225	0.25888608163209637
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.25888608163209637
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.25888608163209637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00704225	0.25888608163209637
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.25888608163209637
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.25888608163209637
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.25888608163209637
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00704225	0.25888608163209637
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.25888608163209637
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.25888608163209637
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.25888608163209637
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.00704225	0.25888608163209637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.25888608163209637
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.25888608163209637
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.25888608163209637
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.25888608163209637
OLIVER SYNDROME	0.00704225	0.25888608163209637
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.25888608163209637
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.25888608163209637
NEURONAL CEROID LIPOFUSCINOSIS	0.007033388999999999	0.2585603349503764
CEREBELLOFACIODENTAL SYNDROME	0.006997164	0.2572286372249162
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.006997164	0.2572286372249162
3Q29 MICRODELETION SYNDROME	0.006997164	0.2572286372249162
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.006997164	0.2572286372249162
GOLDBERG-SHPRINTZEN SYNDROME	0.006997164	0.2572286372249162
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.006997164	0.2572286372249162
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.006997164	0.2572286372249162
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006997164	0.2572286372249162
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.006997164	0.2572286372249162
YUNIS-VARON SYNDROME	0.006997164	0.2572286372249162
CLARK-BARAITSER SYNDROME	0.0069930289999999996	0.25707662700835915
AYME-GRIPP SYNDROME; AYGRP	0.0069930289999999996	0.25707662700835915
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0069930289999999996	0.25707662700835915
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0069930289999999996	0.25707662700835915
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0069930289999999996	0.25707662700835915
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.0069930289999999996	0.25707662700835915
ATKIN-FLAITZ SYNDROME	0.0069930289999999996	0.25707662700835915
CRONKHITE-CANADA SYNDROME	0.0069930289999999996	0.25707662700835915
C SYNDROME	0.006971158999999999	0.25627264552441664
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.006967619999999999	0.2561425453656753
CENTRAL CONGENITAL HYPOTHYROIDISM	0.006967619999999999	0.2561425453656753
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.006967619999999999	0.2561425453656753
MOEBIUS SYNDROME	0.006906890000000001	0.2539099987026746
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.006906890000000001	0.2539099987026746
DUBOWITZ SYNDROME	0.006906890000000001	0.2539099987026746
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.006900754	0.25368442804033026
PRADER-WILLI-LIKE SYNDROME	0.006827603	0.2509952625381868
NEPHROGENIC DIABETES INSIPIDUS	0.006827603	0.2509952625381868
DESANTO-SHINAWI SYNDROME	0.006827603	0.2509952625381868
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006827603	0.2509952625381868
CHROMOSOME 19P13.13 DELETION SYNDROME	0.006827603	0.2509952625381868
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.006827603	0.2509952625381868
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.006827603	0.2509952625381868
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.006827603	0.2509952625381868
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.006827603	0.2509952625381868
ALEXANDER DISEASE	0.006816939	0.25060323425539016
2Q23.1 MICRODELETION SYNDROME	0.006816939	0.25060323425539016
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.006766873000000001	0.24876271587518606
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.006766873000000001	0.24876271587518606
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.006766873	0.24876271587518603
ARGININOSUCCINIC ACIDURIA	0.006612653	0.24309330460615952
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.006612653	0.24309330460615952
BOUCHER-NEUHAUSER SYNDROME	0.00660531	0.24282336240055413
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00657895	0.24185432024615433
BEHR SYNDROME	0.00657895	0.24185432024615433
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00657895	0.24185432024615433
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.00657895	0.24185432024615433
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00657895	0.24185432024615433
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00657895	0.24185432024615433
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00657895	0.24185432024615433
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.00657895	0.24185432024615433
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00657895	0.24185432024615433
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00657895	0.24185432024615433
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00653595	0.2402735610413291
LOEYS-DIETZ SYNDROME 3; LDS3	0.00653595	0.2402735610413291
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00653595	0.2402735610413291
PROLIDASE DEFICIENCY	0.00653595	0.2402735610413291
HAIM-MUNK SYNDROME	0.00653595	0.2402735610413291
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00653595	0.2402735610413291
MOSAIC TRISOMY 1	0.00653595	0.2402735610413291
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.00653595	0.2402735610413291
NON-DISTAL TRISOMY 13Q	0.00653595	0.2402735610413291
LOEYS-DIETZ SYNDROME	0.00653595	0.2402735610413291
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00653595	0.2402735610413291
MARFANOID HYPERMOBILITY SYNDROME	0.00653595	0.2402735610413291
MARFAN SYNDROME; MFS	0.00653595	0.2402735610413291
FRONTOMETAPHYSEAL DYSPLASIA	0.00653595	0.2402735610413291
ACHARD SYNDROME	0.00653595	0.2402735610413291
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00653595	0.2402735610413291
3Q27.3 MICRODELETION SYNDROME	0.00653595	0.2402735610413291
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.00653595	0.2402735610413291
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.00653595	0.2402735610413291
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00653595	0.2402735610413291
MARFANOID HABITUS WITH SITUS INVERSUS	0.00653595	0.2402735610413291
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00653595	0.2402735610413291
FAMILIAL VISCERAL MYOPATHY	0.00653595	0.2402735610413291
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00653595	0.2402735610413291
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00653595	0.2402735610413291
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.00653595	0.2402735610413291
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00653595	0.2402735610413291
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00653595	0.2402735610413291
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.00653595	0.2402735610413291
LOEYS-DIETZ SYNDROME 5	0.00653595	0.2402735610413291
CUTIS LAXA-MARFANOID SYNDROME	0.00653595	0.2402735610413291
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00653595	0.2402735610413291
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00653595	0.2402735610413291
PAPILLON-LEFÈVRE SYNDROME	0.00653595	0.2402735610413291
NAKAJO-NISHIMURA SYNDROME	0.00653595	0.2402735610413291
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.00653595	0.2402735610413291
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00653595	0.2402735610413291
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.00653595	0.2402735610413291
TRISOMY 1Q	0.00653595	0.2402735610413291
ANTLEY-BIXLER SYNDROME	0.00653595	0.2402735610413291
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00653595	0.2402735610413291
STICKLER SYNDROME, TYPE I	0.00653595	0.2402735610413291
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00653595	0.2402735610413291
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00653595	0.2402735610413291
BRITTLE CORNEA SYNDROME	0.00653595	0.2402735610413291
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00653595	0.2402735610413291
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00653595	0.2402735610413291
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.00653595	0.2402735610413291
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.00653595	0.2402735610413291
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00653595	0.2402735610413291
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00653595	0.2402735610413291
601095 HARROD SYNDROME	0.00653595	0.2402735610413291
REFSUM DISEASE	0.00649197	0.23865677523137074
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00645161	0.23717306728935342
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00645161	0.23717306728935342
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00645161	0.23717306728935342
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.00645161	0.23717306728935342
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00645161	0.23717306728935342
SAY SYNDROME	0.00645161	0.23717306728935342
ACROCRANIOFACIAL DYSOSTOSIS	0.00645161	0.23717306728935342
311895 PIERRE ROBIN SEQUENCE WITH FACIAL AND DIGITAL ANOMALIES	0.00645161	0.23717306728935342
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00645161	0.23717306728935342
HURIEZ SYNDROME; HRZ	0.00645161	0.23717306728935342
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 2	0.00645161	0.23717306728935342
ACROMEGALY	0.00645161	0.23717306728935342
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 3; SEMDJL3	0.00645161	0.23717306728935342
SOMATOMAMMOTROPINOMA	0.00645161	0.23717306728935342
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00645161	0.23717306728935342
ERYTHROKERATODERMIA VARIABILIS	0.00645161	0.23717306728935342
BASAN SYNDROME	0.00645161	0.23717306728935342
CLEIDOCRANIAL DYSPLASIA	0.00645161	0.23717306728935342
MYOPATHIC EHLERS-DANLOS SYNDROME	0.00645161	0.23717306728935342
258840 ORAL AND DIGITAL ANOMALIES WITH ICHTHYOSIS	0.00645161	0.23717306728935342
SATOYOSHI SYNDROME	0.00645161	0.23717306728935342
OTOFACIOCERVICAL SYNDROME 2	0.00645161	0.23717306728935342
PARANA HARD SKIN SYNDROME	0.00645161	0.23717306728935342
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00645161	0.23717306728935342
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006364593	0.23397416208641686
SOTOS SYNDROME	0.006362543000000001	0.23389880031037288
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.006362543000000001	0.23389880031037288
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.006362543	0.23389880031037283
CANAVAN DISEASE	0.006362543	0.23389880031037283
METHYLMALONIC ACIDURIA, CBLA TYPE	0.006362543	0.23389880031037283
COFFIN-SIRIS SYNDROME 1; CSS1	0.006362543	0.23389880031037283
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.006362543	0.23389880031037283
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.006362543	0.23389880031037283
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.006362543	0.23389880031037283
VICI SYNDROME	0.006362543	0.23389880031037283
KABUKI SYNDROME 1	0.006362543	0.23389880031037283
CHROMOSOME 16P13.3 DELETION SYNDROME	0.006362543	0.23389880031037283
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.006362543	0.23389880031037283
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0062897230000000005	0.2312218029779224
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.006289723	0.23122180297792239
COFFIN-SIRIS SYNDROME 7; CSS7	0.006286184	0.2310917028191811
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.006286184	0.2310917028191811
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.006286184	0.2310917028191811
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.006286184	0.2310917028191811
AU-KLINE SYNDROME; AUKS	0.006286184	0.2310917028191811
PERIPHERAL HYPOTHYROIDISM	0.006286184	0.2310917028191811
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.006286184	0.2310917028191811
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006282049	0.23093969260262406
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.006282049	0.23093969260262406
JOUBERT SYNDROME 10	0.006225454	0.2288591561561803
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.0062213189999999995	0.22870714593962327
PETTIGREW SYNDROME	0.006215183000000001	0.22848157527727897
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.006215183000000001	0.22848157527727897
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.006135503	0.22555239170889588
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.006114483	0.2247796577906302
MONOSOMY 9Q22.3	0.006114482999999999	0.2247796577906301
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.006071234	0.22318974488715382
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.006067098999999999	0.22303773467059676
RFT1-CDG	0.005960263	0.2191102465216037
JOUBERT SYNDROME WITH OCULAR DEFECT	0.005960263	0.2191102465216037
JOUBERT SYNDROME WITH RENAL DEFECT	0.005960263	0.2191102465216037
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.0059602629999999995	0.21911024652160366
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00595708	0.21899323357860465
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.005885393	0.21635788741310924
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.005885393	0.21635788741310924
HOLOPROSENCEPHALY 2; HPE2	0.005885393	0.21635788741310924
KLEEFSTRA SYNDROME	0.005885393	0.21635788741310924
BAKER-GORDON SYNDROME; BAGOS	0.0058231739999999995	0.21407060236741113
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0058211240000000004	0.21399524059136718
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.0058211240000000004	0.21399524059136718
3C SYNDROME	0.0058211240000000004	0.21399524059136718
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0058211240000000004	0.21399524059136718
HYPOTONIA-CYSTINURIA SYNDROME	0.0058211240000000004	0.21399524059136718
CORNELIA DE LANGE SYNDROME	0.005816989000000001	0.21384323037481012
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.005816989	0.21384323037481012
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.005816989	0.21384323037481012
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.005816989	0.21384323037481012
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.005816989	0.21384323037481012
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.005816989	0.21384323037481012
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.005816989	0.21384323037481012
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.005816989	0.21384323037481012
ACROCARDIOFACIAL SYNDROME	0.005816989	0.21384323037481012
HYPOPHOSPHATASIA	0.005816989	0.21384323037481012
MENKES DISEASE	0.005816989	0.21384323037481012
REVESZ SYNDROME	0.005810534	0.21360593268487646
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.005748303999999999	0.21131824325891665
COFFIN-SIRIS SYNDROME 6; CSS6	0.005748303999999999	0.21131824325891665
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00574063	0.21103613288361833
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00574063	0.21103613288361833
SILVER-RUSSELL SYNDROME	0.00574063	0.21103613288361833
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00574063	0.21103613288361833
CRI-DU-CHAT SYNDROME	0.0056799	0.20880358622061757
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0056799	0.20880358622061757
GMS SYNDROME	0.0056799	0.20880358622061757
MARTSOLF SYNDROME	0.0056799	0.20880358622061757
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005673764	0.2085780155582732
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.2085780155582732
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.005669629000000001	0.20842600534171624
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.20842600534171624
ATYPICAL JUVENILE PARKINSONISM	0.005669629000000001	0.20842600534171624
HUNTINGTON DISEASE; HD	0.005669629000000001	0.20842600534171624
RAPID-ONSET DYSTONIA-PARKINSONISM	0.005669629000000001	0.20842600534171624
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.005669629000000001	0.20842600534171624
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.005594083999999999	0.20564883198989017
GITELMAN SYNDROME	0.005589949	0.20549682177333317
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.005589949	0.20549682177333317
16P11.2P12.2 MICRODELETION SYNDROME	0.005573063999999999	0.20487609807162444
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.005573063999999999	0.20487609807162444
PALLISTER-KILLIAN SYNDROME	0.005568929	0.20472408785506746
14Q12 MICRODELETION SYNDROME	0.0055689289999999985	0.2047240878550674
LARSEN-LIKE SYNDROME	0.0055604240000000004	0.20441142838908982
ASPARTYLGLUCOSAMINURIA; AGU	0.005556289000000001	0.20425941817253285
XYLOSIDASE DEFICIENCY	0.005556289000000001	0.20425941817253285
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005556289	0.2042594181725328
CAMURATI-ENGELMANN DISEASE	0.00552568	0.20313417495159106
15Q11Q13 MICRODUPLICATION SYNDROME	0.005422382999999999	0.19933678696133925
ISOLATED COMPLEX I DEFICIENCY	0.005418844	0.19920668680259798
CHOREOACANTHOCYTOSIS	0.005414709	0.19905467658604095
CITRULLINEMIA TYPE I	0.005414709	0.19905467658604095
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.005343974	0.19645432769410354
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.005343974	0.19645432769410354
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.005343974	0.19645432769410354
FAMILIAL THYROID DYSHORMONOGENESIS	0.005343974	0.19645432769410354
THYROID HEMIAGENESIS	0.005343974	0.19645432769410354
THYROID ECTOPIA	0.005343974	0.19645432769410354
THYROID HYPOPLASIA	0.005343974	0.19645432769410354
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.005343974	0.19645432769410354
LYNCH SYNDROME	0.005339839	0.19630231747754648
FAMILIAL COLORECTAL CANCER TYPE X	0.005339839	0.19630231747754648
HYPOPHOSPHATASIA, INFANTILE	0.005339839	0.19630231747754648
ACUTE ADRENAL INSUFFICIENCY	0.005339839	0.19630231747754648
GOLDENHAR SYNDROME	0.00527557	0.19393967065580442
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.00527557	0.19393967065580442
MYOTONIC DYSTROPHY 1	0.00527557	0.19393967065580442
STÜVE-WIEDEMANN SYNDROME	0.00527557	0.19393967065580442
ESOPHAGEAL ATRESIA	0.00527557	0.19393967065580442
NOONAN SYNDROME	0.00527557	0.19393967065580442
NEMALINE MYOPATHY 4	0.00527557	0.19393967065580442
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.00527557	0.19393967065580442
PRADER-WILLI SYNDROME (TYPE 2)	0.00527557	0.19393967065580442
PRADER-WILLI SYNDROME (TYPE 1)	0.00527557	0.19393967065580442
TREMOR OF INTENTION, ATAXIA, AND LIPOFUSCINOSIS	0.00526498	0.19355036274931375
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.00526498	0.19355036274931375
CEREBELLOPARENCHYMAL DISORDER V	0.00526498	0.19355036274931375
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00526498	0.19355036274931375
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00520275	0.19126267332335395
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.005135553000000001	0.1887923878283159
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.005135553000000001	0.1887923878283159
CORNELIA DE LANGE SYNDROME 3	0.005135553000000001	0.1887923878283159
POTOCKI-LUPSKI SYNDROME	0.005135553000000001	0.1887923878283159
SHASHI-PENA SYNDROME; SHAPNS	0.005135553000000001	0.1887923878283159
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.005135553000000001	0.1887923878283159
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.005135553000000001	0.1887923878283159
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.005135553000000001	0.1887923878283159
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.005135553000000001	0.1887923878283159
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.005135553	0.18879238782831587
PETERS-PLUS SYNDROME; PTRPLS	0.005135553	0.18879238782831587
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00512821	0.1885224456227105
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.1885224456227105
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00512821	0.1885224456227105
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.1885224456227105
CHIARI MALFORMATION TYPE I	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.1885224456227105
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.1885224456227105
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00512821	0.1885224456227105
SYRINGOMYELIA, ISOLATED	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.1885224456227105
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00512821	0.1885224456227105
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.1885224456227105
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.1885224456227105
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.1885224456227105
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00512821	0.1885224456227105
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.1885224456227105
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 38	0.00512821	0.1885224456227105
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00512821	0.1885224456227105
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.1885224456227105
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.1885224456227105
SUSAC SYNDROME	0.00512821	0.1885224456227105
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.1885224456227105
TYPHOID	0.00504853	0.18559326205432744
TURCOT SYNDROME WITH POLYPOSIS	0.00504853	0.18559326205432744
NEUROFERRITINOPATHY	0.00504853	0.18559326205432744
TORIELLO-LACASSIE-DROSTE SYNDROME	0.005027509999999999	0.1848205281360617
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.005027509999999999	0.1848205281360617
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.00501487	0.1843558584535271
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.00501487	0.1843558584535271
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.00501487	0.1843558584535271
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.004887493	0.17967324530857318
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.004887493	0.17967324530857318
8P11.2 DELETION SYNDROME	0.004887493	0.17967324530857318
PHELAN-MCDERMID SYNDROME	0.004887493	0.17967324530857318
MONOSOMY 22Q13.3	0.004887493	0.17967324530857318
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.004887493	0.17967324530857318
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.004887493	0.17967324530857318
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.004887493	0.17967324530857318
TETRASOMY 9P	0.004887493	0.17967324530857318
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.004887493	0.17967324530857318
11Q22.2Q22.3 MICRODELETION SYNDROME	0.004887493	0.17967324530857318
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.004887493	0.17967324530857318
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004887493	0.17967324530857318
JOUBERT SYNDROME 1	0.004880964	0.17943322724233357
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.004876828999999999	0.1792812170257765
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.004874853	0.17920857562603854
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.004874853	0.17920857562603854
CHIARI MALFORMATION TYPE II	0.00487329	0.17915111686703522
JUVENILE DERMATOMYOSITIS	0.00479842	0.1763987577585408
INFANT BOTULISM	0.00479842	0.1763987577585408
POLYMYOSITIS	0.00479842	0.1763987577585408
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.004733273	0.17400383403954667
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004733273	0.17400383403954667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.004733273	0.17400383403954667
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.004733273	0.17400383403954667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.004733273	0.17400383403954667
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.004733273	0.17400383403954667
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.004733273	0.17400383403954667
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.004733273	0.17400383403954667
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004733273	0.17400383403954667
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.004733273	0.17400383403954667
FG SYNDROME TYPE 1	0.004658403	0.17125147493105222
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004658403	0.17125147493105222
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004658403	0.17125147493105222
611961 STEVENSON-CAREY SYNDROME	0.004658403	0.17125147493105222
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.004658403	0.17125147493105222
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004658403	0.17125147493105222
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.004658403	0.17125147493105222
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004658403	0.17125147493105222
PETERS PLUS SYNDROME	0.004594134000000001	0.16888882810931016
OCULOFACIOCARDIODENTAL SYNDROME	0.004594134000000001	0.16888882810931016
WEAVER SYNDROME	0.004594134000000001	0.16888882810931016
SCLERODERMA	0.004589999000000001	0.16873681789275316
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.004589999000000001	0.16873681789275316
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.004589999000000001	0.16873681789275316
2Q33.1 DELETION SYNDROME	0.004589999000000001	0.16873681789275316
HYPOADRENOCORTICISM, FAMILIAL	0.004589999000000001	0.16873681789275316
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.004589999000000001	0.16873681789275316
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.004589999000000001	0.16873681789275316
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.004589999000000001	0.16873681789275316
SYSTEMIC SCLEROSIS	0.004589999000000001	0.16873681789275316
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.004483163	0.16480932974376
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.004483163	0.16480932974376
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004483163	0.16480932974376
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.004483163	0.16480932974376
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004483163	0.16480932974376
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.004483163	0.16480932974376
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.004483163	0.16480932974376
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004483163	0.16480932974376
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.004346074	0.1597696855895675
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.004346073999999999	0.15976968558956745
48,XYYY SYNDROME	0.004346073999999999	0.15976968558956745
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004346073999999999	0.15976968558956745
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.004346073999999999	0.15976968558956745
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.004346073999999999	0.15976968558956745
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.004346073999999999	0.15976968558956745
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004346073999999999	0.15976968558956745
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.004346073999999999	0.15976968558956745
DUPLICATION/INVERSION 15Q11	0.0043419389999999995	0.15961767537301044
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.0043419389999999995	0.15961767537301044
JOUBERT SYNDROME 3; JBTS3	0.00433541	0.1593776573067708
NON-DISTAL MONOSOMY 10Q	0.00433541	0.1593776573067708
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.004333434	0.1593050159070328
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.004333434	0.1593050159070328
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.004329299	0.1591530056904758
ICHTHYOSIS AND MALE HYPOGONADISM	0.004329299	0.1591530056904758
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.004329299	0.1591530056904758
HYPERLEUCINE-ISOLEUCINEMIA	0.004329299	0.1591530056904758
GAPO SYNDROME; GAPOS	0.004329299	0.1591530056904758
EPILEPSY-TELANGIECTASIA	0.004329299	0.1591530056904758
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.004195393	0.15423037447928228
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.004195393	0.15423037447928228
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.004191853999999999	0.15410027432054094
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.004191853999999999	0.15410027432054094
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.004191853999999999	0.15410027432054094
COCKAYNE SYNDROME	0.0041877189999999995	0.15394826410398393
PROPIONIC ACIDEMIA	0.004116984	0.15134791521204652
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.004116984	0.15134791521204652
ADIPOSIS DOLOROSA	0.004112849	0.15119590499548952
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15119590499548952
KAPUR-TORIELLO SYNDROME	0.004112849	0.15119590499548952
ADDISON DISEASE	0.004112849	0.15119590499548952
HEREDITARY COPROPORPHYRIA	0.004112849	0.15119590499548952
PORPHYRIA VARIEGATA	0.004112849	0.15119590499548952
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15119590499548952
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.004112849	0.15119590499548952
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15119590499548952
LOWE OCULOCEREBRORENAL SYNDROME	0.004112849	0.15119590499548952
PORPHYRIA	0.004112849	0.15119590499548952
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15119590499548952
MOWAT-WILSON SYNDROME; MOWS	0.004112849	0.15119590499548952
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15119590499548952
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15119590499548952
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15119590499548952
ADENOCARCINOMA OF THE ESOPHAGUS	0.00404858	0.1488332581737474
CAFFEY DISEASE	0.00404858	0.1488332581737474
RING CHROMOSOME 1 SYNDROME	0.00404858	0.1488332581737474
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00404858	0.1488332581737474
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00404858	0.1488332581737474
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00404858	0.1488332581737474
FREEMAN-SHELDON SYNDROME	0.00404858	0.1488332581737474
AORTIC ARCH DEFECTS	0.00404858	0.1488332581737474
CHERUBISM	0.00404858	0.1488332581737474
INCLUSION BODY MYOSITIS	0.00404858	0.1488332581737474
ISOLATED POLYCYSTIC LIVER DISEASE	0.00404858	0.1488332581737474
APERT SYNDROME	0.00404858	0.1488332581737474
POTASSIUM-AGGRAVATED MYOTONIA	0.00404858	0.1488332581737474
PEMPHIGUS VULGARIS	0.00404858	0.1488332581737474
JEUNE SYNDROME	0.00404858	0.1488332581737474
HYPERKALEMIC PERIODIC PARALYSIS	0.00404858	0.1488332581737474
SCHWARTZ-JAMPEL SYNDROME	0.00404858	0.1488332581737474
LEPRECHAUNISM	0.00404858	0.1488332581737474
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.00404858	0.1488332581737474
SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS	0.00404858	0.1488332581737474
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00404858	0.1488332581737474
2P15-16.1 MICRODELETION SYNDROME	0.00404858	0.1488332581737474
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00404858	0.1488332581737474
LIVER FAILURE, INFANTILE, TRANSIENT	0.00404858	0.1488332581737474
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00404858	0.1488332581737474
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.00404858	0.1488332581737474
HYPOGLOSSIA WITH SITUS INVERSUS	0.00404858	0.1488332581737474
236450 HUTTERITE CEREBROOSTEONEPHRODYSPLASIA SYNDROME;;COND;;CEREBROOSTEONEPHOSIS SYNDROME	0.00404858	0.1488332581737474
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00404858	0.1488332581737474
PIERRE ROBIN SYNDROME	0.00404858	0.1488332581737474
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00404858	0.1488332581737474
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00404858	0.1488332581737474
NEMALINE MYOPATHY 3; NEM3	0.00404858	0.1488332581737474
16P11.2-P12.2 MICRODELETION SYNDROME	0.00404858	0.1488332581737474
TRISOMY X	0.003945283000000001	0.14503587018349565
1Q21.1 MICRODELETION SYNDROME	0.003945283000000001	0.14503587018349565
20P12.3 MICRODELETION SYNDROME	0.003945283000000001	0.14503587018349565
C SYNDROME	0.003945283000000001	0.14503587018349565
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.003945283000000001	0.14503587018349565
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003945283000000001	0.14503587018349565
INFANTILE SIALIC ACID STORAGE DISEASE	0.003945283000000001	0.14503587018349565
LATHOSTEROLOSIS	0.003945283000000001	0.14503587018349565
WEAVER SYNDROME	0.003945283000000001	0.14503587018349565
TEMPLE-BARAITSER SYNDROME; TMBTS	0.003945283000000001	0.14503587018349565
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.003945283000000001	0.14503587018349565
SIMPSON-GOLABI-BEHMEL SYNDROME	0.003945283000000001	0.14503587018349565
MONOSOMY 9P	0.003945283	0.14503587018349562
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.003945283	0.14503587018349562
22Q11.2 MICRODUPLICATION SYNDROME	0.003945283	0.14503587018349562
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003941744	0.1449057700247543
HURLER SYNDROME	0.003941744	0.1449057700247543
GALACTOSE EPIMERASE DEFICIENCY	0.003941744	0.1449057700247543
PRIMARY CONGENITAL HYPOTHYROIDISM	0.003941744	0.1449057700247543
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003941744	0.1449057700247543
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.003937609	0.1447537598081973
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.003937609	0.1447537598081973
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.003937609	0.1447537598081973
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.003937609	0.1447537598081973
KABUKI SYNDROME	0.003937609	0.1447537598081973
5Q14.3 MICRODELETION SYNDROME	0.003937609	0.1447537598081973
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.003937609	0.1447537598081973
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.003937609	0.1447537598081973
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0038005199999999995	0.1397141156540047
VAN MALDERGEM SYNDROME 1; VMLDS1	0.0038005199999999995	0.1397141156540047
VAN MALDERGEM SYNDROME 2; VMLDS2	0.0038005199999999995	0.1397141156540047
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0038005199999999995	0.1397141156540047
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.0037910630000000003	0.13936645891446914
INFANTILE REFSUM DISEASE	0.0037910630000000003	0.13936645891446914
COACH SYNDROME	0.0037910630000000003	0.13936645891446914
MEVALONIC ACIDURIA	0.0037910630000000003	0.13936645891446914
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.0037910630000000003	0.13936645891446914
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0037910630000000003	0.13936645891446914
HARTNUP DISEASE	0.0037910630000000003	0.13936645891446914
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0037910630000000003	0.13936645891446914
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0037910630000000003	0.13936645891446914
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.0037910630000000003	0.13936645891446914
LEIGH SYNDROME; LS	0.0037910630000000003	0.13936645891446914
PELIZAEUS-MERZBACHER DISEASE	0.0037910630000000003	0.13936645891446914
TAY-SACHS DISEASE	0.0037910630000000003	0.13936645891446914
MAPLE SYRUP URINE DISEASE	0.0037910629999999995	0.13936645891446908
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0037910629999999995	0.13936645891446908
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.0037910629999999995	0.13936645891446908
ELEJALDE DISEASE	0.0037910629999999995	0.13936645891446908
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.0037910629999999995	0.13936645891446908
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 2A	0.00378788	0.13924944597147007
THIOPURINE S-METHYLTRANSFERASE DEFICIENCY	0.00378788	0.13924944597147007
ZINC, ELEVATED PLASMA	0.00378788	0.13924944597147007
XANTHINURIA, TYPE I	0.00378788	0.13924944597147007
MACULAR DYSTROPHY, CORNEAL, 1	0.00378788	0.13924944597147007
%193090 TRANSCOBALAMIN I DEFICIENCY;;TCN1 DEFICIENCY;;COBALAMIN PSEUDODEFICIENCY DUE TO TRANSCOBALAMIN DEFICIENCY;;COBALAMIN R BINDER PROTEIN DEFICIENCYTRANSCOBALAMIN I DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED;;R BINDER DEFICIENCY WITH LACTOFERRIN DEFICIENCY, INCLUDED	0.00378788	0.13924944597147007
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.00378788	0.13924944597147007
ALKAPTONURIA	0.00378788	0.13924944597147007
WHITE SPONGE NEVUS OF CANNON	0.00378788	0.13924944597147007
TRISOMY 18-LIKE SYNDROME	0.00378788	0.13924944597147007
DERMATOLEUKODYSTROPHY	0.00378788	0.13924944597147007
VERTEBRAL FUSION, POSTERIOR LUMBOSACRAL, WITH BLEPHAROPTOSIS	0.00378788	0.13924944597147007
ERYTHROCYTOSIS, FAMILIAL, 8; ECYT8	0.00378788	0.13924944597147007
OSTEOMESOPYKNOSIS	0.00378788	0.13924944597147007
SUCRASE-ISOMALTASE DEFICIENCY, CONGENITAL	0.00378788	0.13924944597147007
LACTOSE INTOLERANCE, ADULT TYPE	0.00378788	0.13924944597147007
NEURONAL INTESTINAL DYSPLASIA, TYPE B	0.00378788	0.13924944597147007
VASCULITIS, LYMPHOCYTIC, NODULAR	0.00378788	0.13924944597147007
URATE-BINDING GLOBULIN, DECREASE IN	0.00378788	0.13924944597147007
601195 IRON OVERLOAD IN AFRICA;;AFRICAN IRON OVERLOAD;;BANTU SIDEROSIS	0.00378788	0.13924944597147007
DOPAMINE BETA-HYDROXYLASE, PLASMA, THERMOLABILITY OF	0.00378788	0.13924944597147007
VENTRICULAR TACHYCARDIA, FAMILIAL	0.00378788	0.13924944597147007
COLLAGENOSIS, FAMILIAL REACTIVE PERFORATING	0.00378788	0.13924944597147007
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00378788	0.13924944597147007
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.00378788	0.13924944597147007
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00378788	0.13924944597147007
TINEA IMBRICATA, SUSCEPTIBILITY TO	0.00378788	0.13924944597147007
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.00378788	0.13924944597147007
FINGERPRINT BODY MYOPATHY	0.00378788	0.13924944597147007
CARDIAC LIPIDOSIS, FAMILIAL	0.00378788	0.13924944597147007
CUTANEOUS COLLAGENOUS VASCULOPATHY	0.00378788	0.13924944597147007
PREMATURE CENTROMERE DIVISION; PCD	0.00378788	0.13924944597147007
CEPHALIN LIPIDOSIS	0.00378788	0.13924944597147007
AREDYLD	0.00378788	0.13924944597147007
OSTEOGENESIS IMPERFECTA, TYPE V	0.00378788	0.13924944597147007
CILIARY DISCOORDINATION DUE TO RANDOM CILIARY ORIENTATION	0.00378788	0.13924944597147007
SHORT STATURE SYNDROME, BRUSSELS TYPE	0.00378788	0.13924944597147007
DERMATITIS, ATOPIC	0.00378788	0.13924944597147007
CITRULLINE TRANSPORT DEFECT	0.00378788	0.13924944597147007
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.00378788	0.13924944597147007
ANEMIA, NONSPHEROCYTIC HEMOLYTIC, ASSOCIATED WITH ABNORMALITY OF REDCELL MEMBRANE	0.00378788	0.13924944597147007
PENDRED SYNDROME	0.00378788	0.13924944597147007
ANEMIA, HYPOCHROMIC MICROCYTIC, WITH IRON OVERLOAD 1; AHMIO1	0.00378788	0.13924944597147007
ANEMIA, AUTOIMMUNE HEMOLYTIC	0.00378788	0.13924944597147007
AMOBARBITAL, DEFICIENT N-HYDROXYLATION OF	0.00378788	0.13924944597147007
VISCERAL MYOPATHY, FAMILIAL, WITH EXTERNAL OPHTHALMOPLEGIA	0.00378788	0.13924944597147007
T-SUBSTANCE ANOMALY	0.00378788	0.13924944597147007
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.00378788	0.13924944597147007
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00378788	0.13924944597147007
OSTEOGENIC SARCOMA	0.00378788	0.13924944597147007
SPERMATOGENIC FAILURE 1; SPGF1	0.00378788	0.13924944597147007
OCULORENOCEREBELLAR SYNDROME	0.00378788	0.13924944597147007
257960 OCULOTRICHODYSPLASIA; OTD	0.00378788	0.13924944597147007
%257600 OCULAR MYOPATHY WITH CURARE SENSITIVITY	0.00378788	0.13924944597147007
NEUTROPHIL ACTIN DYSFUNCTION	0.00378788	0.13924944597147007
PROPERDIN DEFICIENCY, X-LINKED	0.00378788	0.13924944597147007
256720 NEUROLOGIC DISEASE, INFANTILE MULTISYSTEM, WITH OSSEOUS FRAGILITY	0.00378788	0.13924944597147007
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00378788	0.13924944597147007
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.00378788	0.13924944597147007
MYOPATHY, GRANULOVACUOLAR LOBULAR, WITH ELECTRICAL MYOTONIA	0.00378788	0.13924944597147007
MYELOPEROXIDASE DEFICIENCY	0.00378788	0.13924944597147007
MYASTHENIA, CONGENITAL, REFRACTORY TO ACETYLCHOLINESTERASE INHIBITORS	0.00378788	0.13924944597147007
SODIUM-POTASSIUM-ATPASE ACTIVITY OF RED CELL	0.00378788	0.13924944597147007
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00378788	0.13924944597147007
CARDIAC VALVULAR DYSPLASIA, X-LINKED; CVD1	0.00378788	0.13924944597147007
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00378788	0.13924944597147007
%270150 SJOGREN SYNDROME;;SICCA SYNDROME	0.00378788	0.13924944597147007
%253240 MUCUS INSPISSATION OF RESPIRATORY TRACT	0.00378788	0.13924944597147007
PREMATURE OVARIAN FAILURE 1	0.00378788	0.13924944597147007
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS, X-LINKED	0.00378788	0.13924944597147007
LUTHERAN SUPPRESSOR, X-LINKED	0.00378788	0.13924944597147007
SPERMATOGENIC FAILURE, X-LINKED, 2; SPGFX2	0.00378788	0.13924944597147007
PYGMY	0.00378788	0.13924944597147007
SURFACTANT METABOLISM DYSFUNCTION, PULMONARY, 1; SMDP1	0.00378788	0.13924944597147007
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.00378788	0.13924944597147007
PSEUDOURIDINURIA AND MENTAL DEFECT	0.00378788	0.13924944597147007
17-@BETA HYDROXYSTEROID DEHYDROGENASE III DEFICIENCY	0.00378788	0.13924944597147007
PROGESTERONE RESISTANCE	0.00378788	0.13924944597147007
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00378788	0.13924944597147007
INTERSTITIAL PNEUMONITIS, DESQUAMATIVE, FAMILIAL; DIP	0.00378788	0.13924944597147007
PLATELET PROSTACYCLIN RECEPTOR DEFECT	0.00378788	0.13924944597147007
PITUITARY DWARFISM IV	0.00378788	0.13924944597147007
LARON SYNDROME	0.00378788	0.13924944597147007
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00378788	0.13924944597147007
253320 MULTICORE MYOPATHY WITH MENTAL RETARDATION, SHORT STATURE, AND HYPOGONADOTROPICHYPOGONADISM;;CHUDLEY SYNDROME	0.00378788	0.13924944597147007
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.00378788	0.13924944597147007
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.00378788	0.13924944597147007
238800 HYPERMETABOLISM DUE TO DEFECT IN MITOCHONDRIA	0.00378788	0.13924944597147007
ONCOCYTOMA	0.00378788	0.13924944597147007
SERTOLI CELL-ONLY SYNDROME	0.00378788	0.13924944597147007
GLUTATHIONURIA	0.00378788	0.13924944597147007
THYROID CANCER, NONMEDULLARY, 2; NMTC2	0.00378788	0.13924944597147007
GAMMA-GLUTAMYLCYSTEINE SYNTHETASE DEFICIENCY, HEMOLYTIC ANEMIA DUETO	0.00378788	0.13924944597147007
600333 MOTOR NEURON DISEASE WITH DEMENTIA AND OPHTHALMOPLEGIA	0.00378788	0.13924944597147007
600459 ARTERIAL DISSECTION WITH LENTIGINOSIS	0.00378788	0.13924944597147007
CONE-ROD DYSTROPHY 1; CORD1	0.00378788	0.13924944597147007
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.00378788	0.13924944597147007
BARTTER SYNDROME	0.00378788	0.13924944597147007
HYPOGONADOTROPIC HYPOGONADISM 24 WITHOUT ANOSMIA; HH24	0.00378788	0.13924944597147007
SCHIZOPHRENIA 4	0.00378788	0.13924944597147007
FETAL IODINE DEFICIENCY DISORDER	0.00378788	0.13924944597147007
HYPOGONADOTROPIC HYPOGONADISM 23 WITHOUT ANOSMIA; HH23	0.00378788	0.13924944597147007
ETHANOLAMINOSIS	0.00378788	0.13924944597147007
HOOFT DISEASE	0.00378788	0.13924944597147007
HYPOASCORBEMIA	0.00378788	0.13924944597147007
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00378788	0.13924944597147007
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00378788	0.13924944597147007
METAPHYSEAL CHONDRODYSPLASIA, PENA TYPE	0.00378788	0.13924944597147007
XM SYSTEM	0.00378788	0.13924944597147007
DELETED IN AZOOSPERMIA	0.00378788	0.13924944597147007
GONADOBLASTOMA	0.00378788	0.13924944597147007
MAGNESIUM, ELEVATED RED CELL	0.00378788	0.13924944597147007
LYMPHOKINE DEFICIENCY	0.00378788	0.13924944597147007
LYMPHOBLASTIC TRANSFORMATION, INTRINSIC DEFECT IN	0.00378788	0.13924944597147007
LYMPHOBLASTIC TRANSFORMATION, INHIBITION OF	0.00378788	0.13924944597147007
LIPASE DEFICIENCY, COMBINED	0.00378788	0.13924944597147007
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.00378788	0.13924944597147007
ASPLENIA, ISOLATED CONGENITAL; ICAS	0.00378788	0.13924944597147007
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.00378788	0.13924944597147007
ACETYLATION, SLOW	0.00378788	0.13924944597147007
INOSINE PHOSPHORYLASE DEFICIENCY, IMMUNE DEFECT DUE TO	0.00378788	0.13924944597147007
TESTICULAR GERM CELL TUMOR; TGCT	0.00378788	0.13924944597147007
MACROCYTOSIS, FAMILIAL	0.00378788	0.13924944597147007
ICHTHYOSIS, X-LINKED	0.00378788	0.13924944597147007
PHAGOCYTOSIS, PLASMA-RELATED DEFECT IN	0.00378788	0.13924944597147007
PACMAN DYSPLASIA	0.00378788	0.13924944597147007
103230 ADRENOCORTICAL HYPOFUNCTION, CHRONIC PRIMARY CONGENITAL;;ADDISON DISEASE, CONGENITAL	0.00378788	0.13924944597147007
POLYCYSTIC OVARY SYNDROME 1	0.00378788	0.13924944597147007
SPONDYLOEPIPHYSEAL DYSPLASIA WITH PUNCTATE CORNEAL DYSTROPHY	0.00378788	0.13924944597147007
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 2	0.00378788	0.13924944597147007
FLOOD FACTOR DEFICIENCY	0.00378788	0.13924944597147007
MACULAR CORNEAL DYSTROPHY	0.00378788	0.13924944597147007
BEETURIA	0.00378788	0.13924944597147007
BLOOD GROUP, DUFFY SYSTEM; FY	0.00378788	0.13924944597147007
MYOPATHY, SPHEROID BODY	0.00378788	0.13924944597147007
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.00378788	0.13924944597147007
CARBOXYLESTERASE 1	0.00378788	0.13924944597147007
HEINZ BODY ANEMIAS	0.00378788	0.13924944597147007
CATECHOL-O-METHYLTRANSFERASE	0.00378788	0.13924944597147007
CHOROIDAL OSTEOMA, BILATERAL	0.00378788	0.13924944597147007
CORONARY ARTERY DISSECTION, SPONTANEOUS	0.00378788	0.13924944597147007
PARAOXONASE 1	0.00378788	0.13924944597147007
COUMARIN RESISTANCE	0.00378788	0.13924944597147007
CYTOCHROME P450, SUBFAMILY I, POLYPEPTIDE 2	0.00378788	0.13924944597147007
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.00378788	0.13924944597147007
GLUTATHIONE REDUCTASE	0.00378788	0.13924944597147007
GLOMUVENOUS MALFORMATIONS	0.00378788	0.13924944597147007
TRANSIENT BULLOUS DERMOLYSIS OF THE NEWBORN	0.00378788	0.13924944597147007
PSEUDOCHOLINESTERASE, INCREASE IN PLASMA LEVEL OF	0.00378788	0.13924944597147007
EPOXIDE HYDROLASE 1, MICROSOMAL	0.00378788	0.13924944597147007
PELVIC LIPOMATOSIS WITH CROSSED RENAL ECTOPIA	0.00378788	0.13924944597147007
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00378788	0.13924944597147007
NORMOKALEMIC PERIODIC PARALYSIS	0.00378788	0.13924944597147007
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00378788	0.13924944597147007
PERRY SYNDROME	0.00378788	0.13924944597147007
OVARIAN CANCER	0.00378788	0.13924944597147007
MYOTONIC MYOPATHY WITH CYLINDRICAL SPIRALS	0.00378788	0.13924944597147007
ALAND ISLAND EYE DISEASE	0.00378788	0.13924944597147007
APOLIPOPROTEIN(A)	0.00378788	0.13924944597147007
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.00378788	0.13924944597147007
KERATOSIS, FAMILIAL ACTINIC	0.00378788	0.13924944597147007
ICHTHYOSIS HYSTRIX, CURTH-MACKLIN TYPE	0.00378788	0.13924944597147007
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00378788	0.13924944597147007
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00378788	0.13924944597147007
HYPERPROGLUCAGONEMIA	0.00378788	0.13924944597147007
CALVARIAL HYPEROSTOSIS	0.00378788	0.13924944597147007
CONE DYSTROPHY, X-LINKED, WITH TAPETAL-LIKE SHEEN	0.00378788	0.13924944597147007
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00378788	0.13924944597147007
JOUBERT SYNDROME 14	0.003653974	0.13432681476027655
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.003653974	0.13432681476027655
OCULODENTODIGITAL DYSPLASIA; ODDD	0.0036498389999999998	0.13417480454371952
OROFACIODIGITAL SYNDROME TYPE 1	0.0036498389999999998	0.13417480454371952
MILLER-DIEKER SYNDROME	0.0036498389999999998	0.13417480454371952
CLASSIC GALACTOSEMIA	0.0036462999999999995	0.1340447043849782
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0036462999999999995	0.1340447043849782
VISCERAL MYOPATHY; VSCM	0.00357143	0.13129234527648379
NK-CELL ENTEROPATHY	0.00357143	0.13129234527648379
WOUND BOTULISM	0.00357143	0.13129234527648379
OCHOA SYNDROME	0.00357143	0.13129234527648379
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.13129234527648379
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.13129234527648379
RHEUMATIC FEVER	0.00357143	0.13129234527648379
SHEEHAN SYNDROME	0.00357143	0.13129234527648379
GRFOMA	0.00357143	0.13129234527648379
PPOMA	0.00357143	0.13129234527648379
GLUCAGONOMA	0.00357143	0.13129234527648379
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.13129234527648379
SOMATOSTATINOMA	0.00357143	0.13129234527648379
PANHYPOPITUITARISM	0.00357143	0.13129234527648379
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00357143	0.13129234527648379
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.13129234527648379
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.13129234527648379
PRUNE BELLY SYNDROME	0.00357143	0.13129234527648379
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.00357143	0.13129234527648379
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.13129234527648379
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00357143	0.13129234527648379
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.13129234527648379
LIDDLE SYNDROME	0.00357143	0.13129234527648379
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.13129234527648379
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.13129234527648379
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.13129234527648379
MALT LYMPHOMA	0.00357143	0.13129234527648379
PUDENDAL NEURALGIA	0.00357143	0.13129234527648379
UROFACIAL SYNDROME	0.00357143	0.13129234527648379
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.13129234527648379
IATROGENIC BOTULISM	0.00357143	0.13129234527648379
BOTULISM	0.00357143	0.13129234527648379
KAPUR-TORIELLO SYNDROME	0.00357143	0.13129234527648379
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.13129234527648379
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.13129234527648379
INHALATIONAL BOTULISM	0.00357143	0.13129234527648379
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.13129234527648379
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.13129234527648379
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.13129234527648379
PSEUDOMYXOMA PERITONEI	0.00357143	0.13129234527648379
FOODBORNE BOTULISM	0.00357143	0.13129234527648379
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.13129234527648379
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.13129234527648379
MYXEDEMA	0.00357143	0.13129234527648379
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.13129234527648379
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.13129234527648379
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.13129234527648379
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.13129234527648379
UROFACIAL SYNDROME 2	0.00357143	0.13129234527648379
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.13129234527648379
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.13129234527648379
ADIPOSIS DOLOROSA	0.00357143	0.13129234527648379
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00357143	0.13129234527648379
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.13129234527648379
HINMAN SYNDROME	0.00357143	0.13129234527648379
FG SYNDROME 2; FGS2	0.00357143	0.13129234527648379
CAP POLYPOSIS	0.00357143	0.13129234527648379
TOWNES-BROCKS SYNDROME	0.00357143	0.13129234527648379
ATTRV30M AMYLOIDOSIS	0.00357143	0.13129234527648379
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.13129234527648379
PURE AUTONOMIC FAILURE	0.00357143	0.13129234527648379
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.13129234527648379
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.13129234527648379
WAARDENBURG-SHAH SYNDROME	0.00357143	0.13129234527648379
NEPHROPATHIC INFANTILE CYSTINOSIS	0.00357143	0.13129234527648379
PORPHYRIA VARIEGATA	0.00357143	0.13129234527648379
PARATHYROID CARCINOMA	0.00357143	0.13129234527648379
HIRSCHSPRUNG DISEASE	0.00357143	0.13129234527648379
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00357143	0.13129234527648379
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.13129234527648379
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.13129234527648379
CODAS SYNDROME	0.0034038640000000004	0.12513231046448992
OROFACIODIGITAL SYNDROME VI	0.0034038640000000004	0.12513231046448992
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0034038640000000004	0.12513231046448992
TRISOMY 18	0.0034038640000000004	0.12513231046448992
17Q21.31 MICRODUPLICATION SYNDROME	0.0034038640000000004	0.12513231046448992
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.0034038640000000004	0.12513231046448992
MONOSOMY 18P	0.0034038640000000004	0.12513231046448992
14Q22Q23 MICRODELETION SYNDROME	0.0034038640000000004	0.12513231046448992
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.0034038640000000004	0.12513231046448992
LATERAL MENINGOCELE SYNDROME	0.0034038640000000004	0.12513231046448992
HADZISELIMOVIC SYNDROME	0.0034038640000000004	0.12513231046448992
DISTAL MONOSOMY 9P	0.0034038640000000004	0.12513231046448992
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0034038640000000004	0.12513231046448992
8Q12 MICRODUPLICATION SYNDROME	0.003403864	0.12513231046448992
TETRASOMY X	0.003403864	0.12513231046448992
CHROMOSOME 18Q DELETION SYNDROME	0.003399729	0.12498030024793289
ZUNICH NEUROECTODERMAL SYNDROME	0.003399729	0.12498030024793289
POTOCKI-SHAFFER SYNDROME	0.003399729	0.12498030024793289
WOLCOTT-RALLISON SYNDROME	0.003399729	0.12498030024793289
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.003399729	0.12498030024793289
DISTAL MONOSOMY 3P	0.0033997289999999998	0.12498030024793287
INFANTILE SYSTEMIC HYALINOSIS	0.0033961899999999995	0.12485020008919155
NATIVE AMERICAN MYOPATHY	0.0033961899999999995	0.12485020008919155
STUVE-WIEDEMANN SYNDROME	0.0033961899999999995	0.12485020008919155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.003256173	0.11970291726170301
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.003256173	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.003256173	0.11970291726170301
COFFIN-SIRIS SYNDROME 3; CSS3	0.003256173	0.11970291726170301
COFFIN-SIRIS SYNDROME 4; CSS4	0.003256173	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.003256173	0.11970291726170301
ZTTK SYNDROME; ZTTKS	0.003256173	0.11970291726170301
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.003256173	0.11970291726170301
COFFIN-SIRIS SYNDROME 2; CSS2	0.003256173	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.003256173	0.11970291726170301
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.003256173	0.11970291726170301
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.003256173	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.003256173	0.11970291726170301
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.003256173	0.11970291726170301
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.003256173	0.11970291726170301
WIEACKER-WOLFF SYNDROME	0.003256173	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.003256173	0.11970291726170301
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.003256173	0.11970291726170301
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.003256173	0.11970291726170301
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.003256173	0.11970291726170301
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.003256173	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.003256173	0.11970291726170301
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.003256173	0.11970291726170301
BOHRING-OPITZ SYNDROME	0.003256173	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.003256173	0.11970291726170301
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.003256173	0.11970291726170301
GAUCHER DISEASE, TYPE II	0.003256173	0.11970291726170301
17Q12 MICRODELETION SYNDROME	0.003256173	0.11970291726170301
HELSMOORTEL-VAN DER AA SYNDROME	0.003256173	0.11970291726170301
KBG SYNDROME	0.003256173	0.11970291726170301
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.003256173	0.11970291726170301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.003256173	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.003256173	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.003256173	0.11970291726170301
SSR4-CDG	0.003256173	0.11970291726170301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.003256173	0.11970291726170301
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.003256173	0.11970291726170301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.003256173	0.11970291726170301
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.003256173	0.11970291726170301
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.003256173	0.11970291726170301
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.003256173	0.11970291726170301
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.003256173	0.11970291726170301
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.003256173	0.11970291726170301
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.003256173	0.11970291726170301
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.003256173	0.11970291726170301
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.003256173	0.11970291726170301
STT3A-CDG	0.0032561729999999994	0.11970291726170298
STT3B-CDG	0.0032561729999999994	0.11970291726170298
GENITOPATELLAR SYNDROME	0.0032561729999999994	0.11970291726170298
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0032561729999999994	0.11970291726170298
JOUBERT SYNDROME 6	0.0032496440000000003	0.11946289919546342
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0032496440000000003	0.11946289919546342
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0032496440000000003	0.11946289919546342
JOUBERT SYNDROME 2	0.0032496440000000003	0.11946289919546342
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0032496440000000003	0.11946289919546342
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0032496440000000003	0.11946289919546342
ARIMA SYNDROME	0.0032496440000000003	0.11946289919546342
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0032496439999999994	0.11946289919546338
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.0032496439999999994	0.11946289919546338
JOUBERT SYNDROME 8	0.0032496439999999994	0.11946289919546338
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0032496439999999994	0.11946289919546338
WAARDENBURG-SHAH SYNDROME	0.0032496439999999994	0.11946289919546338
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0032496439999999994	0.11946289919546338
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.0032496439999999994	0.11946289919546338
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.0032496439999999994	0.11946289919546338
PELIZAEUS-MERZBACHER DISEASE	0.003245509	0.11931088897890639
KALLMANN SYNDROME	0.003245509	0.11931088897890639
LEIGH SYNDROME	0.003245509	0.11931088897890639
BETA-KETOTHIOLASE DEFICIENCY	0.003245509	0.11931088897890639
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003245509	0.11931088897890639
DYSEQUILIBRIUM SYNDROME	0.003245509	0.11931088897890639
CYCLIC VOMITING SYNDROME	0.003245509	0.11931088897890639
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.003245509	0.11931088897890639
ISOLATED CEREBELLAR AGENESIS	0.003245509	0.11931088897890639
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.003245509	0.11931088897890639
METACHROMATIC LEUKODYSTROPHY	0.003245509	0.11931088897890639
SIALIDOSIS TYPE 1	0.003245509	0.11931088897890639
GM1 GANGLIOSIDOSIS	0.003245509	0.11931088897890639
METACHROMATIC LEUKODYSTROPHY	0.003245509	0.11931088897890639
TRIPLE A SYNDROME	0.003245509	0.11931088897890639
ANGELMAN SYNDROME	0.003245509	0.11931088897890639
CAMOS SYNDROME	0.0032455089999999997	0.11931088897890636
LAURENCE-MOON SYNDROME	0.0031084199999999998	0.11427124482471382
8Q21.11 MICRODELETION SYNDROME	0.00285831	0.10507674052892717
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00285831	0.10507674052892717
DOWN SYNDROME	0.00285831	0.10507674052892717
CAREY-FINEMAN-ZITER SYNDROME	0.00285831	0.10507674052892717
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00285831	0.10507674052892717
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00285831	0.10507674052892717
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00285831	0.10507674052892717
6P22 MICRODELETION SYNDROME	0.00285831	0.10507674052892717
MONOSOMY 13Q14	0.00285831	0.10507674052892717
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00285831	0.10507674052892717
HYPOTONIA-CYSTINURIA SYNDROME	0.00285831	0.10507674052892717
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00285831	0.10507674052892717
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00285831	0.10507674052892717
NEUROFACIODIGITORENAL SYNDROME	0.00285831	0.10507674052892717
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00285831	0.10507674052892717
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00285831	0.10507674052892717
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00285831	0.10507674052892717
CARTILAGE-HAIR HYPOPLASIA	0.00285831	0.10507674052892717
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.002718293	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.002718293	0.09992945770143863
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.002718293	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002718293	0.09992945770143863
DISTAL MONOSOMY 1Q	0.002718293	0.09992945770143863
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.002718293	0.09992945770143863
XQ25 DUPLICATION SYNDROME	0.002718293	0.09992945770143863
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002718293	0.09992945770143863
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.002718293	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.002718293	0.09992945770143863
MENTAL RETARDATION, X-LINKED 91; MRX91	0.002718293	0.09992945770143863
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.002718293	0.09992945770143863
XQ25 MICRODUPLICATION SYNDROME	0.002718293	0.09992945770143863
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0027182929999999997	0.09992945770143861
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.0027182929999999997	0.09992945770143861
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.0027182929999999997	0.09992945770143861
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.0027182929999999997	0.09992945770143861
6Q25 MICRODELETION SYNDROME	0.0027182929999999997	0.09992945770143861
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0027182929999999997	0.09992945770143861
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0027182929999999997	0.09992945770143861
MATERNAL PHENYLKETONURIA	0.0027182929999999997	0.09992945770143861
AL KAISSI SYNDROME; ALKAS	0.0027182929999999997	0.09992945770143861
POTOCKI-SHAFFER SYNDROME	0.0027182929999999997	0.09992945770143861
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.0027182929999999997	0.09992945770143861
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.0027182929999999997	0.09992945770143861
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0027182929999999997	0.09992945770143861
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0027182929999999997	0.09992945770143861
SIALURIA	0.0027182929999999997	0.09992945770143861
20Q11.2 MICRODUPLICATION SYNDROME	0.0027182929999999997	0.09992945770143861
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0027182929999999997	0.09992945770143861
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.0027182929999999997	0.09992945770143861
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.0027182929999999997	0.09992945770143861
15Q24 MICRODELETION SYNDROME	0.0027182929999999997	0.09992945770143861
MAN1B1-CDG	0.0027182929999999997	0.09992945770143861
OCULOECTODERMAL SYNDROME; OES	0.0027182929999999997	0.09992945770143861
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0027182929999999997	0.09992945770143861
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.0027182929999999997	0.09992945770143861
EAR-PATELLA-SHORT STATURE SYNDROME	0.0027147539999999998	0.0997993575426973
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0027147539999999998	0.0997993575426973
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0027147539999999998	0.0997993575426973
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0027147539999999998	0.0997993575426973
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.0027147539999999998	0.0997993575426973
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0027147539999999998	0.0997993575426973
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.0027147539999999998	0.0997993575426973
TYSHCHENKO SYNDROME	0.0027147539999999998	0.0997993575426973
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0027147539999999998	0.0997993575426973
TONNE-KALSCHEUER SYNDROME; TOKAS	0.0027147539999999998	0.0997993575426973
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.0027147539999999998	0.0997993575426973
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0027147539999999998	0.0997993575426973
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0027147539999999998	0.0997993575426973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0027147539999999998	0.0997993575426973
AURICULOCONDYLAR SYNDROME	0.0027147539999999998	0.0997993575426973
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.0027147539999999998	0.0997993575426973
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.0027147539999999998	0.0997993575426973
POPOV-CHANG SYNDROME; POPCHAS	0.0027147539999999998	0.0997993575426973
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0027147539999999998	0.0997993575426973
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.0027147539999999998	0.0997993575426973
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0027147539999999998	0.0997993575426973
OROFACIODIGITAL SYNDROME TYPE 4	0.0027147539999999998	0.0997993575426973
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.0027147539999999998	0.0997993575426973
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0027147539999999998	0.0997993575426973
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0027147539999999998	0.0997993575426973
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0027147539999999998	0.0997993575426973
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.0027147539999999998	0.0997993575426973
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.0027106189999999996	0.09964734732614026
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0027106189999999996	0.09964734732614026
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.0027106189999999996	0.09964734732614026
CRISPONI SYNDROME	0.0027106189999999996	0.09964734732614026
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.0027106189999999996	0.09964734732614026
16Q24.3 MICRODELETION SYNDROME	0.0027106189999999996	0.09964734732614026
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.0027106189999999996	0.09964734732614026
SMITH-KINGSMORE SYNDROME; SKS	0.0027106189999999996	0.09964734732614026
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.0027106189999999996	0.09964734732614026
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027106189999999996	0.09964734732614026
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.0027106189999999996	0.09964734732614026
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.0027106189999999996	0.09964734732614026
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.09964734732614026
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0027106189999999996	0.09964734732614026
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0027106189999999996	0.09964734732614026
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0027106189999999996	0.09964734732614026
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0027106189999999996	0.09964734732614026
17Q24.2 MICRODELETION SYNDROME	0.0027106189999999996	0.09964734732614026
MUCOLIPIDOSIS TYPE IV	0.00270409	0.09940732925990067
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00270409	0.09940732925990067
PIEBALDISM	0.00270409	0.09940732925990067
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00270409	0.09940732925990067
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00270409	0.09940732925990067
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00270409	0.09940732925990067
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00270409	0.09940732925990067
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00270409	0.09940732925990067
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.00270409	0.09940732925990067
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00270409	0.09940732925990067
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00270409	0.09940732925990067
JOUBERT SYNDROME 5	0.00270409	0.09940732925990067
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.00270409	0.09940732925990067
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00270409	0.09940732925990067
CEREBELLAR HYPOPLASIA	0.00270409	0.09940732925990067
ABETALIPOPROTEINEMIA	0.00270409	0.09940732925990067
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00270409	0.09940732925990067
KEARNS-SAYRE SYNDROME	0.00270409	0.09940732925990067
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.00270409	0.09940732925990067
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00270409	0.09940732925990067
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.002564073	0.09426004643241212
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002564073	0.09426004643241212
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.0025640729999999996	0.09426004643241209
CEDNIK SYNDROME	0.0025640729999999996	0.09426004643241209
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.0025640729999999996	0.09426004643241209
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0025640729999999996	0.09426004643241209
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0025640729999999996	0.09426004643241209
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0025640729999999996	0.09426004643241209
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0025640729999999996	0.09426004643241209
CHÉDIAK-HIGASHI SYNDROME	0.0025640729999999996	0.09426004643241209
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.0025640729999999996	0.09426004643241209
SRD5A3-CDG	0.0025640729999999996	0.09426004643241209
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0025640729999999996	0.09426004643241209
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0025640729999999996	0.09426004643241209
COWDEN SYNDROME	0.0025640729999999996	0.09426004643241209
NIEMANN-PICK DISEASE TYPE C	0.0025640729999999996	0.09426004643241209
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.0025640729999999996	0.09426004643241209
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.0025640729999999996	0.09426004643241209
CITRULLINEMIA, CLASSIC	0.0025640729999999996	0.09426004643241209
CENTRAL BILATERAL MACROGYRIA	0.0025640729999999996	0.09426004643241209
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0025640729999999996	0.09426004643241209
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.0025640729999999996	0.09426004643241209
MYHRE SYNDROME	0.0025640729999999996	0.09426004643241209
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.0025640729999999996	0.09426004643241209
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.0025640729999999996	0.09426004643241209
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0025640729999999996	0.09426004643241209
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0025640729999999996	0.09426004643241209
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.0025640729999999996	0.09426004643241209
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.0025640729999999996	0.09426004643241209
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0025640729999999996	0.09426004643241209
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0025640729999999996	0.09426004643241209
SULFOCYSTEINURIA	0.0025640729999999996	0.09426004643241209
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.0025640729999999996	0.09426004643241209
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0025640729999999996	0.09426004643241209
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0025640729999999996	0.09426004643241209
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0025640729999999996	0.09426004643241209
EAST SYNDROME	0.0025640729999999996	0.09426004643241209
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.0025640729999999996	0.09426004643241209
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.0025640729999999996	0.09426004643241209
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0025640729999999996	0.09426004643241209
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.0025640729999999996	0.09426004643241209
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0025640729999999996	0.09426004643241209
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.0025640729999999996	0.09426004643241209
CHROMOSOME 1P35 DELETION SYNDROME	0.0025640729999999996	0.09426004643241209
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0025640729999999996	0.09426004643241209
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0025640729999999996	0.09426004643241209
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0025640729999999996	0.09426004643241209
SIALIDOSIS TYPE 2	0.0025640729999999996	0.09426004643241209
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0025640729999999996	0.09426004643241209
FILIPPI SYNDROME	0.002313963	0.08506554213662545
ISOLATED GLYCEROL KINASE DEFICIENCY	0.002313963	0.08506554213662545
FUCOSIDOSIS	0.002313963	0.08506554213662545
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.002313963	0.08506554213662545
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.002313963	0.08506554213662545
GALLOWAY-MOWAT SYNDROME	0.002313963	0.08506554213662545
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.002313963	0.08506554213662545
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002313963	0.08506554213662545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.002313963	0.08506554213662545
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002313963	0.08506554213662545
CHROMOSOME 16P13.2 DELETION SYNDROME	0.002313963	0.08506554213662545
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.002313963	0.08506554213662545
CODAS SYNDROME	0.002313963	0.08506554213662545
3Q29 MICRODUPLICATION SYNDROME	0.002313963	0.08506554213662545
LEBER CONGENITAL AMAUROSIS	0.002313963	0.08506554213662545
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002313963	0.08506554213662545
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.002313963	0.08506554213662545
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002313963	0.08506554213662545
2Q37 MICRODELETION SYNDROME	0.002313963	0.08506554213662545
GRISCELLI SYNDROME, TYPE 1	0.002313963	0.08506554213662545
KLEEFSTRA SYNDROME 2; KLEFS2	0.002313963	0.08506554213662545
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.002313963	0.08506554213662545
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.002313963	0.08506554213662545
ALG3-CDG	0.002313963	0.08506554213662545
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.002313963	0.08506554213662545
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.002313963	0.08506554213662545
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.002313963	0.08506554213662545
RECOMBINANT CHROMOSOME 8 SYNDROME	0.002313963	0.08506554213662545
WALKER-WARBURG SYNDROME	0.002313963	0.08506554213662545
1Q21.1 MICRODUPLICATION SYNDROME	0.002313963	0.08506554213662545
DPAGT1-CDG	0.002313963	0.08506554213662545
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.002313963	0.08506554213662545
CONGENITAL TOXOPLASMOSIS	0.002313963	0.08506554213662545
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.002313963	0.08506554213662545
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.002313963	0.08506554213662545
MICRO SYNDROME	0.002313963	0.08506554213662545
2P21 MICRODELETION SYNDROME	0.002313963	0.08506554213662545
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.002313963	0.08506554213662545
INCONTINENTIA PIGMENTI	0.002313963	0.08506554213662545
VICI SYNDROME; VICIS	0.002313963	0.08506554213662545
MULTIPLE CARBOXYLASE DEFICIENCY	0.002313963	0.08506554213662545
SCHINDLER DISEASE, TYPE I	0.002313963	0.08506554213662545
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.002313963	0.08506554213662545
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.002313963	0.08506554213662545
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.002313963	0.08506554213662545
KETOADIPICACIDURIA	0.002313963	0.08506554213662545
ADAMS-OLIVER SYNDROME 1; AOS1	0.002313963	0.08506554213662545
PYRUVATE CARBOXYLASE DEFICIENCY	0.002313963	0.08506554213662545
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.002313963	0.08506554213662545
SEVERE CANAVAN DISEASE	0.002313963	0.08506554213662545
OPITZ G/BBB SYNDROME	0.0021768739999999996	0.0800258979824329
LIG4 SYNDROME	0.0021768739999999996	0.0800258979824329
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0021768739999999996	0.0800258979824329
FRONTOOCULAR SYNDROME	0.0021768739999999996	0.0800258979824329
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.0021768739999999996	0.0800258979824329
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.0021768739999999996	0.0800258979824329
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.0021768739999999996	0.0800258979824329
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0021768739999999996	0.0800258979824329
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.0800258979824329
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0021768739999999996	0.0800258979824329
AARSKOG-SCOTT SYNDROME	0.0021768739999999996	0.0800258979824329
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.0800258979824329
THAUVIN-ROBINET-FAIVRE SYNDROME	0.0021768739999999996	0.0800258979824329
LYMPHEDEMA, HEREDITARY, III	0.0021768739999999996	0.0800258979824329
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.0021768739999999996	0.0800258979824329
BARATELA-SCOTT SYNDROME	0.0021768739999999996	0.0800258979824329
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.0800258979824329
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.0800258979824329
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0021768739999999996	0.0800258979824329
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.0021768739999999996	0.0800258979824329
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.0800258979824329
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0021768739999999996	0.0800258979824329
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0021768739999999996	0.0800258979824329
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0021768739999999996	0.0800258979824329
DIAPHANOSPONDYLODYSOSTOSIS	0.0021768739999999996	0.0800258979824329
OGDEN SYNDROME; OGDNS	0.0021768739999999996	0.0800258979824329
NOONAN SYNDROME 3; NS3	0.0021768739999999996	0.0800258979824329
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0021768739999999996	0.0800258979824329
MONOSOMY 13Q34	0.0021768739999999996	0.0800258979824329
DISTAL MONOSOMY 6P	0.0021768739999999996	0.0800258979824329
WARSAW BREAKAGE SYNDROME; WABS	0.0021768739999999996	0.0800258979824329
FANCONI ANEMIA	0.0021768739999999996	0.0800258979824329
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0021768739999999996	0.0800258979824329
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0021768739999999996	0.0800258979824329
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0021768739999999996	0.0800258979824329
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.0800258979824329
ICF SYNDROME	0.0021768739999999996	0.0800258979824329
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0021768739999999996	0.0800258979824329
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.0021768739999999996	0.0800258979824329
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.0800258979824329
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0021768739999999996	0.0800258979824329
VASCULAR EHLERS-DANLOS SYNDROME	0.0021768739999999996	0.0800258979824329
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.0021768739999999996	0.0800258979824329
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.0021768739999999996	0.0800258979824329
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.0021768739999999996	0.0800258979824329
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0021768739999999996	0.0800258979824329
NOONAN SYNDROME 5; NS5	0.0021768739999999996	0.0800258979824329
FETAL HYDANTOIN SYNDROME	0.0021768739999999996	0.0800258979824329
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0021768739999999996	0.0800258979824329
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0021768739999999996	0.0800258979824329
FETAL ALCOHOL SYNDROME	0.0021768739999999996	0.0800258979824329
TRISOMY 12P	0.0021768739999999996	0.0800258979824329
PHENOBARBITAL EMBRYOPATHY	0.0021768739999999996	0.0800258979824329
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.0800258979824329
NOONAN SYNDROME 6; NS6	0.0021768739999999996	0.0800258979824329
FETAL TRIMETHADIONE SYNDROME	0.0021768739999999996	0.0800258979824329
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0021768739999999996	0.0800258979824329
ROTHMUND-THOMSON SYNDROME	0.0021768739999999996	0.0800258979824329
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.002172739	0.07987388776587587
TETRASOMY 18P	0.002172739	0.07987388776587587
CHIME SYNDROME	0.002172739	0.07987388776587587
MOMO SYNDROME	0.002172739	0.07987388776587587
FOUNTAIN SYNDROME	0.002172739	0.07987388776587587
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.07987388776587587
KNOBLOCH SYNDROME	0.002172739	0.07987388776587587
OROFACIODIGITAL SYNDROME I; OFD1	0.002172739	0.07987388776587587
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.002172739	0.07987388776587587
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002172739	0.07987388776587587
DUBOWITZ SYNDROME	0.002172739	0.07987388776587587
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.002172739	0.07987388776587587
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.002172739	0.07987388776587587
SAETHRE-CHOTZEN SYNDROME	0.002172739	0.07987388776587587
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.002172739	0.07987388776587587
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.002172739	0.07987388776587587
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.002172739	0.07987388776587587
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.002172739	0.07987388776587587
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.07987388776587587
HENNEKAM SYNDROME	0.002172739	0.07987388776587587
RENPENNING SYNDROME	0.002172739	0.07987388776587587
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002172739	0.07987388776587587
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.002172739	0.07987388776587587
MECKEL SYNDROME, TYPE 10; MKS10	0.002172739	0.07987388776587587
TRIGEMINAL NEURALGIA	0.0021691999999999996	0.07974378760713456
CHILDHOOD APRAXIA OF SPEECH	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.0021691999999999996	0.07974378760713456
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0021691999999999996	0.07974378760713456
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713456
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.0021691999999999996	0.07974378760713456
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.0021691999999999996	0.07974378760713456
19Q13.11 MICRODELETION SYNDROME	0.0021691999999999996	0.07974378760713456
FONTAINE PROGEROID SYNDROME; FPS	0.0021691999999999996	0.07974378760713456
ADENOCARCINOMA OF OVARY	0.0021691999999999996	0.07974378760713456
BETA-THALASSEMIA MAJOR	0.0021691999999999996	0.07974378760713456
LOCKED-IN SYNDROME	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0021691999999999996	0.07974378760713456
CRISS-CROSS HEART	0.0021691999999999996	0.07974378760713456
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0021691999999999996	0.07974378760713456
CEREBROCOSTOMANDIBULAR SYNDROME	0.0021691999999999996	0.07974378760713456
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.0021691999999999996	0.07974378760713456
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.0021691999999999996	0.07974378760713456
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0021691999999999996	0.07974378760713456
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.0021691999999999996	0.07974378760713456
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0021691999999999996	0.07974378760713456
NEMALINE MYOPATHY 2; NEM2	0.0021691999999999996	0.07974378760713456
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.0021691999999999996	0.07974378760713456
PEROXISOME BIOGENESIS DISORDER 11B	0.0021691999999999996	0.07974378760713456
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713456
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.0021691999999999996	0.07974378760713456
FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.07974378760713456
TYPICAL NEMALINE MYOPATHY	0.0021691999999999996	0.07974378760713456
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0021691999999999996	0.07974378760713456
LARYNGOTRACHEAL ANGIOMA	0.0021691999999999996	0.07974378760713456
CHOANAL ATRESIA	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.0021691999999999996	0.07974378760713456
SANDIFER SYNDROME	0.0021691999999999996	0.07974378760713456
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0021691999999999996	0.07974378760713456
JUNCTIONAL EPIDERMOLYSIS BULLOSA, GENERALIZED SEVERE	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 2C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS2C	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0021691999999999996	0.07974378760713456
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 4B, FAST-CHANNEL; CMS4B	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.0021691999999999996	0.07974378760713456
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0021691999999999996	0.07974378760713456
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.0021691999999999996	0.07974378760713456
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0021691999999999996	0.07974378760713456
ATRESIA OF SMALL INTESTINE	0.0021691999999999996	0.07974378760713456
ADULT-ONSET NEMALINE MYOPATHY	0.0021691999999999996	0.07974378760713456
CHARGE SYNDROME	0.0021691999999999996	0.07974378760713456
MEIER-GORLIN SYNDROME 6; MGORS6	0.0021691999999999996	0.07974378760713456
DOUBLE OUTLET RIGHT VENTRICLE	0.0021691999999999996	0.07974378760713456
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.0021691999999999996	0.07974378760713456
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.0021691999999999996	0.07974378760713456
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.0021691999999999996	0.07974378760713456
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.0021691999999999996	0.07974378760713456
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.0021691999999999996	0.07974378760713456
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0021691999999999996	0.07974378760713456
MEIER-GORLIN SYNDROME 3; MGORS3	0.0021691999999999996	0.07974378760713456
PRIMARY DYSTONIA, DYT2 TYPE	0.0021691999999999996	0.07974378760713456
MEIER-GORLIN SYNDROME 2; MGORS2	0.0021691999999999996	0.07974378760713456
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0021691999999999996	0.07974378760713456
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.0020226539999999996	0.07435648671340639
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.0020226539999999996	0.07435648671340639
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0020226539999999996	0.07435648671340639
RICHARDS-RUNDLE SYNDROME; RRNS	0.0020226539999999996	0.07435648671340639
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 17; JBTS17	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 21	0.0020226539999999996	0.07435648671340639
MECKEL SYNDROME 13; MKS13	0.0020226539999999996	0.07435648671340639
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.0020226539999999996	0.07435648671340639
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.0020226539999999996	0.07435648671340639
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.0020226539999999996	0.07435648671340639
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 7	0.0020226539999999996	0.07435648671340639
IMMUNODEFICIENCY 23; IMD23	0.0020226539999999996	0.07435648671340639
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 27	0.0020226539999999996	0.07435648671340639
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 28	0.0020226539999999996	0.07435648671340639
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0020226539999999996	0.07435648671340639
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0020226539999999996	0.07435648671340639
BARDET-BIEDL SYNDROME 1; BBS1	0.0020226539999999996	0.07435648671340639
USHER SYNDROME TYPE 1	0.0020226539999999996	0.07435648671340639
OXOGLUTARIC ACIDURIA	0.0020226539999999996	0.07435648671340639
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0020226539999999996	0.07435648671340639
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.0020226539999999996	0.07435648671340639
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0020226539999999996	0.07435648671340639
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 15	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 33; JBTS33	0.0020226539999999996	0.07435648671340639
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0020226539999999996	0.07435648671340639
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0020226539999999996	0.07435648671340639
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 25	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 32; JBTS32	0.0020226539999999996	0.07435648671340639
PEROXISOME BIOGENESIS DISORDER 6B	0.0020226539999999996	0.07435648671340639
SENIOR-LOKEN SYNDROME	0.0020226539999999996	0.07435648671340639
PELLAGRA-LIKE SYNDROME	0.0020226539999999996	0.07435648671340639
NAVAJO NEUROHEPATOPATHY	0.0020226539999999996	0.07435648671340639
HOYERAAL-HREIDARSSON SYNDROME	0.0020226539999999996	0.07435648671340639
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0020226539999999996	0.07435648671340639
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.0020226539999999996	0.07435648671340639
JOUBERT SYNDROME 35; JBTS35	0.0020226539999999996	0.07435648671340639
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0020226539999999996	0.07435648671340639
FLYNN-AIRD SYNDROME	0.002018519	0.07420447649684937
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.002018519	0.07420447649684937
LISSENCEPHALY 3; LIS3	0.002018519	0.07420447649684937
ALEXANDER DISEASE	0.002018519	0.07420447649684937
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.002018519	0.07420447649684937
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07420447649684937
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.002018519	0.07420447649684937
PERRAULT SYNDROME 5; PRLTS5	0.002018519	0.07420447649684937
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.002018519	0.07420447649684937
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.002018519	0.07420447649684937
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.002018519	0.07420447649684937
RETT SYNDROME	0.002018519	0.07420447649684937
ATYPICAL TERATOID RHABDOID TUMOR	0.002018519	0.07420447649684937
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.002018519	0.07420447649684937
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.002018519	0.07420447649684937
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.002018519	0.07420447649684937
CEREBELLOPARENCHYMAL DISORDER II	0.002018519	0.07420447649684937
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.002018519	0.07420447649684937
XERODERMA PIGMENTOSUM	0.002018519	0.07420447649684937
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.002018519	0.07420447649684937
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002018519	0.07420447649684937
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.002018519	0.07420447649684937
SANDHOFF DISEASE	0.002018519	0.07420447649684937
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.002018519	0.07420447649684937
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.002018519	0.07420447649684937
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.002018519	0.07420447649684937
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.002018519	0.07420447649684937
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.002018519	0.07420447649684937
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.002018519	0.07420447649684937
KUFOR-RAKEB SYNDROME	0.002018519	0.07420447649684937
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.002018519	0.07420447649684937
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.002018519	0.07420447649684937
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.002018519	0.07420447649684937
TYROSINEMIA TYPE 2	0.002018519	0.07420447649684937
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.002018519	0.07420447649684937
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.002018519	0.07420447649684937
NEUROFIBROMATOSIS, TYPE II	0.002018519	0.07420447649684937
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002018519	0.07420447649684937
COCKAYNE SYNDROME A; CSA	0.002018519	0.07420447649684937
ATAXIA-TELANGIECTASIA	0.002018519	0.07420447649684937
GLUTATHIONE SYNTHETASE DEFICIENCY	0.002018519	0.07420447649684937
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.002018519	0.07420447649684937
SYMMETRICAL THALAMIC CALCIFICATIONS	0.002018519	0.07420447649684937
KEARNS-SAYRE SYNDROME; KSS	0.002018519	0.07420447649684937
KNOBLOCH SYNDROME 1; KNO1	0.002018519	0.07420447649684937
SPONTANEOUS PERIODIC HYPOTHERMIA	0.002018519	0.07420447649684937
EARLY-ONSET LAFORA BODY DISEASE	0.002018519	0.07420447649684937
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.002018519	0.07420447649684937
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.002018519	0.07420447649684937
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002018519	0.07420447649684937
THYROCEREBRORETINAL SYNDROME	0.002018519	0.07420447649684937
HEREDITARY HYPEREKPLEXIA	0.002018519	0.07420447649684937
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.002018519	0.07420447649684937
MUCOPOLYSACCHARIDOSIS TYPE 3	0.002018519	0.07420447649684937
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002018519	0.07420447649684937
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.002018519	0.07420447649684937
BEHÇET DISEASE	0.002018519	0.07420447649684937
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002018519	0.07420447649684937
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.002018519	0.07420447649684937
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002018519	0.07420447649684937
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002018519	0.07420447649684937
LHERMITTE-DUCLOS DISEASE	0.002018519	0.07420447649684937
FLYNN-AIRD SYNDROME	0.002018519	0.07420447649684937
EPISODIC ATAXIA TYPE 6	0.002018519	0.07420447649684937
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.002018519	0.07420447649684937
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.002018519	0.07420447649684937
WHIPPLE DISEASE	0.002018519	0.07420447649684937
DILATED CARDIOMYOPATHY WITH ATAXIA	0.002018519	0.07420447649684937
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.002018519	0.07420447649684937
MEGALENCEPHALY WITH DYSMYELINATION	0.002018519	0.07420447649684937
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.002018519	0.07420447649684937
DIAMINOPENTANURIA	0.002018519	0.07420447649684937
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.002018519	0.07420447649684937
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.002018519	0.07420447649684937
ROIFMAN SYNDROME; RFMN	0.001772544	0.06516198241761974
CRANIOSYNOSTOSIS 6; CRS6	0.001772544	0.06516198241761974
17P11.2 MICRODUPLICATION SYNDROME	0.001772544	0.06516198241761974
20Q11.2 MICRODELETION SYNDROME	0.001772544	0.06516198241761974
GENITOPATELLAR SYNDROME; GTPTS	0.001772544	0.06516198241761974
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.001772544	0.06516198241761974
PEROXISOME BIOGENESIS DISORDER 3B	0.001772544	0.06516198241761974
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001772544	0.06516198241761974
17P13.3 MICRODUPLICATION SYNDROME	0.001772544	0.06516198241761974
COLE-CARPENTER SYNDROME	0.001772544	0.06516198241761974
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001772544	0.06516198241761974
GERODERMA OSTEODYSPLASTICA	0.001772544	0.06516198241761974
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001772544	0.06516198241761974
GERMAN SYNDROME	0.001772544	0.06516198241761974
12Q14 MICRODELETION SYNDROME	0.001772544	0.06516198241761974
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.001772544	0.06516198241761974
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001772544	0.06516198241761974
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001772544	0.06516198241761974
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.001772544	0.06516198241761974
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.001772544	0.06516198241761974
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06516198241761974
XQ27.3Q28 DUPLICATION SYNDROME	0.001772544	0.06516198241761974
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001772544	0.06516198241761974
CRANIOFRONTONASAL SYNDROME; CFNS	0.001772544	0.06516198241761974
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001772544	0.06516198241761974
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001772544	0.06516198241761974
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.001772544	0.06516198241761974
FRIED SYNDROME	0.001772544	0.06516198241761974
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.001772544	0.06516198241761974
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.001772544	0.06516198241761974
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.001772544	0.06516198241761974
RITSCHER-SCHINZEL SYNDROME 1	0.001772544	0.06516198241761974
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.001772544	0.06516198241761974
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.001772544	0.06516198241761974
ALG6-CDG	0.001772544	0.06516198241761974
PENTASOMY X	0.001772544	0.06516198241761974
ALPHA-MANNOSIDOSIS	0.001772544	0.06516198241761974
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001772544	0.06516198241761974
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.001772544	0.06516198241761974
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001772544	0.06516198241761974
MICROPHTHALMIA, SYNDROMIC 3	0.001772544	0.06516198241761974
GALACTOSE EPIMERASE DEFICIENCY	0.001772544	0.06516198241761974
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.001772544	0.06516198241761974
MUCOLIPIDOSIS IV; ML4	0.001772544	0.06516198241761974
THANATOPHORIC DYSPLASIA, TYPE I	0.001772544	0.06516198241761974
TRANSKETOLASE DEFICIENCY	0.001772544	0.06516198241761974
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001772544	0.06516198241761974
HYPERLYSINEMIA, TYPE I	0.001768409	0.06500997220106272
HADDAD SYNDROME	0.001768409	0.06500997220106272
MPDU1-CDG	0.001768409	0.06500997220106272
GLYCINE ENCEPHALOPATHY; GCE	0.001768409	0.06500997220106272
INFANTILE NEUROAXONAL DYSTROPHY	0.001768409	0.06500997220106272
L-2-HYDROXYGLUTARIC ACIDURIA	0.001768409	0.06500997220106272
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001768409	0.06500997220106272
ONDINE SYNDROME	0.001768409	0.06500997220106272
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001768409	0.06500997220106272
KRABBE DISEASE	0.001768409	0.06500997220106272
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.001768409	0.06500997220106272
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001768409	0.06500997220106272
LINEAR NEVUS SEBACEUS SYNDROME	0.001768409	0.06500997220106272
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.001768409	0.06500997220106272
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.001768409	0.06500997220106272
CONGENITAL RUBELLA SYNDROME	0.001768409	0.06500997220106272
1P36 MICRODELETION SYNDROME	0.001768409	0.06500997220106272
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.001768409	0.06500997220106272
ALG9-CDG	0.001768409	0.06500997220106272
ZIMMERMANN-LABAND SYNDROME 1	0.001768409	0.06500997220106272
GLUTARIC ACIDEMIA I; GA1	0.001768409	0.06500997220106272
MUSCLE-EYE-BRAIN DISEASE	0.001768409	0.06500997220106272
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.001768409	0.06500997220106272
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.001768409	0.06500997220106272
BENIGN FAMILIAL INFANTILE EPILEPSY	0.001768409	0.06500997220106272
SJÖGREN-LARSSON SYNDROME	0.001768409	0.06500997220106272
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06500997220106272
ISOLATED SPINA BIFIDA	0.001768409	0.06500997220106272
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.001768409	0.06500997220106272
THANATOPHORIC DYSPLASIA	0.001768409	0.06500997220106272
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.001768409	0.06500997220106272
NORRIE DISEASE	0.001768409	0.06500997220106272
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.001768409	0.06500997220106272
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001768409	0.06500997220106272
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.001768409	0.06500997220106272
X-LINKED CENTRONUCLEAR MYOPATHY	0.001768409	0.06500997220106272
THANATOPHORIC DYSPLASIA TYPE 2	0.001768409	0.06500997220106272
FRAGILE X SYNDROME	0.001768409	0.06500997220106272
FETAL GAUCHER DISEASE	0.001768409	0.06500997220106272
VISCERAL STEATOSIS, CONGENITAL	0.001768409	0.06500997220106272
CENTRONUCLEAR MYOPATHY	0.001768409	0.06500997220106272
WOLF-HIRSCHHORN SYNDROME	0.001768409	0.06500997220106272
DISTAL MONOSOMY 7Q36	0.001768409	0.06500997220106272
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.001768409	0.06500997220106272
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001768409	0.06500997220106272
FAMILIAL BENIGN COPPER DEFICIENCY	0.001768409	0.06500997220106272
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.001768409	0.06500997220106272
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001768409	0.06500997220106272
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.001768409	0.06500997220106272
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.001768409	0.06500997220106272
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.001768409	0.06500997220106272
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.001768409	0.06500997220106272
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.001768409	0.06500997220106272
CRIGLER-NAJJAR SYNDROME	0.001768409	0.06500997220106272
THANATOPHORIC DYSPLASIA TYPE 1	0.001768409	0.06500997220106272
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.05997032804687016
OMODYSPLASIA 1; OMOD1	0.00163132	0.05997032804687016
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.05997032804687016
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.05997032804687016
SCARF SYNDROME	0.00163132	0.05997032804687016
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.05997032804687016
PTERYGIUM COLLI, ISOLATED	0.00163132	0.05997032804687016
SCARF SYNDROME	0.00163132	0.05997032804687016
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00163132	0.05997032804687016
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00163132	0.05997032804687016
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.05997032804687016
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00163132	0.05997032804687016
CRANIOECTODERMAL DYSPLASIA	0.00163132	0.05997032804687016
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00163132	0.05997032804687016
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.05997032804687016
SCALP-EAR-NIPPLE SYNDROME; SENS	0.00163132	0.05997032804687016
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.00163132	0.05997032804687016
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.05997032804687016
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00163132	0.05997032804687016
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00163132	0.05997032804687016
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00163132	0.05997032804687016
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00163132	0.05997032804687016
SILLENCE SYNDROME	0.00163132	0.05997032804687016
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00163132	0.05997032804687016
ACRORENAL-MANDIBULAR SYNDROME	0.00163132	0.05997032804687016
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00163132	0.05997032804687016
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.00163132	0.05997032804687016
NOONAN SYNDROME 4; NS4	0.00163132	0.05997032804687016
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00163132	0.05997032804687016
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00163132	0.05997032804687016
MILROY DISEASE	0.00163132	0.05997032804687016
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.05997032804687016
OROFACIODIGITAL SYNDROME IV; OFD4	0.00163132	0.05997032804687016
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.05997032804687016
RING CHROMOSOME 6 SYNDROME	0.00163132	0.05997032804687016
CRANIOECTODERMAL DYSPLASIA 1	0.00163132	0.05997032804687016
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.05997032804687016
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00163132	0.05997032804687016
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.05997032804687016
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.05997032804687016
HYPERTELORISM AND TETRALOGY OF FALLOT	0.00163132	0.05997032804687016
SCHOLTE SYNDROME; SHLTS	0.00163132	0.05997032804687016
BRITTLE CORNEA SYNDROME	0.00163132	0.05997032804687016
BRADDOCK SYNDROME	0.00163132	0.05997032804687016
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.05997032804687016
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00163132	0.05997032804687016
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00163132	0.05997032804687016
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.05997032804687016
BALLER-GEROLD SYNDROME	0.00163132	0.05997032804687016
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00163132	0.05997032804687016
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00163132	0.05997032804687016
ATELOSTEOGENESIS TYPE II	0.00163132	0.05997032804687016
PROGEROID SYNDROME, PETTY TYPE	0.00163132	0.05997032804687016
ACROOTOOCULAR SYNDROME	0.00163132	0.05997032804687016
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00163132	0.05997032804687016
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.05997032804687016
RING CHROMOSOME 8 SYNDROME	0.00163132	0.05997032804687016
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00163132	0.05997032804687016
PENOSCROTAL TRANSPOSITION	0.00163132	0.05997032804687016
DEAFNESS-HYPOGONADISM SYNDROME	0.00163132	0.05997032804687016
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00163132	0.05997032804687016
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.05997032804687016
LEGIUS SYNDROME	0.00163132	0.05997032804687016
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00163132	0.05997032804687016
NOONAN SYNDROME 8; NS8	0.00163132	0.05997032804687016
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00163132	0.05997032804687016
LICHTENSTEIN SYNDROME	0.00163132	0.05997032804687016
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.00163132	0.05997032804687016
CEREBROFACIOTHORACIC DYSPLASIA	0.00163132	0.05997032804687016
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00163132	0.05997032804687016
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.05997032804687016
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00163132	0.05997032804687016
PHAVER SYNDROME	0.00163132	0.05997032804687016
CEREBROOCULONASAL SYNDROME	0.00163132	0.05997032804687016
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00163132	0.05997032804687016
SUMMITT SYNDROME	0.00163132	0.05997032804687016
600736 VELOFACIOSKELETAL SYNDROME	0.00163132	0.05997032804687016
RENAL AGENESIS, BILATERAL	0.00163132	0.05997032804687016
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.00163132	0.05997032804687016
EPICANTHUS	0.00163132	0.05997032804687016
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.05997032804687016
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00163132	0.05997032804687016
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.05997032804687016
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00163132	0.05997032804687016
FRONTONASAL DYSPLASIA 1; FND1	0.00163132	0.05997032804687016
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00163132	0.05997032804687016
RING CHROMOSOME 13 SYNDROME	0.00163132	0.05997032804687016
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00163132	0.05997032804687016
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00163132	0.05997032804687016
MONOSOMY 22	0.00163132	0.05997032804687016
DISTAL TRISOMY 5Q	0.00163132	0.05997032804687016
ACRO-RENAL-OCULAR SYNDROME	0.00163132	0.05997032804687016
JACOBSEN SYNDROME	0.00163132	0.05997032804687016
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.05997032804687016
KEIPERT SYNDROME	0.00163132	0.05997032804687016
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00163132	0.05997032804687016
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00163132	0.05997032804687016
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00163132	0.05997032804687016
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00163132	0.05997032804687016
MYOTONIA PERMANENS	0.00163132	0.05997032804687016
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.05997032804687016
URBAN-ROGERS-MEYER SYNDROME	0.00163132	0.05997032804687016
VELO-FACIAL-SKELETAL SYNDROME	0.00163132	0.05997032804687016
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00163132	0.05997032804687016
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.05997032804687016
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00163132	0.05997032804687016
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.05997032804687016
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00163132	0.05997032804687016
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00163132	0.05997032804687016
DIAMOND-BLACKFAN ANEMIA 1	0.00163132	0.05997032804687016
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.05997032804687016
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00163132	0.05997032804687016
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.05997032804687016
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.05997032804687016
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00163132	0.05997032804687016
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00163132	0.05997032804687016
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.05997032804687016
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00163132	0.05997032804687016
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00163132	0.05997032804687016
OROFACIAL CLEFT 15	0.00163132	0.05997032804687016
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.05997032804687016
ACHALASIA-MICROCEPHALY SYNDROME	0.00163132	0.05997032804687016
JUBERG-MARSIDI SYNDROME	0.00163132	0.05997032804687016
FETAL VALPROATE SYNDROME	0.00163132	0.05997032804687016
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00163132	0.05997032804687016
CEREBROOCULONASAL SYNDROME	0.00163132	0.05997032804687016
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00163132	0.05997032804687016
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00163132	0.05997032804687016
ABRUZZO-ERICKSON SYNDROME	0.00163132	0.05997032804687016
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00163132	0.05997032804687016
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00163132	0.05997032804687016
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00163132	0.05997032804687016
FEINGOLD SYNDROME 1; FGLDS1	0.00163132	0.05997032804687016
FRONTORHINY	0.00163132	0.05997032804687016
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.05997032804687016
ACRODYSOSTOSIS	0.00163132	0.05997032804687016
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00163132	0.05997032804687016
ERDHEIM-CHESTER DISEASE	0.0014770999999999999	0.054300916777843655
STIMMLER SYNDROME	0.0014770999999999999	0.054300916777843655
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0014770999999999999	0.054300916777843655
ARGININOSUCCINIC ACIDURIA	0.0014770999999999999	0.054300916777843655
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0014770999999999999	0.054300916777843655
KIKUCHI-FUJIMOTO DISEASE	0.0014770999999999999	0.054300916777843655
ICHTHYOSIS, HEPATOSPLENOMEGALY, AND CEREBELLAR DEGENERATION	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.0014770999999999999	0.054300916777843655
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.0014770999999999999	0.054300916777843655
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0014770999999999999	0.054300916777843655
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.0014770999999999999	0.054300916777843655
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.054300916777843655
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA 32; SCA32	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0014770999999999999	0.054300916777843655
272600 TAPETORETINAL DEGENERATION WITH ATAXIA	0.0014770999999999999	0.054300916777843655
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.0014770999999999999	0.054300916777843655
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.0014770999999999999	0.054300916777843655
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.0014770999999999999	0.054300916777843655
PITUITARY CARCINOMA	0.0014770999999999999	0.054300916777843655
ADULT POLYGLUCOSAN BODY DISEASE	0.0014770999999999999	0.054300916777843655
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.0014770999999999999	0.054300916777843655
GEMIGNANI SYNDROME	0.0014770999999999999	0.054300916777843655
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.0014770999999999999	0.054300916777843655
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.0014770999999999999	0.054300916777843655
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0014770999999999999	0.054300916777843655
ATAXIA-HYPOGONADISM-CHOROIDAL DYSTROPHY SYNDROME	0.0014770999999999999	0.054300916777843655
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0014770999999999999	0.054300916777843655
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.0014770999999999999	0.054300916777843655
KURU, SUSCEPTIBILITY TO	0.0014770999999999999	0.054300916777843655
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.0014770999999999999	0.054300916777843655
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.0014770999999999999	0.054300916777843655
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.0014770999999999999	0.054300916777843655
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0014770999999999999	0.054300916777843655
WERNICKE-KORSAKOFF SYNDROME	0.0014770999999999999	0.054300916777843655
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.0014770999999999999	0.054300916777843655
CLASSIC HODGKIN LYMPHOMA	0.0014770999999999999	0.054300916777843655
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.0014770999999999999	0.054300916777843655
NEUROPATHY, HEREDITARY SENSORY, ATYPICAL	0.0014770999999999999	0.054300916777843655
PERIPHERAL NEUROPATHY, ATAXIA, FOCAL NECROTIZING ENCEPHALOPATHY, AND	0.0014770999999999999	0.054300916777843655
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.0014770999999999999	0.054300916777843655
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.0014770999999999999	0.054300916777843655
POLYENDOCRINE-POLYNEUROPATHY SYNDROME	0.0014770999999999999	0.054300916777843655
OLIVOPONTOCEREBELLAR ATROPHY II, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.054300916777843655
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0014770999999999999	0.054300916777843655
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.0014770999999999999	0.054300916777843655
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0014770999999999999	0.054300916777843655
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.0014770999999999999	0.054300916777843655
TRYPTOPHANURIA WITH DWARFISM	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0014770999999999999	0.054300916777843655
POSTERIOR CORTICAL ATROPHY	0.0014770999999999999	0.054300916777843655
CHANARIN-DORFMAN SYNDROME	0.0014770999999999999	0.054300916777843655
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0014770999999999999	0.054300916777843655
REFSUM DISEASE	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA, X-LINKED 2	0.0014770999999999999	0.054300916777843655
POLYMYOCLONUS, INFANTILE	0.0014770999999999999	0.054300916777843655
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.0014770999999999999	0.054300916777843655
RICHARDS-RUNDLE SYNDROME	0.0014770999999999999	0.054300916777843655
CHAND SYNDROME	0.0014770999999999999	0.054300916777843655
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.0014770999999999999	0.054300916777843655
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.0014770999999999999	0.054300916777843655
ACERULOPLASMINEMIA	0.0014770999999999999	0.054300916777843655
DE SANCTIS-CACCHIONE SYNDROME	0.0014770999999999999	0.054300916777843655
SANDHOFF DISEASE	0.0014770999999999999	0.054300916777843655
WALDENSTRÖM MACROGLOBULINEMIA	0.0014770999999999999	0.054300916777843655
LEGIONELLOSIS	0.0014770999999999999	0.054300916777843655
212835 CEREBELLAR ATAXIA AND ECTODERMAL DYSPLASIA	0.0014770999999999999	0.054300916777843655
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.0014770999999999999	0.054300916777843655
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.0014770999999999999	0.054300916777843655
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0014770999999999999	0.054300916777843655
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.0014770999999999999	0.054300916777843655
POSTERIOR COLUMN ATAXIA	0.0014770999999999999	0.054300916777843655
VON HIPPEL-LINDAU DISEASE	0.0014770999999999999	0.054300916777843655
HYPOMYELINATION-HYPOGONADOTROPIC HYPOGONADISM-HYPODONTIA SYNDROME	0.0014770999999999999	0.054300916777843655
USHER SYNDROME	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA WITH RIGIDITY AND PERIPHERAL NEUROPATHY	0.0014770999999999999	0.054300916777843655
ACERULOPLASMINEMIA	0.0014770999999999999	0.054300916777843655
AGEL AMYLOIDOSIS	0.0014770999999999999	0.054300916777843655
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.0014770999999999999	0.054300916777843655
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA 41; SCA41	0.0014770999999999999	0.054300916777843655
ABETALIPOPROTEINEMIA	0.0014770999999999999	0.054300916777843655
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0014770999999999999	0.054300916777843655
HEREDITARY SPHEROCYTOSIS	0.0014770999999999999	0.054300916777843655
GILLESPIE SYNDROME; GLSP	0.0014770999999999999	0.054300916777843655
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.0014770999999999999	0.054300916777843655
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.054300916777843655
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.0014770999999999999	0.054300916777843655
ATAXIA-OCULOMOTOR APRAXIA 4; AOA4	0.0014770999999999999	0.054300916777843655
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0014770999999999999	0.054300916777843655
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0014770999999999999	0.054300916777843655
EPISODIC ATAXIA TYPE 4	0.0014770999999999999	0.054300916777843655
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.0014770999999999999	0.054300916777843655
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.0014770999999999999	0.054300916777843655
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.0014770999999999999	0.054300916777843655
OPTIC ATROPHY 1; OPA1	0.0014770999999999999	0.054300916777843655
165200 OPTIC ATROPHY WITH DEMYELINATING DISEASE OF CNS	0.0014770999999999999	0.054300916777843655
DEMENTIA, FAMILIAL DANISH	0.0014770999999999999	0.054300916777843655
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.0014770999999999999	0.054300916777843655
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.0014770999999999999	0.054300916777843655
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.0014770999999999999	0.054300916777843655
CEREBRORETINAL MICROANGIOPATHY WITH CALCIFICATIONS AND CYSTS 2	0.0014770999999999999	0.054300916777843655
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0014770999999999999	0.054300916777843655
RAVINE SYNDROME	0.0014770999999999999	0.054300916777843655
MUSCULAR ATROPHY-ATAXIA-RETINITIS PIGMENTOSA-DIABETES MELLITUS SYNDROME	0.0014770999999999999	0.054300916777843655
ATAXIA WITH FASCICULATIONS	0.0014770999999999999	0.054300916777843655
SPASTIC PARAPLEGIA TYPE 2	0.0014770999999999999	0.054300916777843655
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0014770999999999999	0.054300916777843655
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.0014770999999999999	0.054300916777843655
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.0014770999999999999	0.054300916777843655
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.0014770999999999999	0.054300916777843655
164700 OLIVOPONTOCEREBELLAR ATROPHY V; OPCA V;;OPCA WITH DEMENTIA AND EXTRAPYRAMIDAL SIGNS	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA TYPE 4	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA TYPE 17	0.0014770999999999999	0.054300916777843655
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0014770999999999999	0.054300916777843655
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0014770999999999999	0.054300916777843655
HODGKIN LYMPHOMA	0.0014770999999999999	0.054300916777843655
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.0014770999999999999	0.054300916777843655
FAMILIAL PAROXYSMAL ATAXIA	0.0014770999999999999	0.054300916777843655
JOUBERT SYNDROME 4	0.0014770999999999999	0.054300916777843655
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0014770999999999999	0.054300916777843655
MUSCULAR ATROPHY, ATAXIA, RETINITIS PIGMENTOSA, AND DIABETES MELLITUS	0.0014770999999999999	0.054300916777843655
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0014770999999999999	0.054300916777843655
NYSTAGMUS, HEREDITARY VERTICAL	0.0014770999999999999	0.054300916777843655
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0014770999999999999	0.054300916777843655
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.0014770999999999999	0.054300916777843655
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.0014770999999999999	0.054300916777843655
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0014770999999999999	0.054300916777843655
NEUROFIBROMATOSIS TYPE 2	0.0014770999999999999	0.054300916777843655
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.0014770999999999999	0.054300916777843655
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.0014770999999999999	0.054300916777843655
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.0014770999999999999	0.054300916777843655
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0014770999999999999	0.054300916777843655
LEBER HEREDITARY OPTIC NEUROPATHY	0.0014770999999999999	0.054300916777843655
RHOMBENCEPHALOSYNAPSIS	0.0014770999999999999	0.054300916777843655
ENCEPHALOPATHY WITH INTRACRANIAL CALCIFICATION, GROWTH HORMONE DEFICIENCY, MICROCEPHALY, AND RETINAL DEGENERATION	0.0014770999999999999	0.054300916777843655
PENDRED SYNDROME	0.0014770999999999999	0.054300916777843655
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.0014770999999999999	0.054300916777843655
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.0014770999999999999	0.054300916777843655
HEREDITARY SPASTIC PARAPLEGIA	0.0014770999999999999	0.054300916777843655
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0014770999999999999	0.054300916777843655
USHER SYNDROME TYPE 3	0.0014770999999999999	0.054300916777843655
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.0014770999999999999	0.054300916777843655
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.0014770999999999999	0.054300916777843655
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.0014770999999999999	0.054300916777843655
CENTRAL NEUROCYTOMA	0.0014770999999999999	0.054300916777843655
USHER SYNDROME TYPE 2	0.0014770999999999999	0.054300916777843655
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.0014770999999999999	0.054300916777843655
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.0014770999999999999	0.054300916777843655
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.0014770999999999999	0.054300916777843655
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.0014770999999999999	0.054300916777843655
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.0014770999999999999	0.054300916777843655
SPINOCEREBELLAR ATAXIA 37; SCA37	0.0014770999999999999	0.054300916777843655
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00122699	0.045106412482057004
HYPERCALCEMIA, INFANTILE 2	0.00122699	0.045106412482057004
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00122699	0.045106412482057004
FETAL METHYLMERCURY SYNDROME	0.00122699	0.045106412482057004
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00122699	0.045106412482057004
MULTIPLE METAPHYSEAL DYSPLASIA	0.00122699	0.045106412482057004
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00122699	0.045106412482057004
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00122699	0.045106412482057004
JOHANSON-BLIZZARD SYNDROME; JBS	0.00122699	0.045106412482057004
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00122699	0.045106412482057004
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00122699	0.045106412482057004
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00122699	0.045106412482057004
LAMBERT SYNDROME	0.00122699	0.045106412482057004
GLYCOGEN STORAGE DISEASE II	0.00122699	0.045106412482057004
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00122699	0.045106412482057004
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00122699	0.045106412482057004
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00122699	0.045106412482057004
ERMINE PHENOTYPE	0.00122699	0.045106412482057004
9Q SUBTELOMERIC DELETION SYNDROME	0.00122699	0.045106412482057004
AUTOSOMAL DOMINANT CONGENITAL BENIGN SPINAL MUSCULAR ATROPHY	0.00122699	0.045106412482057004
SMITH-MAGENIS SYNDROME	0.00122699	0.045106412482057004
MENTAL RETARDATION, X-LINKED 93	0.00122699	0.045106412482057004
BEEMER-ERTBRUGGEN SYNDROME	0.00122699	0.045106412482057004
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00122699	0.045106412482057004
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00122699	0.045106412482057004
CAMPOMELIC DYSPLASIA	0.00122699	0.045106412482057004
CENTRAL CORE DISEASE	0.00122699	0.045106412482057004
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.00122699	0.045106412482057004
LESCH-NYHAN SYNDROME; LNS	0.00122699	0.045106412482057004
CAT-EYE SYNDROME	0.00122699	0.045106412482057004
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00122699	0.045106412482057004
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00122699	0.045106412482057004
DIASTROPHIC DWARFISM	0.00122699	0.045106412482057004
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00122699	0.045106412482057004
SPONASTRIME DYSPLASIA	0.00122699	0.045106412482057004
CRANIOFRONTONASAL DYSPLASIA	0.00122699	0.045106412482057004
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00122699	0.045106412482057004
CARDIOMYOPATHY-HYPOTONIA-LACTIC ACIDOSIS SYNDROME	0.00122699	0.045106412482057004
PROXIMAL SPINAL MUSCULAR ATROPHY	0.00122699	0.045106412482057004
ACID PHOSPHATASE DEFICIENCY	0.00122699	0.045106412482057004
GLYCOGEN STORAGE DISEASE IV	0.00122699	0.045106412482057004
DESBUQUOIS DYSPLASIA 1	0.00122699	0.045106412482057004
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.00122699	0.045106412482057004
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.00122699	0.045106412482057004
ANTISYNTHETASE SYNDROME	0.00122699	0.045106412482057004
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00122699	0.045106412482057004
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00122699	0.045106412482057004
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00122699	0.045106412482057004
COG7-CDG	0.00122699	0.045106412482057004
B4GALT1-CDG	0.00122699	0.045106412482057004
OPSISMODYSPLASIA; OPSMD	0.00122699	0.045106412482057004
ALG12-CDG	0.00122699	0.045106412482057004
COOPER-JABS SYNDROME	0.00122699	0.045106412482057004
ACHONDROPLASIA	0.00122699	0.045106412482057004
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.00122699	0.045106412482057004
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00122699	0.045106412482057004
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.00122699	0.045106412482057004
SENGERS SYNDROME	0.00122699	0.045106412482057004
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00122699	0.045106412482057004
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00122699	0.045106412482057004
IMAGE SYNDROME	0.00122699	0.045106412482057004
PSEUDOTRISOMY 13 SYNDROME	0.00122699	0.045106412482057004
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00122699	0.045106412482057004
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00122699	0.045106412482057004
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00122699	0.045106412482057004
KYPHOMELIC DYSPLASIA	0.00122699	0.045106412482057004
INTESTINAL BOTULISM	0.00122699	0.045106412482057004
THAKKER-DONNAI SYNDROME	0.00122699	0.045106412482057004
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.00122699	0.045106412482057004
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00122699	0.045106412482057004
TETRASOMY 12P	0.00122699	0.045106412482057004
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00122699	0.045106412482057004
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00122699	0.045106412482057004
COMBINED IMMUNODEFICIENCY DUE TO CRAC CHANNEL DYSFUNCTION	0.00122699	0.045106412482057004
TRIOSE PHOSPHATE-ISOMERASE DEFICIENCY	0.00122699	0.045106412482057004
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00122699	0.045106412482057004
TRISOMY 4P	0.00122699	0.045106412482057004
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00122699	0.045106412482057004
NEONATAL SEVERE PRIMARY HYPERPARATHYROIDISM	0.00122699	0.045106412482057004
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 4; CEMCOX4	0.00122699	0.045106412482057004
PEARSON SYNDROME	0.00122699	0.045106412482057004
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00122699	0.045106412482057004
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00122699	0.045106412482057004
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.045106412482057004
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00122699	0.045106412482057004
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00122699	0.045106412482057004
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00122699	0.045106412482057004
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00122699	0.045106412482057004
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00122699	0.045106412482057004
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.00122699	0.045106412482057004
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00122699	0.045106412482057004
HYPOMYELINATION NEUROPATHY-ARTHROGRYPOSIS SYNDROME	0.00122699	0.045106412482057004
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00122699	0.045106412482057004
MARSHALL-SMITH SYNDROME; MRSHSS	0.00122699	0.045106412482057004
WARBURG MICRO SYNDROME 1	0.00122699	0.045106412482057004
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00122699	0.045106412482057004
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.00122699	0.045106412482057004
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00122699	0.045106412482057004
PORPHYRIA, ACUTE HEPATIC	0.00122699	0.045106412482057004
NEMALINE MYOPATHY 7; NEM7	0.00122699	0.045106412482057004
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00122699	0.045106412482057004
IMMUNODEFICIENCY 9; IMD9	0.00122699	0.045106412482057004
MACS SYNDROME	0.00122699	0.045106412482057004
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00122699	0.045106412482057004
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00122699	0.045106412482057004
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.00122699	0.045106412482057004
HAWKINSINURIA	0.00122699	0.045106412482057004
FAMILIAL LAMBDOID SYNOSTOSIS	0.00122699	0.045106412482057004
PURE MITOCHONDRIAL MYOPATHY	0.00122699	0.045106412482057004
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.00122699	0.045106412482057004
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00122699	0.045106412482057004
MATTHEW-WOOD SYNDROME	0.00122699	0.045106412482057004
LAURIN-SANDROW SYNDROME	0.00122699	0.045106412482057004
JOHANSON-BLIZZARD SYNDROME	0.00122699	0.045106412482057004
JUNG SYNDROME	0.00122699	0.045106412482057004
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.00122699	0.045106412482057004
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00122699	0.045106412482057004
ISOTRETINOIN SYNDROME	0.00122699	0.045106412482057004
GRANT SYNDROME	0.00122699	0.045106412482057004
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00122699	0.045106412482057004
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00122699	0.045106412482057004
PIERSON SYNDROME	0.00122699	0.045106412482057004
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00122699	0.045106412482057004
STEINERT MYOTONIC DYSTROPHY	0.00122699	0.045106412482057004
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.001086973	0.03995912965456845
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.03995912965456845
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.03995912965456845
WAISMAN SYNDROME; WSMN	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.03995912965456845
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.03995912965456845
SCHIZENCEPHALY	0.001086973	0.03995912965456845
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03995912965456845
MOSAIC TRISOMY 14	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.03995912965456845
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.03995912965456845
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.03995912965456845
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.03995912965456845
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.03995912965456845
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.03995912965456845
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03995912965456845
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.03995912965456845
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03995912965456845
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.03995912965456845
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03995912965456845
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.001086973	0.03995912965456845
RUVALCABA SYNDROME	0.001086973	0.03995912965456845
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.03995912965456845
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03995912965456845
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.03995912965456845
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03995912965456845
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.03995912965456845
L1 SYNDROME	0.001086973	0.03995912965456845
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.03995912965456845
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.03995912965456845
DIGEORGE SYNDROME; DGS	0.001086973	0.03995912965456845
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.03995912965456845
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.03995912965456845
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.03995912965456845
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.03995912965456845
HYPEREKPLEXIA 4; HKPX4	0.001086973	0.03995912965456845
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.03995912965456845
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03995912965456845
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.03995912965456845
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03995912965456845
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03995912965456845
DISTAL MONOSOMY 15Q	0.001086973	0.03995912965456845
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03995912965456845
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.03995912965456845
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.03995912965456845
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03995912965456845
KEUTEL SYNDROME	0.001086973	0.03995912965456845
ARGININEMIA	0.001086973	0.03995912965456845
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03995912965456845
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.03995912965456845
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03995912965456845
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03995912965456845
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.03995912965456845
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03995912965456845
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03995912965456845
TARP SYNDROME	0.001086973	0.03995912965456845
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03995912965456845
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.03995912965456845
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.03995912965456845
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.03995912965456845
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03995912965456845
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.03995912965456845
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.03995912965456845
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.03995912965456845
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.03995912965456845
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.03995912965456845
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001086973	0.03995912965456845
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.03995912965456845
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03995912965456845
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.03995912965456845
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.03995912965456845
NETHERTON SYNDROME	0.001086973	0.03995912965456845
WYBURN-MASON SYNDROME	0.001086973	0.03995912965456845
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001086973	0.03995912965456845
CRANIOPHARYNGIOMA	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.03995912965456845
DUANE RETRACTION SYNDROME	0.001086973	0.03995912965456845
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.03995912965456845
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.001086973	0.03995912965456845
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.03995912965456845
TIMOTHY SYNDROME; TS	0.001086973	0.03995912965456845
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.03995912965456845
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.03995912965456845
ALG1-CDG	0.001086973	0.03995912965456845
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.03995912965456845
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.001086973	0.03995912965456845
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.03995912965456845
CLASSIC PHENYLKETONURIA	0.001086973	0.03995912965456845
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.03995912965456845
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.03995912965456845
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.03995912965456845
MUENKE SYNDROME	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.03995912965456845
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.03995912965456845
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.03995912965456845
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03995912965456845
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03995912965456845
HOLOPROSENCEPHALY 7	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.03995912965456845
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03995912965456845
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.03995912965456845
CATEL-MANZKE SYNDROME; CATMANS	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.03995912965456845
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.03995912965456845
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.03995912965456845
MACDERMOT-WINTER SYNDROME	0.001086973	0.03995912965456845
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.03995912965456845
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03995912965456845
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03995912965456845
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.03995912965456845
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03995912965456845
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.03995912965456845
LANDAU-KLEFFNER SYNDROME	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03995912965456845
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.03995912965456845
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.03995912965456845
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.03995912965456845
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03995912965456845
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.03995912965456845
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.03995912965456845
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.03995912965456845
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.03995912965456845
MIRAGE SYNDROME; MIRAGE	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.03995912965456845
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03995912965456845
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03995912965456845
LISSENCEPHALY 4	0.001086973	0.03995912965456845
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001086973	0.03995912965456845
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.03995912965456845
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.03995912965456845
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03995912965456845
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03995912965456845
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03995912965456845
RECOMBINANT 8 SYNDROME	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03995912965456845
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03995912965456845
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.03995912965456845
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001086973	0.03995912965456845
DONNAI-BARROW SYNDROME	0.001086973	0.03995912965456845
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.03995912965456845
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.03995912965456845
PALLISTER-HALL SYNDROME	0.001086973	0.03995912965456845
KBG SYNDROME	0.001086973	0.03995912965456845
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.03995912965456845
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03995912965456845
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001086973	0.03995912965456845
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03995912965456845
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.03995912965456845
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.03995912965456845
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001086973	0.03995912965456845
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.03995912965456845
15Q14 MICRODELETION SYNDROME	0.001086973	0.03995912965456845
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.03995912965456845
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03995912965456845
ISOVALERIC ACIDEMIA	0.001086973	0.03995912965456845
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03995912965456845
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.001086973	0.03995912965456845
OPTIC PATHWAY GLIOMA	0.001086973	0.03995912965456845
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.03995912965456845
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03995912965456845
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.03995912965456845
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001086973	0.03995912965456845
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03995912965456845
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03995912965456845
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.03995912965456845
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03995912965456845
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.03995912965456845
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.03995912965456845
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03995912965456845
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03995912965456845
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.03995912965456845
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03995912965456845
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.03995912965456845
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03995912965456845
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.001086973	0.03995912965456845
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.03995912965456845
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.03995912965456845
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.03995912965456845
MUCOPOLYSACCHARIDOSIS TYPE 2	0.001086973	0.03995912965456845
PHACE ASSOCIATION	0.001086973	0.03995912965456845
PFEIFFER SYNDROME TYPE 2	0.001086973	0.03995912965456845
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.03995912965456845
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.03995912965456845
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03995912965456845
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.03995912965456845
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.001086973	0.03995912965456845
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.03995912965456845
HYDRANENCEPHALY	0.001086973	0.03995912965456845
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001086973	0.03995912965456845
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.03995912965456845
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.03995912965456845
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.03995912965456845
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.03995912965456845
JOUBERT SYNDROME 26	0.000545554	0.020055569935562737
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020055569935562737
OROFACIODIGITAL SYNDROME XIV; OFD14	0.000545554	0.020055569935562737
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020055569935562737
SEPTOOPTIC DYSPLASIA	0.000545554	0.020055569935562737
MIETENS SYNDROME	0.000545554	0.020055569935562737
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020055569935562737
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020055569935562737
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020055569935562737
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020055569935562737
TRANSALDOLASE DEFICIENCY	0.000545554	0.020055569935562737
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.020055569935562737
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020055569935562737
BARDET-BIEDL SYNDROME 2	0.000545554	0.020055569935562737
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.020055569935562737
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020055569935562737
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020055569935562737
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.020055569935562737
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020055569935562737
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.020055569935562737
NOONAN SYNDROME 11; NS11	0.000545554	0.020055569935562737
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.020055569935562737
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.020055569935562737
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020055569935562737
RABSON-MENDENHALL SYNDROME	0.000545554	0.020055569935562737
RAHMAN SYNDROME	0.000545554	0.020055569935562737
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020055569935562737
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020055569935562737
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020055569935562737
WOLMAN DISEASE	0.000545554	0.020055569935562737
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.020055569935562737
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020055569935562737
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.020055569935562737
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020055569935562737
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020055569935562737
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.020055569935562737
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020055569935562737
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020055569935562737
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020055569935562737
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.000545554	0.020055569935562737
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.000545554	0.020055569935562737
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.020055569935562737
ABLEPHARON MACROSTOMIA SYNDROME	0.000545554	0.020055569935562737
ALAZAMI-YUAN SYNDROME	0.000545554	0.020055569935562737
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020055569935562737
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020055569935562737
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020055569935562737
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020055569935562737
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020055569935562737
CULLER-JONES SYNDROME; CJS	0.000545554	0.020055569935562737
SECKEL SYNDROME 9; SCKL9	0.000545554	0.020055569935562737
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020055569935562737
XIA-GIBBS SYNDROME	0.000545554	0.020055569935562737
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.000545554	0.020055569935562737
1P21.3 MICRODELETION SYNDROME	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.020055569935562737
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020055569935562737
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020055569935562737
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020055569935562737
8P23.1 DUPLICATION SYNDROME	0.000545554	0.020055569935562737
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020055569935562737
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.020055569935562737
TOWNES-BROCKS SYNDROME 1; TBS1	0.000545554	0.020055569935562737
OKAMOTO SYNDROME	0.000545554	0.020055569935562737
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020055569935562737
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020055569935562737
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020055569935562737
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.020055569935562737
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020055569935562737
NOONAN SYNDROME 2; NS2	0.000545554	0.020055569935562737
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000545554	0.020055569935562737
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.020055569935562737
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020055569935562737
MOSAIC TRISOMY 9	0.000545554	0.020055569935562737
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020055569935562737
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020055569935562737
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.020055569935562737
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020055569935562737
TRISOMY 9P	0.000545554	0.020055569935562737
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020055569935562737
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020055569935562737
NOONAN SYNDROME 9; NS9	0.000545554	0.020055569935562737
AL-RAQAD SYNDROME; ARS	0.000545554	0.020055569935562737
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020055569935562737
FRIAS SYNDROME	0.000545554	0.020055569935562737
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020055569935562737
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020055569935562737
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020055569935562737
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020055569935562737
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020055569935562737
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020055569935562737
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020055569935562737
BRESEK SYNDROME	0.000545554	0.020055569935562737
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020055569935562737
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020055569935562737
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.020055569935562737
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020055569935562737
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.020055569935562737
HURLER SYNDROME	0.000545554	0.020055569935562737
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020055569935562737
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020055569935562737
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.020055569935562737
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020055569935562737
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020055569935562737
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.020055569935562737
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020055569935562737
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020055569935562737
EVEN-PLUS SYNDROME	0.000545554	0.020055569935562737
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020055569935562737
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020055569935562737
SYNDROMIC DIARRHEA	0.000545554	0.020055569935562737
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020055569935562737
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020055569935562737
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.020055569935562737
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020055569935562737
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020055569935562737
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020055569935562737
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020055569935562737
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020055569935562737
LIG4 SYNDROME	0.000545554	0.020055569935562737
CHOPS SYNDROME; CHOPS	0.000545554	0.020055569935562737
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.020055569935562737
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020055569935562737
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.020055569935562737
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020055569935562737
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020055569935562737
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.020055569935562737
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020055569935562737
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.020055569935562737
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020055569935562737
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.020055569935562737
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020055569935562737
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020055569935562737
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.020055569935562737
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020055569935562737
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020055569935562737
TREACHER-COLLINS SYNDROME	0.000545554	0.020055569935562737
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020055569935562737
MEIER-GORLIN SYNDROME 7	0.000545554	0.020055569935562737
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.020055569935562737
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020055569935562737
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020055569935562737
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020055569935562737
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.020055569935562737
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020055569935562737
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020055569935562737
HYDROXYKYNURENINURIA	0.000545554	0.020055569935562737
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020055569935562737
CDAGS SYNDROME	0.000545554	0.020055569935562737
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000545554	0.020055569935562737
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020055569935562737
AUSTRALIA ANTIGEN	0.000545554	0.020055569935562737
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020055569935562737
CHAR SYNDROME	0.000545554	0.020055569935562737
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020055569935562737
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020055569935562737
OGDEN SYNDROME	0.000545554	0.020055569935562737
ELSAHY-WATERS SYNDROME; ESWS	0.000545554	0.020055569935562737
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.020055569935562737
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.020055569935562737
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020055569935562737
ZEBRA BODY MYOPATHY	0.000545554	0.020055569935562737
RIGID SPINE SYNDROME	0.000545554	0.020055569935562737
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.020055569935562737
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020055569935562737
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020055569935562737
FARBER DISEASE	0.000545554	0.020055569935562737
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020055569935562737
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020055569935562737
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020055569935562737
ROBERTS SYNDROME	0.000545554	0.020055569935562737
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020055569935562737
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.020055569935562737
ABETAL34V AMYLOIDOSIS	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.020055569935562737
CHAR SYNDROME	0.000545554	0.020055569935562737
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020055569935562737
SAY-BARBER-MILLER SYNDROME	0.000545554	0.020055569935562737
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020055569935562737
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020055569935562737
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020055569935562737
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.020055569935562737
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020055569935562737
HOLOPROSENCEPHALY 11	0.000545554	0.020055569935562737
STEEL SYNDROME; STLS	0.000545554	0.020055569935562737
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.020055569935562737
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020055569935562737
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020055569935562737
ZECHI-CEIDE SYNDROME	0.000545554	0.020055569935562737
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.020055569935562737
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020055569935562737
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020055569935562737
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.020055569935562737
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020055569935562737
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020055569935562737
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020055569935562737
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020055569935562737
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020055569935562737
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.020055569935562737
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020055569935562737
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020055569935562737
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020055569935562737
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020055569935562737
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020055569935562737
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020055569935562737
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020055569935562737
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000545554	0.020055569935562737
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020055569935562737
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020055569935562737
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020055569935562737
JAWAD SYNDROME	0.000545554	0.020055569935562737
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020055569935562737
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.000545554	0.020055569935562737
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020055569935562737
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020055569935562737
HYPERTRICHOSIS CUBITI	0.000545554	0.020055569935562737
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020055569935562737
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020055569935562737
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020055569935562737
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020055569935562737
TEMTAMY SYNDROME	0.000545554	0.020055569935562737
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020055569935562737
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.020055569935562737
DYSKERATOSIS CONGENITA	0.000545554	0.020055569935562737
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020055569935562737
DEXTROCARDIA	0.000545554	0.020055569935562737
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020055569935562737
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020055569935562737
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020055569935562737
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.000545554	0.020055569935562737
TRISOMY 8Q	0.000545554	0.020055569935562737
DISTAL TRISOMY 6P	0.000545554	0.020055569935562737
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020055569935562737
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020055569935562737
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020055569935562737
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020055569935562737
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020055569935562737
8Q22.1 MICRODELETION SYNDROME	0.000545554	0.020055569935562737
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020055569935562737
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.020055569935562737
TARP SYNDROME; TARPS	0.000545554	0.020055569935562737
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020055569935562737
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020055569935562737
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020055569935562737
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020055569935562737
OROTIC ACIDURIA	0.000545554	0.020055569935562737
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020055569935562737
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020055569935562737
RAINE SYNDROME	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020055569935562737
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020055569935562737
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020055569935562737
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020055569935562737
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020055569935562737
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020055569935562737
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020055569935562737
CINCA SYNDROME	0.000545554	0.020055569935562737
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020055569935562737
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020055569935562737
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020055569935562737
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.020055569935562737
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020055569935562737
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020055569935562737
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020055569935562737
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020055569935562737
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000545554	0.020055569935562737
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020055569935562737
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020055569935562737
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020055569935562737
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.020055569935562737
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020055569935562737
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.020055569935562737
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.000545554	0.020055569935562737
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.020055569935562737
EPIDERMAL NEVUS SYNDROME	0.000545554	0.020055569935562737
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020055569935562737
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.020055569935562737
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.020055569935562737
ISOLATED PLAGIOCEPHALY	0.000545554	0.020055569935562737
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020055569935562737
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.020055569935562737
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020055569935562737
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020055569935562737
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020055569935562737
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020055569935562737
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020055569935562737
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.020055569935562737
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020055569935562737
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020055569935562737
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020055569935562737
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020055569935562737
ATELOSTEOGENESIS TYPE III	0.000545554	0.020055569935562737
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020055569935562737
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020055569935562737
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020055569935562737
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020055569935562737
LOWRY-MACLEAN SYNDROME	0.000545554	0.020055569935562737
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020055569935562737
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.019903559719005714
SUBEPENDYMOMA	0.000541419	0.019903559719005714
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.019903559719005714
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.019903559719005714
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.019903559719005714
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.019903559719005714
EPENDYMOMA	0.000541419	0.019903559719005714
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.019903559719005714
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.019903559719005714
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.019903559719005714
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.019903559719005714
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.019903559719005714
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.019903559719005714
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.019903559719005714
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.000541419	0.019903559719005714
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.019903559719005714
EBOLA HEMORRHAGIC FEVER	0.000541419	0.019903559719005714
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.019903559719005714
WORSTER-DROUGHT SYNDROME	0.000541419	0.019903559719005714
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.019903559719005714
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.019903559719005714
PARTINGTON SYNDROME	0.000541419	0.019903559719005714
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.019903559719005714
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.019903559719005714
RIFT VALLEY FEVER	0.000541419	0.019903559719005714
THREONINEMIA	0.000541419	0.019903559719005714
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.019903559719005714
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.019903559719005714
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.019903559719005714
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.019903559719005714
DERMOTRICHIC SYNDROME	0.000541419	0.019903559719005714
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.019903559719005714
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.019903559719005714
IMMUNODEFICIENCY 47	0.000541419	0.019903559719005714
PSEUDO-TORCH SYNDROME 2	0.000541419	0.019903559719005714
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.000541419	0.019903559719005714
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.019903559719005714
FILIPPI SYNDROME; FLPIS	0.000541419	0.019903559719005714
PARIETAL FORAMINA	0.000541419	0.019903559719005714
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.019903559719005714
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.019903559719005714
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.019903559719005714
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.019903559719005714
CONGENITAL HYDROCEPHALUS	0.000541419	0.019903559719005714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.019903559719005714
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.019903559719005714
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.019903559719005714
INCONTINENTIA PIGMENTI; IP	0.000541419	0.019903559719005714
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.019903559719005714
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.019903559719005714
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.019903559719005714
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.019903559719005714
ASPARTYLGLUCOSAMINURIA	0.000541419	0.019903559719005714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.019903559719005714
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.019903559719005714
TAY-SACHS DISEASE; TSD	0.000541419	0.019903559719005714
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.019903559719005714
CENTRAL DIABETES INSIPIDUS	0.000541419	0.019903559719005714
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.019903559719005714
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.019903559719005714
STURGE-WEBER SYNDROME	0.000541419	0.019903559719005714
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.019903559719005714
NIPAH VIRUS DISEASE	0.000541419	0.019903559719005714
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.019903559719005714
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.019903559719005714
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.019903559719005714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.019903559719005714
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.019903559719005714
PFEIFFER SYNDROME TYPE 3	0.000541419	0.019903559719005714
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.019903559719005714
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.019903559719005714
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.019903559719005714
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.019903559719005714
DARIER-WHITE DISEASE; DAR	0.000541419	0.019903559719005714
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.019903559719005714
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.019903559719005714
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.019903559719005714
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.019903559719005714
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.019903559719005714
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.019903559719005714
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.019903559719005714
CROUZON SYNDROME	0.000541419	0.019903559719005714
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.019903559719005714
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.019903559719005714
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.019903559719005714
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.019903559719005714
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.019903559719005714
CORNELIA DE LANGE SYNDROME 1	0.000541419	0.019903559719005714
MERCURY POISONING	0.000541419	0.019903559719005714
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.019903559719005714
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.000541419	0.019903559719005714
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.019903559719005714
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.019903559719005714
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.019903559719005714
MOYNAHAN SYNDROME	0.000541419	0.019903559719005714
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.019903559719005714
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.019903559719005714
GLIOBLASTOMA	0.000541419	0.019903559719005714
TAKAYASU ARTERITIS	0.000541419	0.019903559719005714
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.019903559719005714
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.019903559719005714
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.019903559719005714
ADAMS-OLIVER SYNDROME	0.000541419	0.019903559719005714
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.019903559719005714
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.019903559719005714
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.019903559719005714
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.019903559719005714
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.019903559719005714
ALZHEIMER DISEASE 3; AD	0.000541419	0.019903559719005714
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.019903559719005714
INSULINOMA	0.000541419	0.019903559719005714
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.019903559719005714
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.019903559719005714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.019903559719005714
HYPERPROLINEMIA TYPE 1	0.000541419	0.019903559719005714
PAPILLORENAL SYNDROME	0.000541419	0.019903559719005714
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.019903559719005714
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.019903559719005714
GALACTOSIALIDOSIS	0.000541419	0.019903559719005714
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.019903559719005714
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.019903559719005714
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.019903559719005714
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.019903559719005714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.019903559719005714
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.019903559719005714
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.019903559719005714
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.019903559719005714
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.019903559719005714
MOYAMOYA DISEASE	0.000541419	0.019903559719005714
EPILEPSY, READING	0.000541419	0.019903559719005714
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.019903559719005714
PINEOBLASTOMA	0.000541419	0.019903559719005714
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.019903559719005714
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.019903559719005714
ZIMMERMANN-LABAND SYNDROME	0.000541419	0.019903559719005714
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.019903559719005714
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.019903559719005714
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.019903559719005714
PERRAULT SYNDROME 3	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.019903559719005714
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.019903559719005714
CYSTATHIONINURIA	0.000541419	0.019903559719005714
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.019903559719005714
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.019903559719005714
MICROSPORIDIOSIS	0.000541419	0.019903559719005714
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.019903559719005714
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.019903559719005714
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.019903559719005714
FRONTAL ENCEPHALOCELE	0.000541419	0.019903559719005714
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.019903559719005714
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.019903559719005714
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.019903559719005714
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.019903559719005714
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.019903559719005714
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.019903559719005714
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.019903559719005714
KLEEFSTRA SYNDROME	0.000541419	0.019903559719005714
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.019903559719005714
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.019903559719005714
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.019903559719005714
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.019903559719005714
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.019903559719005714
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.019903559719005714
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.019903559719005714
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.019903559719005714
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.019903559719005714
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.019903559719005714
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.019903559719005714
PROTEUS SYNDROME	0.000541419	0.019903559719005714
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.019903559719005714
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.019903559719005714
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.019903559719005714
RABIES	0.000541419	0.019903559719005714
CADASIL	0.000541419	0.019903559719005714
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.019903559719005714
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.019903559719005714
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.019903559719005714
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.019903559719005714
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.019903559719005714
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.019903559719005714
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.019903559719005714
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.019903559719005714
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.019903559719005714
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.000541419	0.019903559719005714
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.019903559719005714
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.019903559719005714
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.019903559719005714
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.019903559719005714
ATYPICAL RETT SYNDROME	0.000541419	0.019903559719005714
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.019903559719005714
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.019903559719005714
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.019903559719005714
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.019903559719005714
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.019903559719005714
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.019903559719005714
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.019903559719005714
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.000541419	0.019903559719005714
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.019903559719005714
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.019903559719005714
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.019903559719005714
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.019903559719005714
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.019903559719005714
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.019903559719005714
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.019903559719005714
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.019903559719005714
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.019903559719005714
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.019903559719005714
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.019903559719005714
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.019903559719005714
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.019903559719005714
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.019903559719005714
KIFAFA SEIZURE DISORDER	0.000541419	0.019903559719005714
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.019903559719005714
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.000541419	0.019903559719005714
SECKEL SYNDROME 1; SCKL1	0.000541419	0.019903559719005714
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.019903559719005714
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.019903559719005714
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.019903559719005714
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.019903559719005714
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.019903559719005714
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.019903559719005714
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.019903559719005714
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.019903559719005714
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.019903559719005714
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.019903559719005714
PROLACTINOMA	0.000541419	0.019903559719005714
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.019903559719005714
FOUNTAIN SYNDROME	0.000541419	0.019903559719005714
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.000541419	0.019903559719005714
SANJAD-SAKATI SYNDROME	0.000541419	0.019903559719005714
BETA-MANNOSIDOSIS	0.000541419	0.019903559719005714
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.019903559719005714
GURRIERI SYNDROME	0.000541419	0.019903559719005714
BERNARD-SOULIER SYNDROME	0.000541419	0.019903559719005714
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.019903559719005714
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.019903559719005714
PORENCEPHALY	0.000541419	0.019903559719005714
FRYNS SYNDROME; FRNS	0.000541419	0.019903559719005714
MYASTHENIA GRAVIS	0.000541419	0.019903559719005714
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.019903559719005714
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.019903559719005714
LIPOID PROTEINOSIS	0.000541419	0.019903559719005714
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.019903559719005714
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.019903559719005714
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.019903559719005714
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.019903559719005714
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.019903559719005714
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.019903559719005714
ISOLATED BILIARY ATRESIA	0.000541419	0.019903559719005714
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.019903559719005714
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.019903559719005714
RAMON SYNDROME	0.000541419	0.019903559719005714
HYPERPROLINEMIA, TYPE II	0.000541419	0.019903559719005714
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.019903559719005714
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.000541419	0.019903559719005714
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.019903559719005714
NEVUS COMEDONICUS SYNDROME	0.000541419	0.019903559719005714
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.019903559719005714
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.019903559719005714
HYPER-BETA-ALANINEMIA	0.000541419	0.019903559719005714
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.019903559719005714
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.019903559719005714
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.019903559719005714
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.019903559719005714
DYSOSTEOSCLEROSIS	0.000541419	0.019903559719005714
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.019903559719005714
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.019903559719005714
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.019903559719005714
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.000541419	0.019903559719005714
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.019903559719005714
LUJO HEMORRHAGIC FEVER	0.000541419	0.019903559719005714
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.019903559719005714
AICA-RIBOSIDURIA	0.000541419	0.019903559719005714
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.019903559719005714
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.019903559719005714
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.019903559719005714
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.019903559719005714
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.019903559719005714
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.019903559719005714
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.000541419	0.019903559719005714
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.019903559719005714
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.019903559719005714
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.019903559719005714
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.019903559719005714
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.019903559719005714
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.019903559719005714
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.000541419	0.019903559719005714
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.019903559719005714
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.000541419	0.019903559719005714
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.019903559719005714
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.019903559719005714
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.019903559719005714
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.019903559719005714
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.019903559719005714
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.019903559719005714
PHENYLKETONURIA	0.000541419	0.019903559719005714
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.019903559719005714
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.019903559719005714
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.019903559719005714
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.019903559719005714
BARAITSER-WINTER SYNDROME 2; BRWS2	0.000541419	0.019903559719005714
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.019903559719005714
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.019903559719005714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.000541419	0.019903559719005714
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.019903559719005714
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.019903559719005714
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.019903559719005714
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.019903559719005714
SNEDDON SYNDROME	0.000541419	0.019903559719005714
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.019903559719005714
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.019903559719005714
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.019903559719005714
STURGE-WEBER SYNDROME	0.000541419	0.019903559719005714
RAMON SYNDROME	0.000541419	0.019903559719005714
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.019903559719005714
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.019903559719005714
CRANIOSYNOSTOSIS 2	0.000541419	0.019903559719005714
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.019903559719005714
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.019903559719005714
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.000541419	0.019903559719005714
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.019903559719005714
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.019903559719005714
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.019903559719005714
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.019903559719005714
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.019903559719005714
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.019903559719005714
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.019903559719005714
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.019903559719005714
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.019903559719005714
CRYPTOCOCCOSIS	0.000541419	0.019903559719005714
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.019903559719005714
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.019903559719005714
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.019903559719005714
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.019903559719005714
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.019903559719005714
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.019903559719005714
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.019903559719005714
NOCARDIOSIS	0.000541419	0.019903559719005714
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.019903559719005714
MOGS-CDG	0.000541419	0.019903559719005714
20P13 MICRODELETION SYNDROME	0.000541419	0.019903559719005714
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.019903559719005714
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.019903559719005714
ALG2-CDG	0.000541419	0.019903559719005714
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.019903559719005714
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.019903559719005714
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.019903559719005714
AUTISM	0.000541419	0.019903559719005714
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.019903559719005714
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.000541419	0.019903559719005714
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.019903559719005714
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.019903559719005714
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.019903559719005714
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.019903559719005714
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.019903559719005714
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.019903559719005714
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.019903559719005714
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.019903559719005714
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.019903559719005714
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.019903559719005714
ROSAÏ-DORFMAN DISEASE	0.000541419	0.019903559719005714
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.019903559719005714
NASU-HAKOLA DISEASE	0.000541419	0.019903559719005714
ENCEPHALITIS LETHARGICA	0.000541419	0.019903559719005714
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.019903559719005714
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.019903559719005714
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.019903559719005714
SCRUB TYPHUS	0.000541419	0.019903559719005714
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.019903559719005714
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.019903559719005714
COWDEN SYNDROME 5; CWS5	0.000541419	0.019903559719005714
SNEDDON SYNDROME	0.000541419	0.019903559719005714
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.019903559719005714
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.019903559719005714
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.019903559719005714
COWDEN SYNDROME 6; CWS6	0.000541419	0.019903559719005714
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.019903559719005714
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.019903559719005714
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.019903559719005714
47,XYY SYNDROME	0.000541419	0.019903559719005714
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.019903559719005714
